MIME-Version: 1.0
Content-Type: multipart/related; boundary="----=_NextPart_01D75BBF.AB96D8F0"

This document is a Single File Web Page, also known as a Web Archive file.  If you are seeing this message, your browser or editor doesn't support Web Archive files.  Please download a browser that supports Web Archive.

------=_NextPart_01D75BBF.AB96D8F0
Content-Location: file:///C:/C467A08E/Ovaleap_clean.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1252"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:dt=3D"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns:st1=3D"urn:schemas-microsoft-com:office:smarttags"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
2">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 15">
<meta name=3DOriginator content=3D"Microsoft Word 15">
<link rel=3DFile-List href=3D"Ovaleap_clean_files/filelist.xml">
<title>Ovaleap, INN-follitropin alfa</title>
<o:SmartTagType namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"metricconverter"/>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Subject>EPAR</o:Subject>
  <o:Author>CHMP</o:Author>
  <o:Keywords>Ovaleap, INN-follitropin alfa</o:Keywords>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Manish Kumar</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>0</o:TotalTime>
  <o:LastPrinted>2012-12-18T08:23:00Z</o:LastPrinted>
  <o:Created>2021-06-07T11:38:00Z</o:Created>
  <o:LastSaved>2021-06-07T11:38:00Z</o:LastSaved>
  <o:Pages>1</o:Pages>
  <o:Words>10336</o:Words>
  <o:Characters>58916</o:Characters>
  <o:Company>PharmaLex GmbH</o:Company>
  <o:Lines>490</o:Lines>
  <o:Paragraphs>138</o:Paragraphs>
  <o:CharactersWithSpaces>69114</o:CharactersWithSpaces>
  <o:Version>16.00</o:Version>
 </o:DocumentProperties>
 <o:CustomDocumentProperties>
  <o:DM_Status dt:dt=3D"string"></o:DM_Status>
  <o:DM_Authors dt:dt=3D"string"></o:DM_Authors>
  <o:DM_Keywords dt:dt=3D"string"></o:DM_Keywords>
  <o:DM_Subject dt:dt=3D"string">General-EMA/423415/2010</o:DM_Subject>
  <o:DM_Title dt:dt=3D"string"></o:DM_Title>
  <o:DM_Language dt:dt=3D"string"></o:DM_Language>
  <o:DM_Owner dt:dt=3D"string">Espinasse Claire</o:DM_Owner>
  <o:DM_emea_cc dt:dt=3D"string"></o:DM_emea_cc>
  <o:DM_emea_message_subject dt:dt=3D"string"></o:DM_emea_message_subject>
  <o:DM_emea_doc_number dt:dt=3D"string">423415</o:DM_emea_doc_number>
  <o:DM_emea_received_date dt:dt=3D"string">nulldate</o:DM_emea_received_da=
te>
  <o:DM_emea_resp_body dt:dt=3D"string"></o:DM_emea_resp_body>
  <o:DM_emea_revision_label dt:dt=3D"string"></o:DM_emea_revision_label>
  <o:DM_emea_to dt:dt=3D"string"></o:DM_emea_to>
  <o:DM_emea_bcc dt:dt=3D"string"></o:DM_emea_bcc>
  <o:DM_emea_doc_category dt:dt=3D"string">General</o:DM_emea_doc_category>
  <o:DM_emea_from dt:dt=3D"string"></o:DM_emea_from>
  <o:DM_emea_internal_label dt:dt=3D"string">EMA</o:DM_emea_internal_label>
  <o:DM_emea_legal_date dt:dt=3D"string">nulldate</o:DM_emea_legal_date>
  <o:DM_emea_year dt:dt=3D"string">2010</o:DM_emea_year>
  <o:DM_emea_sent_date dt:dt=3D"string">nulldate</o:DM_emea_sent_date>
  <o:DM_emea_doc_lang dt:dt=3D"string"></o:DM_emea_doc_lang>
  <o:DM_emea_meeting_status dt:dt=3D"string"></o:DM_emea_meeting_status>
  <o:DM_emea_meeting_action dt:dt=3D"string"></o:DM_emea_meeting_action>
  <o:DM_emea_meeting_hyperlink dt:dt=3D"string"></o:DM_emea_meeting_hyperli=
nk>
  <o:DM_emea_meeting_title dt:dt=3D"string"></o:DM_emea_meeting_title>
  <o:DM_emea_meeting_ref dt:dt=3D"string"></o:DM_emea_meeting_ref>
  <o:DM_emea_meeting_flags dt:dt=3D"string"></o:DM_emea_meeting_flags>
  <o:DM_Version dt:dt=3D"string">CURRENT,1.1</o:DM_Version>
  <o:DM_Name dt:dt=3D"string">Hqrdtemplatecleanen</o:DM_Name>
  <o:DM_Creation_Date dt:dt=3D"string">13/07/2011 15:43:34</o:DM_Creation_D=
ate>
  <o:DM_Modify_Date dt:dt=3D"string">13/07/2011 15:43:34</o:DM_Modify_Date>
  <o:DM_Creator_Name dt:dt=3D"string">Espinasse Claire</o:DM_Creator_Name>
  <o:DM_Modifier_Name dt:dt=3D"string">Espinasse Claire</o:DM_Modifier_Name>
  <o:DM_Type dt:dt=3D"string">emea_document</o:DM_Type>
  <o:DM_DocRefId dt:dt=3D"string">EMA/555113/2011</o:DM_DocRefId>
  <o:DM_Category dt:dt=3D"string">Product Information</o:DM_Category>
  <o:DM_Path dt:dt=3D"string">/13. Projects/02-004-00014-PIM Implementation=
/Implementation/DES 2.8 Construction/QRD Template</o:DM_Path>
  <o:DM_emea_doc_ref_id dt:dt=3D"string">EMA/555113/2011</o:DM_emea_doc_ref=
_id>
  <o:DM_Modifer_Name dt:dt=3D"string">Espinasse Claire</o:DM_Modifer_Name>
  <o:DM_Modified_Date dt:dt=3D"string">13/07/2011 15:43:34</o:DM_Modified_D=
ate>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Enabled dt:dt=3D"strin=
g">true</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Enabled>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_SetDate dt:dt=3D"strin=
g">2021-05-18T11:50:03Z</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_=
SetDate>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Method dt:dt=3D"string=
">Standard</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Method>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Name dt:dt=3D"string">=
0eea11ca-d417-4147-80ed-01a58412c458</o:MSIP_Label_0eea11ca-d417-4147-80ed-=
01a58412c458_Name>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_SiteId dt:dt=3D"string=
">bc9dc15c-61bc-4f03-b60b-e5b6d8922839</o:MSIP_Label_0eea11ca-d417-4147-80e=
d-01a58412c458_SiteId>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_ActionId dt:dt=3D"stri=
ng">5be76445-1216-4d34-a35f-a6a72c3aada7</o:MSIP_Label_0eea11ca-d417-4147-8=
0ed-01a58412c458_ActionId>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_ContentBits dt:dt=3D"s=
tring">2</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_ContentBits>
  <o:ContentTypeId dt:dt=3D"string">0x010100726F91DD1AE57B44B1BCEB7F1056F5D=
0</o:ContentTypeId>
 </o:CustomDocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=3DdataStoreItem href=3D"Ovaleap_clean_files/item0001.xml"
target=3D"Ovaleap_clean_files/props002.xml">
<link rel=3DdataStoreItem href=3D"Ovaleap_clean_files/item0003.xml"
target=3D"Ovaleap_clean_files/props004.xml">
<link rel=3DdataStoreItem href=3D"Ovaleap_clean_files/item0005.xml"
target=3D"Ovaleap_clean_files/props006.xml">
<link rel=3DthemeData href=3D"Ovaleap_clean_files/themedata.thmx">
<link rel=3DcolorSchemeMapping href=3D"Ovaleap_clean_files/colorschememappi=
ng.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves/>
  <w:TrackFormatting/>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:DisplayHorizontalDrawingGridEvery>0</w:DisplayHorizontalDrawingGridEve=
ry>
  <w:DisplayVerticalDrawingGridEvery>0</w:DisplayVerticalDrawingGridEvery>
  <w:UseMarginsForDrawingGridOrigin/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>ES</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>AR-SA</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
   <w:UseFELayout/>
  </w:Compatibility>
  <w:DocumentVariables>
   <w:Registered>-1</w:Registered>
   <w:Version>0</w:Version>
  </w:DocumentVariables>
  <m:mathPr>
   <m:mathFont m:val=3D"Cambria Math"/>
   <m:brkBin m:val=3D"before"/>
   <m:brkBinSub m:val=3D"&#45;-"/>
   <m:smallFrac m:val=3D"off"/>
   <m:dispDef/>
   <m:lMargin m:val=3D"0"/>
   <m:rMargin m:val=3D"0"/>
   <m:defJc m:val=3D"centerGroup"/>
   <m:wrapIndent m:val=3D"1440"/>
   <m:intLim m:val=3D"subSup"/>
   <m:naryLim m:val=3D"undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState=3D"false" DefUnhideWhenUsed=3D"false"
  DefSemiHidden=3D"false" DefQFormat=3D"false" DefPriority=3D"99"
  LatentStyleCount=3D"376">
  <w:LsdException Locked=3D"false" Priority=3D"0" QFormat=3D"true" Name=3D"=
Normal"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 9"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 9"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"footnote text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"annotation text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"header"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"footer"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index heading"/>
  <w:LsdException Locked=3D"false" Priority=3D"35" QFormat=3D"true" Name=3D=
"caption"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"table of figures"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"envelope address"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"envelope return"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"footnote reference"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"annotation reference"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"line number"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"page number"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"endnote reference"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"endnote text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"table of authorities"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"macro"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toa heading"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"10" QFormat=3D"true" Name=3D=
"Title"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Closing"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Signature"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Default Paragraph Font"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Message Header"/>
  <w:LsdException Locked=3D"false" Priority=3D"11" QFormat=3D"true" Name=3D=
"Subtitle"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Salutation"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Date"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text First Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text First Indent 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Note Heading"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Block Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Hyperlink"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"FollowedHyperlink"/>
  <w:LsdException Locked=3D"false" Priority=3D"22" QFormat=3D"true" Name=3D=
"Strong"/>
  <w:LsdException Locked=3D"false" Priority=3D"20" QFormat=3D"true" Name=3D=
"Emphasis"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Document Map"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Plain Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"E-mail Signature"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Top of Form"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Bottom of Form"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal (Web)"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Acronym"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Address"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Cite"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Code"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Definition"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Keyboard"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Preformatted"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Sample"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Typewriter"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Variable"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal Table"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"annotation subject"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"No List"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Contemporary"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Elegant"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Professional"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Subtle 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Subtle 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Balloon Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"59" Name=3D"Table Grid"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Theme"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" Name=3D"Placeholder =
Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" QFormat=3D"true" Name=3D"=
No Spacing"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" Name=3D"Revision"/>
  <w:LsdException Locked=3D"false" Priority=3D"34" QFormat=3D"true"
   Name=3D"List Paragraph"/>
  <w:LsdException Locked=3D"false" Priority=3D"29" QFormat=3D"true" Name=3D=
"Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"30" QFormat=3D"true"
   Name=3D"Intense Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"19" QFormat=3D"true"
   Name=3D"Subtle Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"21" QFormat=3D"true"
   Name=3D"Intense Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"31" QFormat=3D"true"
   Name=3D"Subtle Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"32" QFormat=3D"true"
   Name=3D"Intense Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"33" QFormat=3D"true" Name=3D=
"Book Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"37" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Bibliography"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"TOC Heading"/>
  <w:LsdException Locked=3D"false" Priority=3D"41" Name=3D"Plain Table 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"42" Name=3D"Plain Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"43" Name=3D"Plain Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"44" Name=3D"Plain Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"45" Name=3D"Plain Table 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"40" Name=3D"Grid Table Light=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"46" Name=3D"Grid Table 1 Lig=
ht"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k"/>
  <w:LsdException Locked=3D"false" Priority=3D"51" Name=3D"Grid Table 6 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"52" Name=3D"Grid Table 7 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"46" Name=3D"List Table 1 Lig=
ht"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k"/>
  <w:LsdException Locked=3D"false" Priority=3D"51" Name=3D"List Table 6 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"52" Name=3D"List Table 7 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Mention"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Smart Hyperlink"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Hashtag"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Unresolved Mention"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Smart Link"/>
 </w:LatentStyles>
</xml><![endif]--><!--[if !mso]><object
 classid=3D"clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=3Dieooui></objec=
t>
<style>
st1\:*{behavior:url(#ieooui) }
</style>
<![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;
	mso-font-alt:"MS Mincho";
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-alt:\5B8B\4F53;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 680460288 22 0 262145 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536869121 1107305727 33554432 0 415 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073732485 9 0 511 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610610945 1073750107 16 0 415 0;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536869121 1107305727 33554432 0 415 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520081665 -1073717157 41 0 66047 0;}
@font-face
	{font-family:"\@SimSun";
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 680460288 22 0 262145 0;}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
h1
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 1 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	tab-stops:28.35pt;
	font-size:16.0pt;
	font-family:"Arial",sans-serif;
	mso-font-kerning:16.0pt;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
h2
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 2 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:28.35pt;
	font-size:14.0pt;
	font-family:"Arial",sans-serif;
	mso-ansi-language:EN-GB;
	font-weight:bold;
	font-style:italic;}
h3
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 3 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	tab-stops:28.35pt;
	font-size:13.0pt;
	font-family:"Arial",sans-serif;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
h4
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 4 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	tab-stops:28.35pt;
	font-size:14.0pt;
	font-family:"Times New Roman",serif;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
h5
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 5 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:5;
	tab-stops:28.35pt;
	font-size:13.0pt;
	font-family:"Times New Roman",serif;
	mso-ansi-language:EN-GB;
	font-weight:bold;
	font-style:italic;}
h6
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 6 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:6;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 7 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:7;
	tab-stops:28.35pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 8 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:8;
	tab-stops:28.35pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	font-style:italic;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 9 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:9;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoIndex1, li.MsoIndex1, div.MsoIndex1
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:11.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoIndex2, li.MsoIndex2, div.MsoIndex2
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:22.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoIndex3, li.MsoIndex3, div.MsoIndex3
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:33.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoIndex4, li.MsoIndex4, div.MsoIndex4
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:44.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoIndex5, li.MsoIndex5, div.MsoIndex5
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:55.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoIndex6, li.MsoIndex6, div.MsoIndex6
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:66.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoIndex7, li.MsoIndex7, div.MsoIndex7
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:77.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoIndex8, li.MsoIndex8, div.MsoIndex8
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:88.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoIndex9, li.MsoIndex9, div.MsoIndex9
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:99.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoToc1, li.MsoToc1, div.MsoToc1
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoToc2, li.MsoToc2, div.MsoToc2
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoToc3, li.MsoToc3, div.MsoToc3
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:22.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoToc4, li.MsoToc4, div.MsoToc4
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:33.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoToc5, li.MsoToc5, div.MsoToc5
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:44.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoToc6, li.MsoToc6, div.MsoToc6
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:55.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoToc7, li.MsoToc7, div.MsoToc7
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:66.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoToc8, li.MsoToc8, div.MsoToc8
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:77.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoToc9, li.MsoToc9, div.MsoToc9
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:88.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoNormalIndent, li.MsoNormalIndent, div.MsoNormalIndent
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:35.4pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Footnote Text Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Comment Text Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Header Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt center 207.65pt right 415.3pt;
	font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Footer Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt center 3.15in right 415.3pt;
	font-size:8.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-no-proof:yes;}
p.MsoIndexHeading, li.MsoIndexHeading, div.MsoIndexHeading
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:"Index 1";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
p.MsoTof, li.MsoTof, div.MsoTof
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoEnvelopeAddress, li.MsoEnvelopeAddress, div.MsoEnvelopeAddress
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.05pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	mso-element:frame;
	mso-element-frame-width:3.0in;
	mso-element-frame-height:1.5in;
	mso-element-frame-hspace:7.05pt;
	mso-element-wrap:auto;
	mso-element-anchor-horizontal:page;
	mso-element-left:center;
	mso-element-top:bottom;
	mso-height-rule:exactly;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoEnvelopeReturn, li.MsoEnvelopeReturn, div.MsoEnvelopeReturn
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
span.MsoCommentReference
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-ansi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	font-family:"Times New Roman",serif;
	mso-bidi-font-family:"Times New Roman";}
p.MsoEndnoteText, li.MsoEndnoteText, div.MsoEndnoteText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Endnote Text Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoToa, li.MsoToa, div.MsoToa
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:11.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoMacroText, li.MsoMacroText, div.MsoMacroText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-link:"Macro Text Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:24.0pt 48.0pt 1.0in 96.0pt 120.0pt 2.0in 168.0pt 192.0pt 3.0in;
	font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoToaHeading, li.MsoToaHeading, div.MsoToaHeading
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
p.MsoList, li.MsoList, div.MsoList
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:14.15pt;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoListBullet, li.MsoListBullet, div.MsoListBullet
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l9 level1 lfo14;
	tab-stops:list .25in left 28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoListNumber, li.MsoListNumber, div.MsoListNumber
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l8 level1 lfo19;
	tab-stops:list .25in left 28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoList2, li.MsoList2, div.MsoList2
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoList3, li.MsoList3, div.MsoList3
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoList4, li.MsoList4, div.MsoList4
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoList5, li.MsoList5, div.MsoList5
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoListBullet2, li.MsoListBullet2, div.MsoListBullet2
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l7 level1 lfo15;
	tab-stops:28.35pt list 32.15pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoListBullet3, li.MsoListBullet3, div.MsoListBullet3
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l6 level1 lfo16;
	tab-stops:28.35pt list 46.3pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoListBullet4, li.MsoListBullet4, div.MsoListBullet4
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l5 level1 lfo17;
	tab-stops:28.35pt list 60.45pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoListBullet5, li.MsoListBullet5, div.MsoListBullet5
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l4 level1 lfo18;
	tab-stops:28.35pt list 74.6pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoListNumber2, li.MsoListNumber2, div.MsoListNumber2
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l3 level1 lfo20;
	tab-stops:28.35pt list 32.15pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoListNumber3, li.MsoListNumber3, div.MsoListNumber3
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l2 level1 lfo21;
	tab-stops:28.35pt list 46.3pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoListNumber4, li.MsoListNumber4, div.MsoListNumber4
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l1 level1 lfo22;
	tab-stops:28.35pt list 60.45pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoListNumber5, li.MsoListNumber5, div.MsoListNumber5
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l0 level1 lfo23;
	tab-stops:28.35pt list 74.6pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Title Char";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	tab-stops:28.35pt;
	font-size:16.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-font-kerning:14.0pt;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
p.MsoClosing, li.MsoClosing, div.MsoClosing
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Closing Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:212.6pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoSignature, li.MsoSignature, div.MsoSignature
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Signature Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:212.6pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Body Text Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	color:green;
	mso-ansi-language:EN-GB;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Body Text Indent Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoListContinue, li.MsoListContinue, div.MsoListContinue
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoListContinue2, li.MsoListContinue2, div.MsoListContinue2
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:28.3pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoListContinue3, li.MsoListContinue3, div.MsoListContinue3
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:42.45pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoListContinue4, li.MsoListContinue4, div.MsoListContinue4
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:56.6pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoListContinue5, li.MsoListContinue5, div.MsoListContinue5
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:70.75pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoMessageHeader, li.MsoMessageHeader, div.MsoMessageHeader
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Message Header Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-indent:-56.7pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	background:#CCCCCC;
	mso-shading:windowtext;
	mso-pattern:gray-20 auto;
	border:none;
	mso-border-alt:solid windowtext .75pt;
	padding:0in;
	mso-padding-alt:1.0pt 1.0pt 1.0pt 1.0pt;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoSubtitle, li.MsoSubtitle, div.MsoSubtitle
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Subtitle Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	mso-outline-level:2;
	tab-stops:28.35pt;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoSalutation, li.MsoSalutation, div.MsoSalutation
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Salutation Char";
	mso-style-next:Normal;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoDate, li.MsoDate, div.MsoDate
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Date Char";
	mso-style-next:Normal;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoBodyTextFirstIndent, li.MsoBodyTextFirstIndent, div.MsoBodyTextFirstIn=
dent
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"Body Text";
	mso-style-link:"Body Text First Indent Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-indent:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoBodyTextFirstIndent2, li.MsoBodyTextFirstIndent2, div.MsoBodyTextFirst=
Indent2
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"Body Text Indent";
	mso-style-link:"Body Text First Indent 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	text-indent:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoNoteHeading, li.MsoNoteHeading, div.MsoNoteHeading
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Note Heading Char";
	mso-style-next:Normal;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Body Text 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:200%;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Body Text 3 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Body Text Indent 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	line-height:200%;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Body Text Indent 3 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoBlockText, li.MsoBlockText, div.MsoBlockText
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:6.0pt;
	margin-left:1.0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	color:purple;
	text-decoration:underline;
	text-underline:single;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Document Map Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	background:navy;
	font-size:10.0pt;
	font-family:"Tahoma",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Plain Text Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoAutoSig, li.MsoAutoSig, div.MsoAutoSig
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"E-mail Signature Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
address
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"HTML Address Char";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-ansi-language:EN-GB;
	font-style:italic;}
pre
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"HTML Preformatted Char";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"Comment Text";
	mso-style-link:"Comment Subject Char";
	mso-style-next:"Comment Text";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Balloon Text Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing
	{mso-style-priority:1;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoRMPane, li.MsoRMPane, div.MsoRMPane
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParag=
raphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListPar=
agraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagra=
phCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoQuote, li.MsoQuote, div.MsoQuote
	{mso-style-priority:29;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Quote Char";
	mso-style-next:Normal;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	color:black;
	mso-themecolor:text1;
	mso-ansi-language:EN-GB;
	font-style:italic;}
p.MsoIntenseQuote, li.MsoIntenseQuote, div.MsoIntenseQuote
	{mso-style-priority:30;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Intense Quote Char";
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:.65in;
	margin-bottom:14.0pt;
	margin-left:.65in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	border:none;
	mso-border-bottom-alt:solid #4F81BD .5pt;
	mso-border-bottom-themecolor:accent1;
	padding:0in;
	mso-padding-alt:0in 0in 4.0pt 0in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	color:#4F81BD;
	mso-themecolor:accent1;
	mso-ansi-language:EN-GB;
	font-weight:bold;
	font-style:italic;}
p.MsoBibliography, li.MsoBibliography, div.MsoBibliography
	{mso-style-noshow:yes;
	mso-style-priority:37;
	mso-style-next:Normal;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.MsoTocHeading, li.MsoTocHeading, div.MsoTocHeading
	{mso-style-noshow:yes;
	mso-style-priority:39;
	mso-style-qformat:yes;
	mso-style-parent:"Heading 1";
	mso-style-next:Normal;
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	tab-stops:28.35pt;
	font-size:14.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 1";
	mso-ansi-font-size:16.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:SimSun;
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:16.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 2";
	mso-ansi-font-size:14.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:SimSun;
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;
	font-style:italic;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 3";
	mso-ansi-font-size:13.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:SimSun;
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;}
span.Heading4Char
	{mso-style-name:"Heading 4 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 4";
	mso-ansi-font-size:14.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:SimSun;
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:Arial;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;}
span.Heading5Char
	{mso-style-name:"Heading 5 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 5";
	mso-ansi-font-size:13.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:SimSun;
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:Arial;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;
	font-style:italic;}
span.Heading6Char
	{mso-style-name:"Heading 6 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 6";
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:SimSun;
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:Arial;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;}
span.Heading7Char
	{mso-style-name:"Heading 7 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 7";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:SimSun;
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:Arial;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.Heading8Char
	{mso-style-name:"Heading 8 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 8";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:SimSun;
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:Arial;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-style:italic;}
span.Heading9Char
	{mso-style-name:"Heading 9 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 9";
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:SimSun;
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Footer;
	mso-bidi-font-size:10.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Header;
	mso-bidi-font-size:10.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MemoHeaderStyle, li.MemoHeaderStyle, div.MemoHeaderStyle
	{mso-style-name:MemoHeaderStyle;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.9pt;
	text-align:justify;
	text-justify:inter-ideograph;
	mso-line-height-alt:6.0pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-bidi-font-family:"Times New Roman";
	font-variant:small-caps;
	mso-ansi-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
span.BodyTextChar
	{mso-style-name:"Body Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body Text";
	mso-bidi-font-size:10.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.EMEAEnBodyText, li.EMEAEnBodyText, div.EMEAEnBodyText
	{mso-style-name:"EMEA En Body Text";
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:justify;
	text-justify:inter-ideograph;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-US;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Balloon Text";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:"Tahoma",sans-serif;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.BodytextAgency, li.BodytextAgency, div.BodytextAgency
	{mso-style-name:"Body text \(Agency\)";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Body text \(Agency\) Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
span.BodytextAgencyChar
	{mso-style-name:"Body text \(Agency\) Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body text \(Agency\)";
	mso-ansi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
p.DraftingNotesAgency, li.DraftingNotesAgency, div.DraftingNotesAgency
	{mso-style-name:"Drafting Notes \(Agency\)";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Drafting Notes \(Agency\) Char";
	mso-style-next:"Body text \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#339966;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	font-style:italic;
	mso-bidi-font-style:normal;}
span.DraftingNotesAgencyChar
	{mso-style-name:"Drafting Notes \(Agency\) Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Drafting Notes \(Agency\)";
	mso-ansi-font-size:9.0pt;
	font-family:"Courier New";
	mso-ascii-font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Courier New";
	color:#339966;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.NormalAgency, li.NormalAgency, div.NormalAgency
	{mso-style-name:"Normal \(Agency\)";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-link:"Normal \(Agency\) Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
p.TableheadingrowsAgency, li.TableheadingrowsAgency, div.TableheadingrowsAg=
ency
	{mso-style-name:"Table heading rows \(Agency\)";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"Body text \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	tab-stops:.5in;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.TabletextrowsAgency, li.TabletextrowsAgency, div.TabletextrowsAgency
	{mso-style-name:"Table text rows \(Agency\)";
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	line-height:14.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:ZH-CN;}
span.NormalAgencyChar
	{mso-style-name:"Normal \(Agency\) Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Normal \(Agency\)";
	mso-ansi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
p.TitleA, li.TitleA, div.TitleA
	{mso-style-name:"Title A";
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	tab-stops:-1.0in -.5in 28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;
	mso-no-proof:yes;}
p.TitleB, li.TitleB, div.TitleB
	{mso-style-name:"Title B";
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-indent:-28.35pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;
	mso-no-proof:yes;}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Comment Subject";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Comment Text";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.berarbeitung1, li.berarbeitung1, div.berarbeitung1
	{mso-style-name:berarbeitung1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.berarbeitung2, li.berarbeitung2, div.berarbeitung2
	{mso-style-name:berarbeitung2;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
span.SalutationChar
	{mso-style-name:"Salutation Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Salutation;
	mso-bidi-font-size:10.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.DateChar
	{mso-style-name:"Date Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Date;
	mso-bidi-font-size:10.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.DocumentMapChar
	{mso-style-name:"Document Map Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Document Map";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:"Tahoma",sans-serif;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.E-mailSignatureChar
	{mso-style-name:"E-mail Signature Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"E-mail Signature";
	mso-bidi-font-size:10.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.EndnoteTextChar
	{mso-style-name:"Endnote Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Endnote Text";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.NoteHeadingChar
	{mso-style-name:"Note Heading Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Note Heading";
	mso-bidi-font-size:10.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.FootnoteTextChar
	{mso-style-name:"Footnote Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Footnote Text";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.ClosingChar
	{mso-style-name:"Closing Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Closing;
	mso-bidi-font-size:10.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.HTMLAddressChar
	{mso-style-name:"HTML Address Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"HTML Address";
	mso-bidi-font-size:10.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-style:italic;}
span.HTMLPreformattedChar
	{mso-style-name:"HTML Preformatted Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"HTML Preformatted";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-ascii-font-family:"Courier New";
	mso-hansi-font-family:"Courier New";
	mso-bidi-font-family:"Courier New";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.MacroTextChar
	{mso-style-name:"Macro Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Macro Text";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-ascii-font-family:"Courier New";
	mso-hansi-font-family:"Courier New";
	mso-bidi-font-family:"Courier New";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.MessageHeaderChar
	{mso-style-name:"Message Header Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Message Header";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:SimSun;
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	background:#CCCCCC;
	mso-shading:windowtext;
	mso-pattern:gray-20 auto;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.PlainTextChar
	{mso-style-name:"Plain Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Plain Text";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Courier New";
	mso-ascii-font-family:"Courier New";
	mso-hansi-font-family:"Courier New";
	mso-bidi-font-family:"Courier New";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.BodyText2Char
	{mso-style-name:"Body Text 2 Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body Text 2";
	mso-bidi-font-size:10.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.BodyText3Char
	{mso-style-name:"Body Text 3 Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body Text 3";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.BodyTextIndent2Char
	{mso-style-name:"Body Text Indent 2 Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body Text Indent 2";
	mso-bidi-font-size:10.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.BodyTextIndent3Char
	{mso-style-name:"Body Text Indent 3 Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body Text Indent 3";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.BodyTextFirstIndentChar
	{mso-style-name:"Body Text First Indent Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body Text First Indent";}
span.BodyTextIndentChar
	{mso-style-name:"Body Text Indent Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body Text Indent";
	mso-bidi-font-size:10.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.BodyTextFirstIndent2Char
	{mso-style-name:"Body Text First Indent 2 Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body Text First Indent 2";}
span.TitleChar
	{mso-style-name:"Title Char";
	mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Title;
	mso-ansi-font-size:16.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:SimSun;
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:14.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;}
span.SignatureChar
	{mso-style-name:"Signature Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Signature;
	mso-bidi-font-size:10.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.SubtitleChar
	{mso-style-name:"Subtitle Char";
	mso-style-priority:11;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Subtitle;
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:SimSun;
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.Inhaltsverzeichnisberschrift1, li.Inhaltsverzeichnisberschrift1, div.Inha=
ltsverzeichnisberschrift1
	{mso-style-name:Inhaltsverzeichnisberschrift1;
	mso-style-noshow:yes;
	mso-style-priority:39;
	mso-style-qformat:yes;
	mso-style-parent:"Heading 1";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	tab-stops:28.35pt;
	font-size:16.0pt;
	font-family:"Cambria",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:16.0pt;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
p.IntensivesZitat1, li.IntensivesZitat1, div.IntensivesZitat1
	{mso-style-name:"Intensives Zitat1";
	mso-style-priority:30;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Intensives Zitat Zchn";
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:.65in;
	margin-bottom:14.0pt;
	margin-left:.65in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	border:none;
	mso-border-bottom-alt:solid #4F81BD .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 4.0pt 0in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	color:#4F81BD;
	mso-ansi-language:EN-GB;
	font-weight:bold;
	font-style:italic;}
span.IntensivesZitatZchn
	{mso-style-name:"Intensives Zitat Zchn";
	mso-style-priority:30;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Intensives Zitat1";
	mso-ansi-font-size:11.0pt;
	color:#4F81BD;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;
	font-style:italic;}
p.KeinLeerraum1, li.KeinLeerraum1, div.KeinLeerraum1
	{mso-style-name:"Kein Leerraum1";
	mso-style-priority:1;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.Listenabsatz1, li.Listenabsatz1, div.Listenabsatz1
	{mso-style-name:Listenabsatz1;
	mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:35.4pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.Literaturverzeichnis1, li.Literaturverzeichnis1, div.Literaturverzeichnis1
	{mso-style-name:Literaturverzeichnis1;
	mso-style-noshow:yes;
	mso-style-priority:37;
	mso-style-next:Normal;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;}
p.Zitat1, li.Zitat1, div.Zitat1
	{mso-style-name:Zitat1;
	mso-style-priority:29;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Zitat Zchn";
	mso-style-next:Normal;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	color:black;
	mso-ansi-language:EN-GB;
	font-style:italic;}
span.ZitatZchn
	{mso-style-name:"Zitat Zchn";
	mso-style-priority:29;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Zitat1;
	mso-ansi-font-size:11.0pt;
	color:black;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-style:italic;}
span.IntenseQuoteChar
	{mso-style-name:"Intense Quote Char";
	mso-style-priority:30;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Intense Quote";
	mso-ansi-font-size:11.0pt;
	color:#4F81BD;
	mso-themecolor:accent1;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;
	font-style:italic;}
span.QuoteChar
	{mso-style-name:"Quote Char";
	mso-style-priority:29;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Quote;
	mso-ansi-font-size:11.0pt;
	color:black;
	mso-themecolor:text1;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-style:italic;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-size:10.0pt;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:DE;
	mso-fareast-language:DE;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("Ovaleap_clean_files/header.htm") fs;
	mso-footnote-continuation-separator:url("Ovaleap_clean_files/header.htm") =
fcs;
	mso-endnote-separator:url("Ovaleap_clean_files/header.htm") es;
	mso-endnote-continuation-separator:url("Ovaleap_clean_files/header.htm") e=
cs;
	mso-endnote-numbering-style:arabic;}
@page WordSection1
	{size:595.35pt 842.0pt;
	margin:56.7pt 70.9pt 56.7pt 70.9pt;
	mso-header-margin:36.85pt;
	mso-footer-margin:36.85pt;
	mso-title-page:yes;
	mso-footer:url("Ovaleap_clean_files/header.htm") f1;
	mso-first-footer:url("Ovaleap_clean_files/header.htm") ff1;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;
	mso-endnote-numbering-style:arabic;}
 /* List Definitions */
 @list l0
	{mso-list-id:-132;
	mso-list-type:simple;
	mso-list-template-ids:309228354;}
@list l0:level1
	{mso-level-style-link:"List Number 5";
	mso-level-tab-stop:74.6pt;
	mso-level-number-position:left;
	margin-left:74.6pt;
	text-indent:-.25in;
	mso-bidi-font-family:"Times New Roman";}
@list l1
	{mso-list-id:-131;
	mso-list-type:simple;
	mso-list-template-ids:-1843613426;}
@list l1:level1
	{mso-level-style-link:"List Number 4";
	mso-level-tab-stop:60.45pt;
	mso-level-number-position:left;
	margin-left:60.45pt;
	text-indent:-.25in;
	mso-bidi-font-family:"Times New Roman";}
@list l2
	{mso-list-id:-130;
	mso-list-type:simple;
	mso-list-template-ids:-2090820862;}
@list l2:level1
	{mso-level-style-link:"List Number 3";
	mso-level-tab-stop:46.3pt;
	mso-level-number-position:left;
	margin-left:46.3pt;
	text-indent:-.25in;
	mso-bidi-font-family:"Times New Roman";}
@list l3
	{mso-list-id:-129;
	mso-list-type:simple;
	mso-list-template-ids:1995611574;}
@list l3:level1
	{mso-level-style-link:"List Number 2";
	mso-level-tab-stop:32.15pt;
	mso-level-number-position:left;
	margin-left:32.15pt;
	text-indent:-.25in;
	mso-bidi-font-family:"Times New Roman";}
@list l4
	{mso-list-id:-128;
	mso-list-type:simple;
	mso-list-template-ids:-534094090;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet 5";
	mso-level-text:\F0B7;
	mso-level-tab-stop:74.6pt;
	mso-level-number-position:left;
	margin-left:74.6pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l5
	{mso-list-id:-127;
	mso-list-type:simple;
	mso-list-template-ids:38569508;}
@list l5:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet 4";
	mso-level-text:\F0B7;
	mso-level-tab-stop:60.45pt;
	mso-level-number-position:left;
	margin-left:60.45pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l6
	{mso-list-id:-126;
	mso-list-type:simple;
	mso-list-template-ids:-1109255184;}
@list l6:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet 3";
	mso-level-text:\F0B7;
	mso-level-tab-stop:46.3pt;
	mso-level-number-position:left;
	margin-left:46.3pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l7
	{mso-list-id:-125;
	mso-list-type:simple;
	mso-list-template-ids:985833952;}
@list l7:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet 2";
	mso-level-text:\F0B7;
	mso-level-tab-stop:32.15pt;
	mso-level-number-position:left;
	margin-left:32.15pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l8
	{mso-list-id:-120;
	mso-list-type:simple;
	mso-list-template-ids:-1091297798;}
@list l8:level1
	{mso-level-style-link:"List Number";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	mso-bidi-font-family:"Times New Roman";}
@list l9
	{mso-list-id:-119;
	mso-list-type:simple;
	mso-list-template-ids:-1949918924;}
@list l9:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet";
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l10
	{mso-list-id:-2;
	mso-list-type:simple;
	mso-list-template-ids:-1;}
@list l10:level1
	{mso-level-start-at:0;
	mso-level-text:*;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;
	mso-bidi-font-family:"Times New Roman";}
@list l11
	{mso-list-id:592786408;
	mso-list-type:hybrid;
	mso-list-template-ids:-2049810264 67567617 67567619 67567621 67567617 6756=
7619 67567621 67567617 67567619 67567621;}
@list l11:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l11:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l11:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l11:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l11:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l11:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l11:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l11:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l11:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l12
	{mso-list-id:639768276;
	mso-list-type:hybrid;
	mso-list-template-ids:1038792534 67567617 67567619 67567621 67567617 67567=
619 67567621 67567617 67567619 67567621;}
@list l12:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l12:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l12:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l12:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l12:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l12:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l12:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l12:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l12:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l13
	{mso-list-id:1065109409;
	mso-list-type:hybrid;
	mso-list-template-ids:-890859682 67567617 67567619 67567621 67567617 67567=
619 67567621 67567617 67567619 67567621;}
@list l13:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l13:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l13:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l13:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l13:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l13:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l13:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l13:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l13:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l14
	{mso-list-id:1082068650;
	mso-list-type:hybrid;
	mso-list-template-ids:191665526 67567617 67567619 67567621 67567617 675676=
19 67567621 67567617 67567619 67567621;}
@list l14:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l14:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l14:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l14:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l14:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l14:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l14:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l14:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l14:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l15
	{mso-list-id:1187330242;
	mso-list-type:hybrid;
	mso-list-template-ids:-1983894820 67567617 67567619 67567621 67567617 6756=
7619 67567621 67567617 67567619 67567621;}
@list l15:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l15:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l15:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l15:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l15:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l15:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l15:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l15:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l15:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l16
	{mso-list-id:1225944973;
	mso-list-type:hybrid;
	mso-list-template-ids:-1638384452 67567617 67567619 67567621 67567617 6756=
7619 67567621 67567617 67567619 67567621;}
@list l16:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l16:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l16:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l16:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l16:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l16:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l16:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l16:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l16:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l17
	{mso-list-id:1293752539;
	mso-list-type:hybrid;
	mso-list-template-ids:-1416222200 67567617 67567619 67567621 67567617 6756=
7619 67567621 67567617 67567619 67567621;}
@list l17:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l17:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l17:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l17:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l17:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l17:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l17:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l17:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l17:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l18
	{mso-list-id:1467628241;
	mso-list-type:hybrid;
	mso-list-template-ids:132156038 67567617 67567619 67567621 67567617 675676=
19 67567621 67567617 67567619 67567621;}
@list l18:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l18:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l18:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l18:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l18:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l18:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l18:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l18:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l18:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l19
	{mso-list-id:1890921793;
	mso-list-type:hybrid;
	mso-list-template-ids:140795052 67567617 67567619 67567621 67567617 675676=
19 67567621 67567617 67567619 67567621;}
@list l19:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l19:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l19:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l19:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l19:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l19:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l19:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l19:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l19:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l20
	{mso-list-id:2047872296;
	mso-list-type:hybrid;
	mso-list-template-ids:798277818 -42433902 1788004580 336330779 336330767 3=
36330777 336330779 336330767 336330777 336330779;}
@list l20:level1
	{mso-level-number-format:alpha-upper;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:283.5pt;
	text-indent:-283.5pt;
	mso-ansi-font-weight:bold;}
@list l20:level2
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:82.5pt;
	text-indent:-28.5pt;
	mso-ansi-font-weight:bold;
	mso-ansi-font-style:normal;}
@list l20:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l20:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l20:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l20:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l20:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l20:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l20:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l21
	{mso-list-id:2083795058;
	mso-list-type:hybrid;
	mso-list-template-ids:-1584736442 -1 67567619 67567621 67567617 67567619 6=
7567621 67567617 67567619 67567621;}
@list l21:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:92.7pt;
	text-indent:-.25in;}
@list l21:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:128.7pt;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l21:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:164.7pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l21:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:200.7pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l21:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:236.7pt;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l21:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:272.7pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l21:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:308.7pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l21:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:344.7pt;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l21:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:380.7pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l22
	{mso-list-id:2132508293;
	mso-list-type:hybrid;
	mso-list-template-ids:-799899264 67567617 67567619 67567621 67567617 67567=
619 67567621 67567617 67567619 67567621;}
@list l22:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l22:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l22:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l22:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l22:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l22:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l22:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l22:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l22:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l10:level1 lfo1
	{mso-level-start-at:1;
	mso-level-number-format:bullet;
	mso-level-numbering:continue;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:.25in;
	mso-level-legacy-space:0in;
	margin-left:.25in;
	text-indent:-.25in;}
@list l10:level1 lfo2
	{mso-level-start-at:1;
	mso-level-number-format:bullet;
	mso-level-numbering:continue;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:.25in;
	mso-level-legacy-space:0in;
	margin-left:.25in;
	text-indent:-.25in;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-ansi-language:DE;
	mso-fareast-language:DE;}
table.MsoTableGrid
	{mso-style-name:"Table Grid";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-priority:99;
	mso-style-unhide:no;
	border:solid black 1.0pt;
	mso-border-alt:solid black .5pt;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-border-insideh:.5pt solid black;
	mso-border-insidev:.5pt solid black;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-ansi-language:DE;
	mso-fareast-language:DE;}
table.TablegridAgencyblack
	{mso-style-name:"Table grid \(Agency\) black";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-border-insideh:.75pt solid windowtext;
	mso-border-insidev:.75pt solid windowtext;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Verdana",sans-serif;
	mso-ansi-language:DE;
	mso-fareast-language:DE;}
table.TablegridAgencyblackFirstRow
	{mso-style-name:"Table grid \(Agency\) black";
	mso-table-condition:first-row;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-tstyle-border-top:.5pt solid windowtext;
	mso-tstyle-border-left:.5pt solid windowtext;
	mso-tstyle-border-bottom:.5pt solid windowtext;
	mso-tstyle-border-right:.5pt solid windowtext;
	mso-tstyle-diagonal-down:cell-none;
	mso-tstyle-diagonal-up:cell-none;
	mso-tstyle-border-insideh:.75pt solid windowtext;
	mso-tstyle-border-insidev:.75pt solid windowtext;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"4097"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=3DEN-US link=3Dblue vlink=3Dpurple style=3D'tab-interval:.5in;wo=
rd-wrap:
break-word'>

<div class=3DWordSection1>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-paginati=
on:none;
tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:18=
7.4pt;
margin-bottom:0in;margin-left:188.5pt;margin-bottom:.0001pt;text-align:cent=
er'><b><span
lang=3DES style=3D'mso-ansi-language:ES'>ANEXO I</span></b><span lang=3DES
style=3D'mso-ansi-language:ES'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso=
-ansi-language:
ES'><o:p>&nbsp;</o:p></span></p>

<p class=3DTitleA><span lang=3DES style=3D'mso-ansi-language:ES'>FICHA TCN=
ICA O
RESUMEN DE LAS CARACTERSTICAS DEL PRODUCTO<o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<span lang=3DES style=3D'font-size:11.0pt;font-family:"Times New Roman",ser=
if;
mso-fareast-font-family:SimSun;mso-ansi-language:ES;mso-fareast-language:EN=
-US;
mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'mso-spec=
ial-character:
line-break;page-break-before:always'>
</span>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>1.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>NOMBRE DEL MEDICAMENTO</span></b><=
span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap 300&nbsp;=
UI/0,5&nbsp;ml
</span><span lang=3DES style=3D'mso-ansi-language:ES'>solucin inyectable<o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-bidi-font-style:italic;mso-no-proof:yes'>Ov=
aleap
450&nbsp;UI/0,75&nbsp;ml solucin inyectable<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-bidi-font-style:italic;mso-no-proof:yes'>Ov=
aleap
900&nbsp;UI/1,5&nbsp;ml solucin inyectable</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-bidi-font-style:italic;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-bidi-font-style:italic;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>2.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>COMPOSICIN CUALITATIVA Y CUANTITA=
TIVA</span></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Cada ml de la solucin contiene 600&nbsp;UI </span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>(equivalentes a 44&nbsp;microgramos) </span><span lang=3DES
style=3D'mso-ansi-language:ES'>de folitropina alfa</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>*.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><u><span lang=3DES style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap
300&nbsp;UI/0,5&nbsp;ml </span></u><u><span lang=3DES style=3D'mso-ansi-lan=
guage:
ES'>solucin inyectable</span></u><u><span lang=3DES style=3D'mso-bidi-font=
-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span=
></u></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Cada cartucho
contiene 300&nbsp;UI (equivalentes a 22&nbsp;microgramos) de folitropina al=
fa en
0,5&nbsp;ml de </span><span lang=3DES style=3D'mso-ansi-language:ES'>soluci=
n
inyectable</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:b=
lack;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><u><span lang=3DES style=3D'm=
so-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-bidi-font-style:italic;mso-no-proof:yes'>Ov=
aleap
450&nbsp;UI/0,75&nbsp;ml solucin inyectable</span></u><u><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Cada cartucho
contiene 450&nbsp;UI (equivalentes a 33&nbsp;microgramos) de folitropina al=
fa
en 0,75&nbsp;ml de </span><span lang=3DES style=3D'mso-ansi-language:ES'>so=
lucin
inyectable</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:b=
lack;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><u><span lang=3DES style=3D'm=
so-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-bidi-font-style:italic;mso-no-proof:yes'>Ov=
aleap
900&nbsp;UI/1,5&nbsp;ml solucin inyectable</span></u><u><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Cada cartucho
contiene 900&nbsp;UI (equivalentes a 66&nbsp;microgramos) de folitropina al=
fa
en 1,5&nbsp;ml de </span><span lang=3DES style=3D'mso-ansi-language:ES'>sol=
ucin
inyectable</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:b=
lack;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>*La folitropina alfa</span><span lang=3DES style=3D'mso-bidi-font-size=
:11.0pt;
color:black;mso-ansi-language:ES;mso-bidi-font-weight:bold'> (</span><span
lang=3DES style=3D'mso-ansi-language:ES'>hormona foliculoestimulante humana
recombinante</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color=
:black;
mso-ansi-language:ES;mso-bidi-font-weight:bold'> [r&#8209;hFSH]) se produce=
 </span><span
lang=3DES style=3D'mso-ansi-language:ES'>en clulas de ovario de hmster ch=
ino (CHO
</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-a=
nsi-language:
ES;mso-bidi-font-weight:bold'>DHFR<sup>-</sup></span><span lang=3DES
style=3D'mso-ansi-language:ES'>) mediante tecnologa de ADN recombinante</s=
pan><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-bidi-font-weight:bold'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-layout-grid-align:none;text-autospace:non=
e'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DES style=3D'mso-bidi-font=
-size:
11.0pt;color:black;mso-ansi-language:ES;mso-bidi-font-weight:bold;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><u><span =
lang=3DES
style=3D'mso-ansi-language:ES'>Excipiente(s) con efecto conocido:<o:p></o:p=
></span></u></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>Ovaleap contiene 0,02&nbsp;mg por ml de clor=
uro de
benzalconio.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>Ovaleap contiene 10,0&nbsp;mg por ml de alco=
hol
benclico.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><u><span =
lang=3DES
style=3D'mso-ansi-language:ES'><o:p><span style=3D'text-decoration:none'>&n=
bsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>Para consultar la lista completa de excipien=
tes,
ver seccin&nbsp;6.1.</span><span lang=3DES style=3D'mso-bidi-font-size:11.=
0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>3.<span style=3D'mso-tab-coun=
t:
1'> </span></span></b><b><span lang=3DES style=3D'mso-ansi-language:E=
S'>FORMA
FARMACUTICA</span></b><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
text-transform:uppercase;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-ansi-language:
ES'>Solucin inyectable</span><span lang=3DES style=3D'mso-bidi-font-size:1=
1.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'> (inyeccin).<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Solucin transparente, incolora.</span><span lang=3DES style=3D'mso-bid=
i-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>El pH de la solucin es de</span><span lang=3DES style=3D'mso-bidi-font=
-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'> 6,8&#8209;7,2.<o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;text-transform:uppercase;mso-ansi-language:ES;mso-no-proof:yes'>4.<s=
pan
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>DATOS CLNICOS</span></b><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;text-transform:uppercase;mso-ansi-langua=
ge:
ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>4.1<span style=3D'mso-tab-cou=
nt:
1'> </span></span></b><b><span lang=3DES style=3D'mso-ansi-language:ES'=
>Indicaciones
teraputicas</span></b><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;tab-stops:.5in'><u><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-bidi-font-style:italic;mso-no-proof:yes'>En mujeres adultas<o:p></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;page=
-break-after:
avoid;tab-stops:.5in'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;page=
-break-after:
avoid;mso-list:l13 level1 lfo3;tab-stops:.5in'><![if !supportLists]><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast=
-font-family:
Symbol;mso-bidi-font-family:Symbol;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Anovulacin
(incluyendo el sndrome del ovario poliqustico) en mujeres que no han
respondido al tratamiento con citrato de clomifeno</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l13 level1 lfo3;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Estimulacin
del desarrollo folicular mltiple en mujeres sometidas a superovulacin para
realizar tcnicas de reproduccin asistida (TRA), tales como la fertilizaci=
n <i
style=3D'mso-bidi-font-style:normal'>in vitro </i>(FIV), transferencia
intratubrica de gametos y transferencia intratubrica de cigotos.</span><s=
pan
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l13 level1 lfo3;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-bidi-font-size:=
11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap</span><span lang=
=3DES
style=3D'mso-ansi-language:ES'>, asociado a un preparado de hormona luteini=
zante
(LH), se recomienda para la estimulacin del desarrollo folicular en mujeres
con deficiencia severa de LH y FSH. En los ensayos clnicos, estas paciente=
s se
definieron por un nivel srico de LH endgena de &lt;&nbsp;1,2&nbsp;UI/l.</=
span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;tab-stops:.5in'><u><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-bidi-font-style:italic;mso-no-proof:yes'>En hombres adultos<o:p></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;page=
-break-after:
avoid;tab-stops:.5in'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;page=
-break-after:
avoid;mso-list:l13 level1 lfo3;tab-stops:.5in'><![if !supportLists]><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast=
-font-family:
Symbol;mso-bidi-font-family:Symbol;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-bidi-font-size:=
11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap </span><span
lang=3DES style=3D'mso-ansi-language:ES'>est indicado para estimular la
espermatognesis en hombres con hipogonadismo hipogonadotropo congnito o
adquirido, administrado de forma concomitante con gonadotropina corinica
humana (hCG)</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color=
:black;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;mso-outline-level:1'><b style=3D'mso-bidi-font-weigh=
t:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>4.2<span style=3D'mso-tab-count:1'> </span></span></b=
><b><span
lang=3DES style=3D'mso-ansi-language:ES'>Posologa y forma de administraci=
n</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DES
style=3D'mso-ansi-language:ES'>El tratamiento con folitropina alfa se debe
iniciar bajo la supervisin de un mdico con experiencia en el tratamiento =
de
trastornos de la fertilidad</span><span lang=3DES style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><u><span =
lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>Posologa<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>Las recomendaciones posolgicas para la
folitropina alfa son las mismas que se utilizan para la FSH urinaria. La
evaluacin clnica de la folitropina alfa indica que sus dosis diarias, pau=
tas
de administracin y procedimientos para monitorizar el tratamiento no deben=
 ser
distintos de los que se utilizan actualmente para los medicamentos que
contienen FSH urinaria. Se aconseja </span><span lang=3DES style=3D'mso-bid=
i-font-size:
11.0pt;color:black;mso-ansi-language:ES'>cumplir con</span><span lang=3DES
style=3D'mso-ansi-language:ES'> las dosis de inicio recomendadas, indicadas=
 a
continuacin</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color=
:black;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>Estudios clnicos comparativos han demostrad=
o que,
de media, los pacientes requieren una dosis acumulativa menor y un periodo =
de
tratamiento ms corto con folitropina alfa que con el tratamiento con FSH
urinaria. Por tanto, se considera apropiado dar una dosis total menor de
folitropina alfa que la generalmente utilizada para la FSH urinaria, no slo
para optimizar el desarrollo folicular sino tambin para minimizar el riesg=
o de
hiperestimulacin ovrica no deseada (ver seccin&nbsp;5.1)</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-bid=
i-font-style:
italic;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><i
style=3D'mso-bidi-font-style:normal'><u><span lang=3DES style=3D'mso-bidi-f=
ont-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Mujeres con
anovulacin (incluyendo el sndrome de ovario poliqustico)<o:p></o:p></spa=
n></u></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>La folitropina alfa se puede administrar med=
iante
un ciclo de inyecciones diarias. En las mujeres con menstruacin, el
tratamiento debe comenzar dentro de los primeros 7&nbsp;das del ciclo
menstrual.</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:b=
lack;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>Una pauta utilizada de forma comn comienza con 75&#8209;150&nbsp;UI de
FSH diarias y se incrementa preferiblemente en 37,5  75&nbsp;UI a interval=
os
de 7&nbsp;das o, preferiblemente, 14&nbsp;das, si fuera necesario para
obtener una respuesta adecuada, pero no excesiva. El tratamiento se debe
adaptar a la respuesta individual de la paciente, evaluada mediante el tama=
o
folicular determinado por una ecografa y/o la secrecin de estrgenos. La
dosis mxima diaria no suele ser superior a 225&nbsp;UI de FSH. Si una paci=
ente
no responde de forma adecuada despus de 4&nbsp;semanas de tratamiento, ese
ciclo se debe interrumpir y la paciente se debe someter a evaluaciones
adicionales antes de que pueda reiniciar el tratamiento con una dosis inici=
al
ms alta que la del ciclo cancelado.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>Cuando se obtiene una respuesta ptima, se debe administrar una inyecc=
in
nica de 250&nbsp;microgramos de coriogonadotropina alfa humana recombinant=
e (r&#8209;hCG),
 de 5.000&nbsp;UI a 10.000&nbsp;UI de hCG, 24&#8209;48 horas despus de la
ltima inyeccin de folitropina alfa. Se recomienda a la paciente que reali=
ce
el coito el mismo da de la administracin de hCG, as como al da siguient=
e.
Alternativamente, puede se practicar inseminacin intrauterina (IIU).<o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>Si se obtiene una respuesta excesiva, se debe
interrumpir el tratamiento y no administrar hCG (ver la seccin&nbsp;4.4). =
El
tratamiento debe reiniciarse en el ciclo siguiente con una dosis ms baja q=
ue
la del ciclo previo</span><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><i><span =
lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;mso-outline-level:1;
tab-stops:.5in'><i><u><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>Mujeres sometidas a
estimulacin ovrica para el desarrollo folicular mltiple previo a la
fertilizacin in vitro u otras TRA<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'margin-right:-1.0pt'><span lang=3DES style=3D=
'mso-ansi-language:
ES'>Una pauta frecuente de tratamiento para inducir superovulacin consiste=
 en
la administracin de 150&#8209;225 UI de folitropina alfa por da, comenzan=
do
el da 2  3 del ciclo. El tratamiento debe continuar hasta que se alcance =
un
desarrollo folicular adecuado (segn los niveles sricos de estrgenos y/o =
la
ecografa)</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:b=
lack;
mso-ansi-language:ES'> con la dosis ajustada</span><span lang=3DES
style=3D'mso-ansi-language:ES'> en funcin de la respuesta de la paciente, =
habitualmente
no ms de 450&nbsp;UI diarias. En general, se alcanza un desarrollo folicul=
ar
adecuado como media antes del dcimo da de tratamiento (entre 5 y 20&nbsp;=
das)</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>Al cabo de 24&#8209;48&nbsp;horas de la lti=
ma
inyeccin de folitropina alfa, se debe administrar una nica inyeccin de 2=
50&nbsp;microgramos
de r&#8209;hCG,  5.000&nbsp;UI, hasta 10.000&nbsp;UI, de hCG, para inducir=
 la
maduracin folicular final</span><span lang=3DES style=3D'mso-bidi-font-siz=
e:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>En la actualidad, se realiza de forma frecuente un bloqueo hipofisario=
 con
un agonista o antagonista de la hormona liberadora de gonadotropinas (GnRH),
para suprimir el pico endgeno de LH y controlar su secrecin. En un protoc=
olo
habitual, la administracin de </span><span lang=3DES style=3D'mso-ansi-lan=
guage:
ES'>folitropina alfa</span><span lang=3DES style=3D'mso-bidi-font-size:11.0=
pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'> se inicia aproximadamen=
te 2&nbsp;semanas
despus de iniciar el tratamiento con el agonista, continuando ambos tratam=
ientos
hasta lograr un desarrollo folicular adecuado. Por ejemplo, tras 2&nbsp;sem=
anas
de tratamiento con el agonista, se administran 150&#8209;225&nbsp;UI de </s=
pan><span
lang=3DES style=3D'mso-ansi-language:ES'>folitropina alfa</span><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'> durante los primeros 7&nbsp;das y, a continuacin, se ajusta la dosis
segn la respuesta ovrica.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>La experiencia global con tcnicas de FIV in=
dica
que, en general, la tasa de xito del tratamiento permanece estable durante=
 los
primeros cuatro intentos, disminuyendo posteriormente de forma gradual</spa=
n><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><i><span =
lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><i><u><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>Mujeres con anovulacin debida a un dficit severo de LH y
FSH<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>En mujeres con dficit de LH y FSH (hipogona=
dismo
hipogonadotropo), el objetivo del tratamiento con folitropina alfa asociado=
 a
lutropina alfa es desarrollar un nico folculo de Graaf maduro, a partir d=
el
cual se liberar el ovocito tras la administracin de hCG. La folitropina a=
lfa se
debe administrar como un ciclo de inyecciones diarias, conjuntamente con
lutropina alfa. Puesto que estas pacientes son amenorreicas y tienen una es=
casa
secrecin endgena de estrgenos, el tratamiento puede comenzar en cualquier
momento</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:blac=
k;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>Una pauta recomendada comienza con 75&nbsp;U=
I de
lutropina alfa por da junto con 75&#8209;150&nbsp;UI de FSH. El tratamient=
o se
debe adaptar a la respuesta individual de la paciente, evaluada mediante el
tamao folicular determinado por una ecografa y la respuesta estrognica</=
span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>Si se considera apropiado aumentar la dosis =
de
FSH, el ajuste de dosis se debe realizar preferiblemente a intervalos de 7&=
#8209;14
das y preferiblemente con incrementos de 37,5&#8209;75&nbsp;UI. Puede ser
aceptable prolongar la duracin de la estimulacin en un ciclo determinado
hasta 5&nbsp;semanas</span><span lang=3DES style=3D'mso-bidi-font-size:11.0=
pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>Cuando se obtiene una respuesta ptima, se d=
ebe
administrar una inyeccin nica de 250&nbsp;microgramos de r&#8209;hCG,  5=
.000&nbsp;UI,
hasta 10.000&nbsp;UI, de hCG, 24&#8209;48 horas despus de la ltima inyecc=
in
de folitropina alfa y lutropina alfa. Se recomienda a la paciente que reali=
ce
el coito el mismo da de la administracin de hCG, as como al da siguient=
e</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>. </span><span lang=3DES style=3D'mso-ansi-language:ES'>D=
e forma
alternativa, se puede realizar IIU</span><span lang=3DES style=3D'mso-bidi-=
font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>Se puede considerar la necesidad de apoyo de=
 la
fase ltea, ya que la falta de sustancias con actividad luteotropa (LH/hCG)
despus de la ovulacin puede dar lugar a un fracaso prematuro del cuerpo l=
teo</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>Si se obtiene una respuesta excesiva, se debe
interrumpir el tratamiento y no administrar hCG. El tratamiento se debe
reiniciar en el ciclo siguiente con una dosis de FSH ms baja que la del ci=
clo
previo</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><i><span =
lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><i><u><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>Hombres con hipogonadismo hipogonadotropo<o:p></o:p></spa=
n></u></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>La folitropina alfa se debe administrar a do=
sis de
150&nbsp;UI tres veces por semana, concomitantemente con hCG, durante un m=
nimo
de 4&nbsp;meses. Si despus de este periodo el paciente no ha respondido, s=
e puede
continuar el tratamiento combinado. La experiencia clnica actual indica qu=
e se
puede requerir un tratamiento de al menos 18&nbsp;meses para lograr la
espermatognesis</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;mso-outline-level:1;
tab-stops:.5in'><i style=3D'mso-bidi-font-style:normal'><u><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>Poblaciones especiales<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;mso-outline-level:1;
tab-stops:.5in'><i><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color=
:black;
mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;mso-outline-level:1;
tab-stops:.5in'><u><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color=
:black;
mso-ansi-language:ES;mso-bidi-font-style:italic;mso-no-proof:yes'>Poblacin=
 de
edad avanzada<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES'>El uso=
 de</span><span
lang=3DES style=3D'mso-ansi-language:ES'> folitropina alfa en la poblacin =
de edad
avanzada</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:bla=
ck;
mso-ansi-language:ES'> no es relevante</span><span lang=3DES style=3D'mso-a=
nsi-language:
ES'>. No se ha establecido la seguridad y eficacia de la folitropina alfa en
los pacientes de edad avanzada</span><span lang=3DES style=3D'mso-bidi-font=
-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><i><span =
lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><u><span =
lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-bid=
i-font-style:
italic;mso-no-proof:yes'>Insuficiencia renal o heptica<o:p></o:p></span></=
u></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>No se ha establecido la seguridad, la eficac=
ia ni
las propiedades farmacocinticas de la folitropina alfa en los pacientes con
insuficiencia renal o heptica</span><span lang=3DES style=3D'mso-bidi-font=
-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><u><span lang=3D=
ES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>Poblacin peditrica<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DES
style=3D'mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DES
style=3D'mso-ansi-language:ES'>El uso de folitropina alfa en la poblacin
peditrica </span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:=
black;
mso-ansi-language:ES'>no es relevante<span style=3D'mso-no-proof:yes'>.<o:p=
></o:p></span></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><i
style=3D'mso-bidi-font-style:normal'><u><span lang=3DES style=3D'mso-bidi-f=
ont-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Forma de
administracin<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>Ovaleap</span><span lang=3DES style=3D'mso-ansi-language:ES'> est ind=
icado
para uso por va subcutnea. La primera inyeccin </span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>se </span><span lang=3DES style=3D'mso-ansi-language:ES'>debe realizar=
 bajo
supervisin mdica directa. La autoadministracin slo debe ser realizada p=
or
pacientes que estn bien motivados, adecuadamente instrudos y que tengan
acceso a los consejos de un profesional</span><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>Dado que el cartucho multidosis est pensado=
 para
varias inyecciones, se deben proporcionar instrucciones claras a los pacien=
tes,
a fin de evitar el uso inadecuado del medicamento</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>El cartucho Ovale=
ap est
diseado para uso exclusivo con la Ovaleap Pen, que se suministra por separ=
ado.
Para consultar las instrucciones de la administracin con la Ovaleap Pen, v=
er
seccin&nbsp;6.6.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>4.3<span style=3D'mso-tab-cou=
nt:
1'> </span></span></b><b><span lang=3DES style=3D'mso-ansi-language:ES'=
>Contraindicaciones</span></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l13 level1 lfo3;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Hipersensibilidad
al principio activo folitropina alfa, a la FSH o a alguno de los excipiente=
s</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'> incluidos en la seccin&nbsp;6.1.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l13 level1 lfo3;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Tumores
del hipotlamo o de la hipfisis</span><span lang=3DES style=3D'mso-bidi-fo=
nt-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l13 level1 lfo3;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Aumento
del tamao de los ovarios o quistes ovricos no causados por el sndrome del
ovario poliqustico.</span><span lang=3DES style=3D'mso-bidi-font-size:11.0=
pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l13 level1 lfo3;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Hemorragias
ginecolgicas de etiologa desconocida.</span><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l13 level1 lfo3;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Carcinoma
ovrico, uterino o mamario.</span><span lang=3DES style=3D'mso-bidi-font-si=
ze:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;tab-=
stops:
.5in'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;tab-=
stops:
.5in'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-an=
si-language:
ES;mso-no-proof:yes'>Ovaleap </span><span lang=3DES style=3D'mso-ansi-langu=
age:
ES'>no se debe utilizar cuando no se puede obtener una respuesta eficaz, en
casos tales como</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l13 level1 lfo3;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Insuficiencia
ovrica primaria.</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l13 level1 lfo3;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Malformaciones
de los rganos sexuales incompatibles con el embarazo.</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l13 level1 lfo3;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Tumores
fibroides del tero incompatibles con el embarazo.</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l13 level1 lfo3;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Insuficiencia
testicular primaria.</span><span lang=3DES style=3D'mso-bidi-font-size:11.0=
pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>4.4<span style=3D'mso-tab-cou=
nt:
1'> </span></span></b><b><span lang=3DES style=3D'mso-ansi-language:ES'=
>Advertencias
y precauciones especiales de empleo</span></b><b style=3D'mso-bidi-font-wei=
ght:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i style=3D'mso-bidi-font-sty=
le:normal'><u><span
lang=3DES style=3D'mso-ansi-language:ES'>Trazabilidad<o:p></o:p></span></u>=
</i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Con el fin de mejorar la trazabilidad de los medicamentos biolgicos, se
deben registrar claramente el nombre comercial y el nmero de lote del
medicamento administrado en la historia clnica del paciente.<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i style=3D'mso-bidi-font-sty=
le:normal'><u><span
lang=3DES style=3D'mso-ansi-language:ES'>General<o:p></o:p></span></u></i><=
/p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>La folitropina alfa es una sustancia gonadotrpica potente capaz de cau=
sar
reacciones adversas de leves a graves y solo se debe utilizar por mdicos q=
ue
estn muy familiarizados con los problemas de la infertilidad y su tratamie=
nto</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-right:3.75pt'><span lang=3DES style=3D=
'mso-ansi-language:
ES'>El tratamiento con gonadotropinas requiere una cierta dedicacin de tie=
mpo
por parte de los mdicos y profesionales sanitarios, adems de disponer de
instalaciones de monitorizacin apropiadas. En mujeres, el uso seguro y efi=
caz
de la folitropina alfa requiere monitorizar la respuesta ovrica mediante
ecografas, solas o preferiblemente combinadas con la determinacin de los
niveles sricos de estradiol, de manera regular. Puede existir un cierto gr=
ado
de variabilidad en la respuesta a la administracin de FSH entre pacientes,=
 con
una respuesta escasa a la FSH en algunas pacientes y una respuesta exagerad=
a en
otras. Tanto en hombres como en mujeres, se debera utilizar la mnima dosis
efectiva para lograr el objetivo del tratamiento</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;tab-stops:.5in'><i
style=3D'mso-bidi-font-style:normal'><u><span lang=3DES style=3D'mso-bidi-f=
ont-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Porfiria<o:p></o:=
p></span></u></i></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;tab-stops:.5in'><span =
lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;tab-stops:.5in'><span =
lang=3DES
style=3D'mso-ansi-language:ES'>Los pacientes con porfiria o con antecedentes
familiares de porfiria se deben controlar estrechamente durante el tratamie=
nto
con folitropina alfa. El deterioro de dicha enfermedad o su aparicin por
primera vez puede requerir la interrupcin del tratamiento</span><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><u><span lang=3DES style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i style=3D'mso-bidi-font-sty=
le:normal'><u><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>Tratamiento en mujeres<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Antes de iniciar el tratamiento, se debe valorar de forma adecuada el t=
ipo
de infertilidad de la pareja y la posible existencia de contraindicaciones =
para
el embarazo. En particular, se debe descartar la presencia de hipotiroidism=
o,
insuficiencia suprarrenal e hiperprolactinemia, instaurando el tratamiento
especfico apropiado</span><span lang=3DES style=3D'mso-bidi-font-size:11.0=
pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Las pacientes
sometidas a estimulacin del desarrollo folicular, ya sea como tratamiento =
de
la infertilidad por anovulacin o bien para practicar TRA, pueden presentar
aumento del tamao de los ovarios o hiperestimulacin. La incidencia de est=
os
eventos se puede minimizar aplicando las dosis y pautas de administracin d=
e </span><span
lang=3DES style=3D'mso-ansi-language:ES'>folitropina alfa</span><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'> recomendadas y monitorizando cuidadosamente el tratamiento. Para la
interpretacin correcta de los ndices de desarrollo y maduracin folicular=
, el
mdico debe tener experiencia en la interpretacin de las pruebas
correspondientes.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>En los ensayos
clnicos se ha demostrado un aumento de la sensibilidad ovrica a la </span=
><span
lang=3DES style=3D'mso-ansi-language:ES'>folitropina alfa</span><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'> cuando se administra con lutropina alfa. Si se considera apropiado
aumentar la dosis de FSH, el ajuste de dosis se debe realizar preferiblemen=
te a
intervalos de 7&#8209;14&nbsp;das y preferiblemente con incrementos de 37,=
5&#8209;75
UI.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>No se ha efectuado una comparacin directa de la folitropina alfa/LH fr=
ente
a la gonadotropina menopusica humana (hMG). La comparacin con datos
histricos sugiere que la tasa de ovulacin obtenida con la folitropina alf=
a/LH
es similar a la que se obtiene con hMG</span><span lang=3DES style=3D'mso-b=
idi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DES style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DES style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Sndrome de
hiperestimulacin ovrica (SHO)<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Un cierto grado de incremento del tamao del ovario es un efecto espera=
do
de la estimulacin ovrica controlada. Se observa con mayor frecuencia en
mujeres con sndrome del ovario poliqustico y, por lo general, remite sin
tratamiento</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:=
black;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>A diferencia del aumento de tamao ovrico no complicado, el SHO es una
afeccin que puede manifestarse con grados crecientes de gravedad. Incluye =
un
aumento marcado del tamao de los ovarios, niveles sricos elevados de
esteroides sexuales y un aumento de la permeabilidad vascular que puede dar
lugar a una acumulacin de lquidos en la cavidad peritoneal, pleural y,
raramente, pericrdica</span><span lang=3DES style=3D'mso-bidi-font-size:11=
.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>En los casos de SHO grave se puede observar la siguiente sintomatologa:
dolor abdominal, distensin abdominal, aumento importante del tamao de los
ovarios, aumento de peso, disnea, oliguria y sntomas gastrointestinales
incluyendo nuseas, vmitos y diarrea. La evaluacin clnica puede revelar
hipovolemia, hemoconcentracin, desequilibrio electroltico, ascitis,
hemoperitoneo, derrames pleurales, hidrotrax o distrs respiratorio agudo.=
 Muy
raramente, el SHO grave se puede complicar con torsin del ovario o acontec=
imientos
tromboemblicos como embolia pulmonar, accidente cerebrovascular isqumico o
infarto de miocardio</span><span lang=3DES style=3D'mso-bidi-font-size:11.0=
pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Algunos factores =
de
riesgo independientes para presentar el sndrome de hiperestimulacin ovri=
ca
son el sndrome del ovario poliqustico, las concentraciones absolutas alta=
s o
en rpido aumento de estradiol en el suero (por ejemplo, &gt;&nbsp;900&nbsp=
;pg/ml
o &gt;&nbsp;3.300&nbsp;pmol/l en anovulacin; &gt;&nbsp;3.000&nbsp;pg/ml o =
&gt;&nbsp;11.000&nbsp;pmol/l
en TRA) y una gran cantidad de folculos ovricos en desarrollo (por ejempl=
o, &gt;&nbsp;3&nbsp;folculos
de &#8805;&nbsp;14&nbsp;mm de dimetro en anovulacin; &#8805;&nbsp;20&nbsp=
;folculos
de &#8805;&nbsp;12&nbsp;mm de dimetro en TRA).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>El cumplimiento de la dosis recomendada de folitropina alfa y la pauta =
de
administracin pueden minimizar el riesgo de hiperestimulacin ovrica (ver
secciones&nbsp;4.2 y 4.8). Para identificar tempranamente los factores de
riesgo, se recomienda la </span><span lang=3DES style=3D'mso-bidi-font-size=
:11.0pt;
color:black;mso-ansi-language:ES'>monitorizacin</span><span lang=3DES
style=3D'mso-ansi-language:ES'> de los ciclos de estimulacin mediante ecog=
rafas
y determinaciones de estradiol</span><span lang=3DES style=3D'mso-bidi-font=
-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Hay evidencias que
indican que la hCG desempea una funcin fundamental en el desencadenamiento
del SHO y que el sndrome puede ser ms grave y puede tener una duracin ms
prolongada si se produce un embarazo. Por tanto, si se producen signos de
hiperestimulacin ovrica, por ejemplo, una concentracin srica de estradi=
ol
&gt; 5.500 pg/ml o &gt; 20.200 pmol/ml y/o &#8805; 40 folculos en total, se
recomienda no administrar hCG y se debe advertir a la paciente que no reali=
ce
el coito o que utilice mtodos anticonceptivos de barrera durante al menos
cuatro das. El SHO puede progresar rpidamente (en menos de 24 horas) o en
varios das hasta convertirse en un cuadro clnico grave. La mayora de las
veces se produce despus de que el tratamiento hormonal se ha suspendido y
alcanza su mxima intensidad de <st1:metricconverter ProductID=3D"7 a" w:st=
=3D"on">7
 a</st1:metricconverter> 10 das despus del tratamiento, aproximadamente. =
Por
lo tanto, se debe seguir a las pacientes durante al menos 2 semanas tras la
administracin de hCG.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>En las tcnicas de reproduccin asistida, la aspiracin de todos los
folculos antes de la ovulacin, puede reducir la incidencia de
hiperestimulacin</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>El sndrome de hiperestimulacin ovrica leve o moderado se resuelve
generalmente de manera espontnea. Si se produce un SHO grave, se recomienda
interrumpir el tratamiento con gonadotropinas si es que todava contina y
hospitalizar a la paciente e iniciar el tratamiento adecuado</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><i><span lang=3DES style=3D'mso-bidi=
-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Embarazo mltiple=
<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DES style=3D'mso-ansi-la=
nguage:
ES'>En pacientes sometidas a induccin de la ovulacin, la incidencia de
embarazo mltiple es ms elevada que en el caso de la concepcin natural. La
mayora de embarazos mltiples son gemelares. El embarazo mltiple,
especialmente si el nmero de fetos es alto, conlleva un mayor riesgo de
complicaciones maternas y perinatales</span><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Para minimizar el riesgo de embarazo mltiple, se recomienda una
monitorizacin cuidadosa de la respuesta ovrica</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>El riesgo de embarazos mltiples en pacientes sometidas a tcnicas de
reproduccin asistida se relaciona principalmente con el nmero de embriones
transferidos, con la calidad de los mismos y con la edad de la paciente</sp=
an><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Antes de empezar el tratamiento se debe informar a las pacientes del ri=
esgo
potencial de partos mltiples</span><span lang=3DES style=3D'mso-bidi-font-=
size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DES style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DES style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Prdida del embar=
azo<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>La incidencia de prdida del embarazo debido a aborto espontneo o
provocado es mayor en pacientes sometidas a estimulacin del desarrollo
folicular para inducir la ovulacin o practicar TRA que la observada tras la
concepcin natural</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DES style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DES style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Embarazo ectpico=
<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Las mujeres con historia de enfermedad tubrica presentan riesgo de
embarazo ectpico, tanto si el embarazo es por concepcin espontnea como s=
i se
logra mediante tratamientos de fertilidad. Se ha notificado que la prevalen=
cia
del embarazo ectpico tras practicar TRA es mayor que en la poblacin gener=
al</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DES style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></i></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><i><span lang=3DES style=3D'mso-bidi=
-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Neoplasias del
aparato reproductor<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Se han descrito neoplasias, tanto benignas como malignas, del ovario y =
de
otros rganos del aparato reproductor, en mujeres sometidas a mltiples pau=
tas
teraputicas para el tratamiento de la infertilidad. Todava no est
establecido si el tratamiento con gonadotropinas aumenta o no el riesgo de
estos tumores en mujeres estriles</span><span lang=3DES style=3D'mso-bidi-=
font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DES style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></i></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><i><span lang=3DES style=3D'mso-bidi=
-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Malformaciones
congnitas<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>La prevalencia de malformaciones congnitas tras TRA puede ser ligerame=
nte
superior a la observada tras la concepcin natural. Esto se considera debid=
o a
diferencias en las caractersticas de los progenitores (por ejemplo, la eda=
d de
la madre, las caractersticas del semen) y a los embarazos mltiples</span>=
<span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DES style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DES style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Fenmenos
tromboemblicos<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>En mujeres con enfermedad tromboemblica reciente o en curso o en mujer=
es
con factores de riesgo e general reconocidos para presentar problemas
tromboemblicos, tales como antecedentes familiares o personal, el tratamie=
nto
con gonadotropinas puede aumentar ms el riesgo de empeoramiento o aparici=
n de
dichos fenmenos. En estas mujeres, los beneficios de la administracin de
gonadotropinas se deben sopesar frente a los riesgos. No obstante, hay que
tener en cuenta que el embarazo por s mismo, as como el sndrome de
hiperestimulacin ovrica, tambin comportan un aumento del riesgo de fenm=
enos
tromboemblicos</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i style=3D'mso-bidi-font-sty=
le:normal'><u><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>Tratamiento en hombres<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Unos niveles elevados de FSH endgena indican fallo testicular primario.
Dichos pacientes no responden al tratamiento con folitropina alfa/hCG. La
folitropina alfa no se debe usar cuando no se pueda obtener una respuesta
eficaz</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Se recomienda practicar espermiogramas de <st1:metricconverter
ProductID=3D"4 a" w:st=3D"on">4 a</st1:metricconverter> 6&nbsp;meses despu=
s de
iniciar el tratamiento, como parte de la evaluacin de la respuesta</span><=
span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><i style=3D'mso-bidi-font-style:norm=
al'><u><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>Contenido de cloruro de benzalconio<o:p></o:p></span></u>=
</i></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><i style=3D'mso-bidi-font-style:norm=
al'><u><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'><o:p><span style=3D'text-decoration:none'>&nbsp;</span></=
o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>Ovaleap contiene 0,02&nbsp;mg por ml de clor=
uro de
benzalconio.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><u><span =
lang=3DES
style=3D'mso-ansi-language:ES'><o:p><span style=3D'text-decoration:none'>&n=
bsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><i style=3D'mso-bidi-font-style:norm=
al'><u><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>Contenido de alcohol benclico<o:p></o:p></span></u></i><=
/p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><u><span lang=3DES style=3D'mso-ansi=
-language:
ES'><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u=
></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>Ovaleap contiene 10,0&nbsp;mg por ml de alco=
hol
benclico.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><u><span =
lang=3DES
style=3D'mso-ansi-language:ES'>El alcohol benclico puede causar reacciones
alrgicas.<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>Los volmenes altos se deben usar con precau=
cin y
solo en caso necesario, especialmente en sujetos con disfuncin heptica o =
renal
y en mujeres embarazadas o en periodo de lactancia, debido al riesgo de
acumulacin y toxicidad (acidosis metablica).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><i style=3D'mso-bidi-font-style:norm=
al'><u><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'><o:p><span style=3D'text-decoration:none'>&nbsp;</span></=
o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><i style=3D'mso-bidi-font-style:norm=
al'><u><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>Contenido de sodio<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DES style=3D'mso-bidi-fo=
nt-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DES style=3D'mso-bidi-fo=
nt-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap </span><s=
pan
lang=3DES style=3D'mso-ansi-language:ES'>contiene menos de 1&nbsp;mmol de s=
odio (23&nbsp;mg)
por dosis; esto es, esencialmente exento de sodio.</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-outline-level:1'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>4.5<span style=3D'mso-tab-cou=
nt:
1'> </span></span></b><b><span lang=3DES style=3D'mso-ansi-language:ES'=
>Interaccin
con otros medicamentos y otras formas de interaccin</span></b><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DES style=3D'mso-ansi-la=
nguage:
ES'>La utilizacin concomitante de folitropina alfa con otros medicamentos
utilizados para estimular la ovulacin (por ejemplo, hCG, citrato de clomif=
eno)
puede potenciar la respuesta folicular, mientras que la utilizacin
concomitante de un agonista o antagonista de la GnRH para provocar una
desensibilizacin hipofisaria puede incrementar la dosis de folitropina alf=
a necesaria
para lograr una respuesta ovrica adecuada. No se han descrito otras intera=
cciones
con medicamentos clnicamente significativas durante el tratamiento con fol=
itropina
alfa</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;page=
-break-after:
avoid;mso-outline-level:1'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>4.6<span style=3D'mso-tab-count:1'> </span></span></b><b><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>Fertilidad, embarazo y lactancia</span></b><=
span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;tab-stops:.5in'><i
style=3D'mso-bidi-font-style:normal'><u><span lang=3DES style=3D'mso-bidi-f=
ont-size:
11.0pt;color:black;mso-ansi-language:ES;mso-fareast-language:DE'>Embarazo<o=
:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;tab-stops:.5in'><span =
lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>No existe ninguna indicacin para utilizar </span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>Ovaleap </span><span lang=3DES style=3D'mso-ansi-language:ES'>durante =
el
embarazo. Existen datos sobre un nmero limitado de embarazos expuestos (da=
tos
en menos de 300&nbsp;embarazos) que indican que la folitropina alfa no prod=
uce
malformaciones ni toxicidad fetal/neonatal</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.0pt'><span lang=3DES style=3D=
'mso-ansi-language:
ES'>No se han observado efectos teratognicos en los estudios en animales (=
ver
seccin&nbsp;5.3). En caso de exposicin durante el embarazo, los datos
clnicos no son suficientes para descartar un efecto teratgeno de la
folitropina alfa</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><i style=3D'mso-bidi-font-style:norm=
al'><u><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>Lactancia<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><u><span lang=3DES style=3D'mso-bidi=
-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap</span><sp=
an
lang=3DES style=3D'mso-ansi-language:ES'> no est indicado durante la lacta=
ncia</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i style=3D'mso-bidi-font-sty=
le:normal'><u><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>Fertilidad<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><u><span lang=3DES style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap </span><s=
pan
lang=3DES style=3D'mso-ansi-language:ES'>est indicado para su uso en la in=
fertilidad
(ver seccin&nbsp;4.1)</span><span lang=3DES style=3D'mso-bidi-font-size:11=
.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>4.7<span style=3D'mso-tab-cou=
nt:
1'> </span>Efectos </span></b><b><span lang=3DES style=3D'mso-ansi-lang=
uage:
ES'>sobre la capacidad para conducir y utilizar mquinas</span></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>La infl=
uencia de </span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>Ovaleap </span><span lang=3DES style=3D'mso-ansi-language=
:ES'>sobre
la capacidad para conducir y utilizar mquinas es nula o insignificante</sp=
an><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>4.8<span style=3D'mso-tab-count:1'> </span></span></b=
><b><span
lang=3DES style=3D'mso-ansi-language:ES'>Reacciones adversas</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i style=3D'mso-bidi-font-sty=
le:normal'><u><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>Resumen del perfil de seguridad<o:p></o:p></span></u></i>=
</p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Las reacciones adversas notificadas con mayor frecuencia son cefalea,
quistes ovricos y reacciones locales en la zona de inyeccin (por ejemplo,
dolor, eritema, hematoma, hinchazn y/o irritacin en la zona de la inyecci=
n)</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Se ha notificado con frecuencia sndrome de hiperestimulacin ovrica (=
</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES'>SHO)
</span><span lang=3DES style=3D'mso-ansi-language:ES'>leve o moderado y debe
considerarse como un riesgo intrnseco del proceso de estimulacin. El SHO
grave es poco frecuente (ver seccin&nbsp;4.4)</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>En muy raras ocasiones se puede producir tromboembolismo (ver seccin&n=
bsp;4.4)</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i style=3D'mso-bidi-font-sty=
le:normal'><u><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>Tabla de reacciones adversas<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;mso-fareast-font-family:"Times New Roman";mso-ansi-language:ES'>Las
reacciones adversas se clasifican por categoras de frecuencia utilizando la
siguiente convencin: muy frecuentes (&#8805;1/10), frecuentes (&#8805;1/10=
0 a
&lt;1/10), poco frecuentes (&#8805;1/1.000 a &lt;1/100), raras (&#8805;1/10=
.000
a &lt;1/1.000), muy raras (&lt;1/10.000) y frecuencia no conocida (no puede
estimarse a partir de los datos disponibles). Las reacciones adversas se
enumeran en orden decreciente de gravedad dentro de cada intervalo de
frecuencia.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;mso-fareast-font-family:"Times New Roman";mso-ansi-language:ES'><o:p=
>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><i style=3D'mso-bidi-font-style:norm=
al'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>Tratamiento en mujeres<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;tab-stops:.5in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;border:none;mso-border-bottom-alt:solid =
windowtext .5pt;
 mso-yfti-tbllook:480;mso-padding-alt:0in 5.4pt 0in 5.4pt;mso-border-inside=
h:
 .5pt solid windowtext;mso-border-insidev:.5pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D614 colspan=3D3 valign=3Dtop style=3D'width:460.6pt;border:no=
ne;
  border-bottom:solid windowtext 1.0pt;mso-border-bottom-alt:solid windowte=
xt .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span la=
ng=3DES
  style=3D'mso-ansi-language:ES'>Tabla&nbsp;1: Reacciones adversas en mujer=
es<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span la=
ng=3DES
  style=3D'mso-ansi-language:ES'>Sistema de clasificacin de rganos <o:p><=
/o:p></span></b></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span la=
ng=3DES
  style=3D'mso-ansi-language:ES'>Frecuencia<o:p></o:p></span></b></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span la=
ng=3DES
  style=3D'mso-ansi-language:ES'>Reaccin adversa<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;height:59.6pt'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:59.6pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:.5in'><i style=3D'mso-bidi-font-style:no=
rmal'><span
  lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'>Trasto=
rnos del
  sistema inmunolgico<o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:5=
9.6pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Muy raras</span><span
  lang=3DES style=3D'mso-ansi-language:ES'><o:p></o:p></span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:5=
9.6pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-ansi-language:ES'>Re=
acciones
  de hipersensibilidad de leves a graves, incluyendo shock y reacciones ana=
filcticas<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:.5in'><i style=3D'mso-bidi-font-style:no=
rmal'><span
  lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'>Trasto=
rnos del
  sistema nervioso<o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Muy frecuentes</span><=
span
  lang=3DES style=3D'mso-ansi-language:ES'><o:p></o:p></span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:28.35pt center 71.35pt'><span lang=3DES
  style=3D'mso-ansi-language:ES'>Cefalea<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:.5in'><i><span lang=3DES style=3D'mso-bi=
di-font-size:
  11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Trastornos
  vasculares<o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Muy raras</span><span
  lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'><o:p><=
/o:p></span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:28.35pt center 71.35pt'><span lang=3DES
  style=3D'mso-ansi-language:ES'>Tromboembolismo (asociado o independiente =
del
  SHO)</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
  ES'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:.5in'><i><span lang=3DES style=3D'mso-bi=
di-font-size:
  11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Trastornos
  respiratorios, torcicos y mediastnicos<o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Muy raras</span><span
  lang=3DES style=3D'mso-ansi-language:ES'><o:p></o:p></span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-ansi-language:ES'>Ex=
acerbacin
  o empeoramiento del asma<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><i><span lang=3DES style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Trastornos
  gastrointestinales<o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Frecuentes</span><span
  lang=3DES style=3D'mso-ansi-language:ES'><o:p></o:p></span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-ansi-language:ES'>Do=
lor
  abdominal, distensin abdominal, molestias abdominales, nuseas, vmitos,
  diarrea<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7'>
  <td width=3D205 rowspan=3D4 valign=3Dtop style=3D'width:153.5pt;border:so=
lid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><i><span lang=3DES style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Trastornos del aparato
  reproductor y de la mama<o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Muy frecuentes</span><=
span
  lang=3DES style=3D'mso-ansi-language:ES'><o:p></o:p></span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-ansi-language:ES'>Qu=
istes
  ovricos<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:8'>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Frecuentes</span><span
  lang=3DES style=3D'mso-ansi-language:ES'><o:p></o:p></span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-ansi-language:ES'>SH=
O leve o
  moderado (incluida la sintomatologa relacionada)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:9'>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-ansi-language:ES'>Po=
co
  frecuentes<o:p></o:p></span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-ansi-language:ES'>SH=
O grave
  (incluida la sintomatologa relacionada) (ver seccin&nbsp;4.4)<o:p></o:p=
></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:10'>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Raras</span><span lang=
=3DES
  style=3D'mso-ansi-language:ES'><o:p></o:p></span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-ansi-language:ES'>Co=
mplicacin
  del sndrome de hiperestimulacin ovrica grave<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:11;mso-yfti-lastrow:yes'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lan=
g=3DES
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'>Trastornos gener=
ales y
  alteraciones en el lugar de administracin<o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Muy frecuentes</span><=
span
  lang=3DES style=3D'mso-ansi-language:ES'><o:p></o:p></span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-ansi-language:ES'>Re=
acciones
  la zona de inyeccin (por ejemplo, dolor, eritema, hematoma, hinchazn o
  irritacin en la zona de inyeccin)<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt;tab-=
stops:
.5in'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt;tab-=
stops:
.5in'><i style=3D'mso-bidi-font-style:normal'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Tratamiento en ho=
mbres<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt;tab-=
stops:
.5in'><i><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></i></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;border:none;mso-border-bottom-alt:solid =
windowtext .5pt;
 mso-yfti-tbllook:480;mso-padding-alt:0in 5.4pt 0in 5.4pt;mso-border-inside=
h:
 .5pt solid windowtext;mso-border-insidev:.5pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D614 colspan=3D3 valign=3Dtop style=3D'width:460.6pt;border:no=
ne;
  border-bottom:solid windowtext 1.0pt;mso-border-bottom-alt:solid windowte=
xt .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span la=
ng=3DES
  style=3D'mso-ansi-language:ES'>Tabla&nbsp;2: Reacciones adversas en hombr=
es<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span la=
ng=3DES
  style=3D'mso-ansi-language:ES'>Sistema de clasificacin de rganos <o:p><=
/o:p></span></b></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span la=
ng=3DES
  style=3D'mso-ansi-language:ES'>Frecuencia <o:p></o:p></span></b></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span la=
ng=3DES
  style=3D'mso-ansi-language:ES'>Reaccin adversa<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:.5in'><i style=3D'mso-bidi-font-style:no=
rmal'><span
  lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'>Trasto=
rnos del
  sistema inmunolgico</span></i><i style=3D'mso-bidi-font-style:normal'><s=
pan
  lang=3DES style=3D'mso-ansi-language:ES'><o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Muy raras</span><span
  lang=3DES style=3D'mso-ansi-language:ES'><o:p></o:p></span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-ansi-language:ES'>Re=
acciones
  de hipersensibilidad de leves a graves, incluyendo shock y reacciones ana=
filcticas<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:.5in'><i><span lang=3DES style=3D'mso-bi=
di-font-size:
  11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Trastornos
  respiratorios, torcicos y mediastnicos</span></i><i style=3D'mso-bidi-f=
ont-style:
  normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-langu=
age:
  ES'><o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Muy raras</span><span
  lang=3DES style=3D'mso-ansi-language:ES'><o:p></o:p></span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-ansi-language:ES'>Ex=
acerbacin
  o empeoramiento del asma<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><i><span lang=3DES style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Trastornos de la piel y
  del tejido subcutneo<o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Frecuentes</span><span
  lang=3DES style=3D'mso-ansi-language:ES'><o:p></o:p></span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Acn</span><span lang=
=3DES
  style=3D'mso-ansi-language:ES'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><i><span lang=3DES style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Trastornos del aparato
  reproductor y de la mama<o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Frecuentes<o:p></o:p><=
/span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-ansi-language:ES'>Gi=
necomastia,
  varicocele</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color=
:black;
  mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lan=
g=3DES
  style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'>Trastornos gener=
ales y
  alteraciones en el lugar de administracin</span></i><i style=3D'mso-bidi=
-font-style:
  normal'><span lang=3DES style=3D'mso-ansi-language:ES'><o:p></o:p></span>=
</i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Muy frecuentes</span><=
span
  lang=3DES style=3D'mso-ansi-language:ES'><o:p></o:p></span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-ansi-language:ES'>Re=
acciones
  en la zona de inyeccin (por ejemplo, dolor, eritema, hematoma, hinchazn=
 y/o
  irritacin en la zona de inyeccin)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7;mso-yfti-lastrow:yes'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><i><span lang=3DES style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Exploraciones compleme=
ntarias<o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
  color:black;mso-ansi-language:ES;mso-no-proof:yes'>Frecuentes<o:p></o:p><=
/span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DES style=3D'mso-ansi-language:ES'>Au=
mento de
  peso</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;
  mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt;tab-=
stops:
.5in'><i><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><u><span lang=3DES style=3D'm=
so-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Notificacin de sospechas de
reacciones adversas<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Es importante notificar sospe=
chas
de reacciones adversas al medicamento tras su autorizacin. Ello permite una
supervisin continuada de la relacin beneficio/riesgo del medicamento. Se
invita a los profesionales sanitarios a notificar las sospechas de reaccion=
es
adversas a travs del <span style=3D'background:lightgrey;mso-highlight:lig=
htgrey'>sistema
nacional de notificacin incluido en el </span></span><span lang=3DEN-GB><a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc"><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;background:lightgrey;mso-highl=
ight:
lightgrey;mso-ansi-language:ES'>Apndice&nbsp;V</span></a></span><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>4.9<span style=3D'mso-tab-cou=
nt:
1'> </span></span></b><b><span lang=3DES style=3D'mso-ansi-language:ES'=
>Sobredosis</span></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Los efectos de una sobredosis de folitropina alfa son desconocidos; sin
embargo, existe la posibilidad de que se produzca un sndrome de
hiperestimulacin ovrica (ver seccin&nbsp;4.4)</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid'><b style=3D'mso-bidi-fo=
nt-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>5.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>PROPIEDADES FARMACOLGICAS</span><=
/b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-outline-level:1'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>5.1<span style=3D'mso-tab-cou=
nt:
1'> </span></span></b><b><span lang=3DES style=3D'mso-ansi-language:ES'=
>Propiedades
farmacodinmicas</span></b><span lang=3DES style=3D'mso-bidi-font-size:11.0=
pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-bidi-font-style=
:italic;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Grupo farmacoteraputico: hormonas sexuales y moduladores del sistema
genital, gonadotropinas. Cdigo ATC</span><span lang=3DES style=3D'mso-bidi=
-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>: G03GA05.<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap</span><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES'> es
un medicamento biosimilar. La i</span><span lang=3DES style=3D'mso-bidi-fon=
t-size:
12.0pt;mso-ansi-language:ES'>nformacin detallada sobre este medicamento es=
t
disponible en la pgina web de la Agencia Europea de Medicamentos </span><s=
pan
lang=3DEN-GB><a href=3D"http://www.ema.europa.eu"><span lang=3DES style=3D'=
mso-bidi-font-size:
12.0pt;mso-ansi-language:ES'>http://www.ema.europa.eu</span></a></span><span
lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES'>.</span>=
<span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><i style=3D'mso-bidi-font-s=
tyle:
normal'><u><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;
mso-ansi-language:ES;mso-no-proof:yes'>Efectos farmacodinmicos<o:p></o:p><=
/span></u></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>En mujeres, el efecto ms importante que se
produce tras la administracin parenteral de FSH es el desarrollo de folcu=
los
de Graaf maduros. En mujeres con anovulacin, el objetivo del tratamiento c=
on folitropina
alfa es desarrollar un nico folculo de Graaf maduro a partir del cual se
liberar el vulo despus de la administracin de hCG</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><i><u><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>Eficacia clnica y seguridad en mujeres<o:p></o:p></span>=
</u></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>En los ensayos clnicos, las pacientes con d=
ficit
severo de FSH y LH se definieron por un nivel srico de LH endgena de &lt;=
&nbsp;1,2&nbsp;UI/l,
medido en un laboratorio central. Sin embargo, se debe tener en cuenta que
existen variaciones entre las determinaciones de LH realizadas en diferentes
laboratorios</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color=
:black;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>En estudios clnicos comparativos de r&#8209=
;hFSH
(folitropina alfa) y FSH urinaria en las tcnicas de reproduccin asistida =
(ver
tabla&nbsp;3 a continuacin) y en induccin a la ovulacin, la folitropina =
alfa
se mostr ms potente que la FSH urinaria en trminos de una dosis total me=
nor
necesaria y un periodo de tratamiento ms corto para desencadenar la madura=
cin
folicular</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:bl=
ack;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>En las tcnicas de reproduccin asistida, la
folitropina alfa, a una dosis total menor y durante un periodo de tratamien=
to
ms corto que la FSH urinaria, permiti la recuperacin de un nmero mayor =
de
ovocitos, en comparacin con la FSH urinaria</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>Tabla&nbsp;3: Resultados del estudio GF 8407 (estudio paralelo
aleatorizado que compara la eficacia y seguridad de la folitropina alfa con=
 la
FSH urinaria en TRA)<o:p></o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D536
 style=3D'width:402.3pt;margin-left:5.4pt;border-collapse:collapse;border:n=
one;
 mso-border-alt:solid windowtext .5pt;mso-yfti-tbllook:480;mso-padding-alt:
 0in 5.4pt 0in 5.4pt;mso-border-insideh:.5pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D236 valign=3Dtop style=3D'width:177.1pt;border:solid windowte=
xt 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DES
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-n=
o-proof:
  yes'><o:p>&nbsp;</o:p></span></p>
  </td>
  <td width=3D149 valign=3Dtop style=3D'width:111.85pt;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-pagina=
tion:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:.5in;mso-layout-grid-align:none;text-aut=
ospace:
  none'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-=
ansi-language:
  ES;mso-fareast-language:DE;mso-bidi-font-weight:bold'>F</span><span lang=
=3DES
  style=3D'mso-ansi-language:ES'>olitropina alfa</span><span lang=3DES
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-f=
areast-language:
  DE;mso-bidi-font-weight:bold'><o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-pagina=
tion:widow-orphan lines-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DES
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-f=
areast-language:
  DE;mso-bidi-font-weight:bold'>(n =3D 130)</span><span lang=3DES style=3D'=
mso-bidi-font-size:
  11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></sp=
an></p>
  </td>
  <td width=3D151 valign=3Dtop style=3D'width:113.35pt;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-pagina=
tion:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:.5in;mso-layout-grid-align:none;text-aut=
ospace:
  none'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-=
ansi-language:
  ES;mso-fareast-language:DE;mso-bidi-font-weight:bold'>FSH urinaria<o:p></=
o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-pagina=
tion:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:.5in;mso-layout-grid-align:none;text-aut=
ospace:
  none'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-=
ansi-language:
  ES;mso-fareast-language:DE;mso-bidi-font-weight:bold'>(n =3D 116)<span
  style=3D'mso-no-proof:yes'><o:p></o:p></span></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D236 valign=3Dtop style=3D'width:177.1pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DES
  style=3D'mso-ansi-language:ES'>Nmero de ovocitos recuperados</span><span
  lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-languag=
e:ES;
  mso-no-proof:yes'><o:p></o:p></span></p>
  </td>
  <td width=3D149 valign=3Dtop style=3D'width:111.85pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.0pt;margin-b=
ottom:
  0in;margin-left:30.7pt;margin-bottom:.0001pt'><span lang=3DES style=3D'ms=
o-ansi-language:
  ES'>11,0  5,9<o:p></o:p></span></p>
  </td>
  <td width=3D151 valign=3Dtop style=3D'width:113.35pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.0pt;margin-b=
ottom:
  0in;margin-left:33.4pt;margin-bottom:.0001pt'><span lang=3DES style=3D'ms=
o-ansi-language:
  ES'>8,8  4,8<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2'>
  <td width=3D236 valign=3Dtop style=3D'width:177.1pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-1.0pt;tab-stops:15.9pt'><span
  lang=3DES style=3D'mso-ansi-language:ES'>Das de estimulacin con FSH<o:p=
></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.0pt;margin-b=
ottom:
  0in;margin-left:5.1pt;margin-bottom:.0001pt;text-indent:-5.1pt'><span
  lang=3DES style=3D'mso-ansi-language:ES'>requeridos<o:p></o:p></span></p>
  </td>
  <td width=3D149 valign=3Dtop style=3D'width:111.85pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.0pt;margin-b=
ottom:
  0in;margin-left:30.55pt;margin-bottom:.0001pt'><span lang=3DES
  style=3D'mso-ansi-language:ES'>11,7  1,9<o:p></o:p></span></p>
  </td>
  <td width=3D151 valign=3Dtop style=3D'width:113.35pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.0pt;margin-b=
ottom:
  0in;margin-left:30.6pt;margin-bottom:.0001pt'><span lang=3DES style=3D'ms=
o-ansi-language:
  ES'>14,5  3,3<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3'>
  <td width=3D236 valign=3Dtop style=3D'width:177.1pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-right:-1.0pt'><span lang=3DES
  style=3D'mso-ansi-language:ES'>Dosis total de FSH requerida (nmero de am=
pollas
  de FSH 75 UI)<o:p></o:p></span></p>
  </td>
  <td width=3D149 valign=3Dtop style=3D'width:111.85pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.0pt;margin-b=
ottom:
  0in;margin-left:27.8pt;margin-bottom:.0001pt'><span lang=3DES style=3D'ms=
o-ansi-language:
  ES'>27,6  10,2<o:p></o:p></span></p>
  </td>
  <td width=3D151 valign=3Dtop style=3D'width:113.35pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.0pt;margin-b=
ottom:
  0in;margin-left:27.85pt;margin-bottom:.0001pt'><span lang=3DES
  style=3D'mso-ansi-language:ES'>40,7  13,6<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;mso-yfti-lastrow:yes'>
  <td width=3D236 valign=3Dtop style=3D'width:177.1pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.0pt;margin-b=
ottom:
  0in;margin-left:5.1pt;margin-bottom:.0001pt;text-indent:-5.1pt'><span
  lang=3DES style=3D'mso-ansi-language:ES'>Necesidad de aumentar la dosis (=
%)<o:p></o:p></span></p>
  </td>
  <td width=3D149 valign=3Dtop style=3D'width:111.85pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
40.2pt;
  margin-bottom:0in;margin-left:41.6pt;margin-bottom:.0001pt;text-align:cen=
ter'><span
  lang=3DES style=3D'mso-ansi-language:ES'>56,2<o:p></o:p></span></p>
  </td>
  <td width=3D151 valign=3Dtop style=3D'width:113.35pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-top:0in;margin-right:=
40.35pt;
  margin-bottom:0in;margin-left:41.55pt;margin-bottom:.0001pt;text-align:ce=
nter'><span
  lang=3DES style=3D'mso-ansi-language:ES'>85,3<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-far=
east-language:
DE'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-far=
east-language:
DE'>Las diferencias entre los dos grupos fueron estadsticamente significat=
ivas
(p&nbsp;&lt;&nbsp;0,05) para todos los criterios listados.<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-far=
east-language:
DE'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><i><u><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>Eficacia clnica y seguridad en hombres<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>En hombres con dficit de FSH, la folitropin=
a alfa
administrada concomitantemente con hCG durante al menos 4&nbsp;meses induce=
 la
espermatognesis.</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-bidi-font-style=
:italic;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-outline-level:1'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>5.2<span style=3D'mso-tab-cou=
nt:
1'> </span></span></b><b><span lang=3DES style=3D'mso-ansi-language:ES'=
>Propiedades
farmacocinticas</span></b><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-bidi-font-style=
:italic;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip'><span lang=
=3DES
style=3D'mso-ansi-language:ES'>Tras la administracin intravenosa, la folit=
ropina
alfa se distribuye en el espacio extracelular. La semivida de distribucin =
es
de unas 2&nbsp;horas y la semivida de eliminacin, de alrededor de 1&nbsp;d=
a.
En estado estacionario, el volumen de distribucin es de <st1:metricconvert=
er
ProductID=3D"10&#65440;l" w:st=3D"on">10&nbsp;l</st1:metricconverter> y el
aclaramiento total, de 0,6&nbsp;l/h. La octava parte de la dosis de folitro=
pina
alfa administrada se excreta en la orina</span><span lang=3DES style=3D'mso=
-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-bidi-font-style:italic;mso-no-p=
roof:
yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-bid=
i-font-style:
italic;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip'><span lang=
=3DES
style=3D'mso-ansi-language:ES'>Tras la administracin subcutnea, la
biodisponibilidad absoluta es de alrededor del 70&nbsp;%. Tras la
administracin de dosis repetidas de folitropina alfa, se produce una
acumulacin de 3&nbsp;veces, alcanzando un equilibrio estacionario en un
periodo de 3&#8209;4&nbsp;das. En mujeres con supresin de la secrecin
endgena de gonadotropinas, la folitropina alfa estimula de forma adecuada =
el
desarrollo folicular y la esteroidognesis, a pesar de unos niveles
indetectables de LH</span><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
color:black;mso-ansi-language:ES;mso-bidi-font-style:italic;mso-no-proof:ye=
s'>.
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-bidi-font-style=
:italic;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-outline-level:1'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>5.3<span style=3D'mso-tab-cou=
nt:
1'> </span></span></b><b><span lang=3DES style=3D'mso-ansi-language:ES'=
>Datos
preclnicos sobre seguridad</span></b><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DES style=3D'mso-ansi-la=
nguage:
ES'>Los datos de los estudios no clnicos no muestran riesgos especiales pa=
ra
los seres humanos segn los estudios convencionales de toxicidad a dosis n=
ica
y a dosis repetidas y genotoxicidad, adicionales a los ya descritos en otras
secciones de esta ficha tcnica</span><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Se han observado trastornos de la fertilidad en ratas expuestas a dosis
farmacolgicas de folitropina alfa (&#8805;&nbsp;40&nbsp;UI/kg/da) durante
largos perodos de tiempo, mostrando una disminucin de la fecundidad</span=
><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>La administracin de dosis altas (&#8805;&nbsp;5&nbsp;UI/kg/da) de fol=
itropina
alfa produjo un descenso en el nmero de fetos viables, aunque no tuvo efec=
tos
teratgenos, as como distocia similar a la observada con la hormona
Gonadotropina Menopusica (hMG) urinaria. Sin embargo, puesto que Ovaleap no
est indicado en el embarazo, estos datos tienen escasa relevancia clnica<=
/span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid'><b style=3D'mso-bidi-fo=
nt-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>6.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>DATOS FARMACUTICOS</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-outline-level:1'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>6.1<span style=3D'mso-tab-cou=
nt:
1'> </span></span></b><b><span lang=3DES style=3D'mso-ansi-language:ES'=
>Lista
de excipientes</span></b><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'colo=
r:black;
mso-ansi-language:ES'>Dihidrogenofosfato de sodio dihidrato</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'colo=
r:black;
mso-ansi-language:ES'>Hidrxido de sodio (<st1:metricconverter ProductID=3D=
"2&#65440;M"
w:st=3D"on">2&nbsp;M</st1:metricconverter>) (para ajuste del pH)<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Manitol<o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Metionina</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;colo=
r:black;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Polisorbato 20<o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Alcohol benclico=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Cloruro de benzal=
conio<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Agua para preparaciones inyectables</span><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span=
></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>6.2<span style=3D'mso-tab-cou=
nt:
1'> </span></span></b><b><span lang=3DES style=3D'mso-ansi-language:ES'=
>Incompatibilidades</span></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>En ausencia de
estudios de compatibilidad, este medicamento no debe mezclarse con otros.<o=
:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>6.3<span style=3D'mso-tab-cou=
nt:
1'> </span></span></b><b><span lang=3DES style=3D'mso-ansi-language:ES'=
>Periodo
de validez</span></b><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:red;mso-ansi-language:ES;mso-no-proof:yes'>3&nbsp;</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>aos.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><u><span lang=3DES style=3D'mso-bidi=
-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Periodo de validez y condicio=
nes
de conservacin tras la primera apertura<span style=3D'color:black'><o:p></=
o:p></span></span></u></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>El cartucho en uso dentro de la pluma se puede conservar durante un per=
iodo
mximo de 28&nbsp;das. No conservar a temperatura superior a <st1:metricco=
nverter
ProductID=3D"25&#65466;C" w:st=3D"on">25C</st1:metricconverter></span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.</span><span lang=3DES style=3D'mso-ansi-language:ES'> El
paciente debe anotar la fecha del primer uso en el diario del paciente
suministrado con la Ovaleap Pen</span><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>La cpsula de cie=
rre
de la pluma se debe recolocar en la misma despus de cada inyeccin para
protegerla de la luz.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>6.4<span style=3D'mso-tab-cou=
nt:
1'> </span></span></b><b><span lang=3DES style=3D'mso-ansi-language:ES'=
>Precauciones
especiales de conservacin</span></b><b style=3D'mso-bidi-font-weight:norma=
l'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Conservar en nevera (entre <st1:metricconverter ProductID=3D"2&#65466;C"
w:st=3D"on">2C</st1:metricconverter> y <st1:metricconverter ProductID=3D"8=
&#65466;C"
w:st=3D"on">8C</st1:metricconverter>).</span><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>No congelar.</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES;mso-no-proof:yes'>Conservar<b style=3D'mso-bidi-font-weight:normal'> </b=
>el
cartucho en el embalaje exterior</span><span lang=3DES style=3D'mso-bidi-fo=
nt-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'> </span><span
lang=3DES style=3D'mso-ansi-language:ES;mso-no-proof:yes'>para protegerlo d=
e la luz</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Antes de la apertura y dentro de su periodo de validez, el medicamento
puede extraerse de la nevera, sin refrigerar de nuevo, hasta un mximo de 3=
&nbsp;meses.
No conservar a temperatura superior a <st1:metricconverter ProductID=3D"25&=
#65466;C"
w:st=3D"on">25C</st1:metricconverter>. El medicamento debe desecharse si d=
espus
de 3&nbsp;meses no se ha utilizado.</span><span lang=3DES style=3D'mso-bidi=
-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>Para las
condiciones de conservacin tras la primera apertura del medicamento, ver
seccin&nbsp;6.3.</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;mso-outline-level:1'><b style=3D'mso-bidi-font-weigh=
t:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>6.5<span style=3D'mso-tab-count:1'> </span></span></b=
><b><span
lang=3DES style=3D'mso-ansi-language:ES'>Naturaleza y contenido del envase<=
/span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><u><span lang=3DES style=3D'mso-bidi=
-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap
300&nbsp;UI/0,5&nbsp;ml </span></u><u><span lang=3DES style=3D'mso-ansi-lan=
guage:
ES'>solucin inyectable</span></u><span lang=3DES style=3D'mso-ansi-languag=
e:ES'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DES style=3D'mso-ansi-la=
nguage:
ES'>Cartucho </span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;colo=
r:black;
mso-ansi-language:ES;mso-no-proof:yes'>(</span><span lang=3DES style=3D'mso=
-ansi-language:
ES'>vidrio de tipo I</span><span lang=3DES style=3D'mso-bidi-font-size:11.0=
pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>) con un pistn de goma =
(goma
de bromobutilo) y una cpsula de cierre (aluminio) con un septo (goma de br=
omobutilo),
que contiene </span><span lang=3DES style=3D'mso-ansi-language:ES'>0,5&nbsp=
;ml de solucin.</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DES style=3D'mso-bidi-fo=
nt-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Agujas para inyec=
cin
(acero inoxidable; 0,33&nbsp;mm&nbsp;x&nbsp;12&nbsp;mm, 29&nbsp;G&nbsp;x&nb=
sp;&quot;).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-pagination:widow-orphan lines-together;page-break-after:avoid;mso-layou=
t-grid-align:
none;text-autospace:none'><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
color:black;background:lightgrey;mso-highlight:lightgrey;mso-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-pagination:widow-orphan lines-together;page-break-after:avoid;mso-layou=
t-grid-align:
none;text-autospace:none'><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>Tamao de envase de 1&nb=
sp;cartucho
y 10&nbsp;</span><span lang=3DES style=3D'mso-ansi-language:ES'>agujas para
inyeccin</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:bl=
ack;
mso-ansi-language:ES;mso-no-proof:yes'>.<span style=3D'background:lightgrey;
mso-highlight:lightgrey'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;color:black;background:lightgrey;mso-highlight:lightgrey;mso-ansi-la=
nguage:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'>Puede que solamente estn comercializados algunos tama=
os
de envases</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ans=
i-language:
ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><u><span lang=3DES style=3D'mso-bidi=
-font-size:
11.0pt;mso-ansi-language:ES;mso-bidi-font-style:italic;mso-no-proof:yes'>Ov=
aleap
450&nbsp;UI/0,75&nbsp;ml solucin inyectable</span></u><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DES style=3D'mso-bidi-fo=
nt-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>C</span><span
lang=3DES style=3D'mso-ansi-language:ES'>artucho </span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>(</span><span lang=3DES style=3D'mso-ansi-language:ES'>vidrio de tipo =
I</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>) con un pistn de goma (goma de bromobutilo) y una cpsu=
la
de cierre (aluminio) con un septo (goma de bromobutilo), que contiene </spa=
n><span
lang=3DES style=3D'mso-ansi-language:ES'>0,75&nbsp;ml de solucin.</span><s=
pan
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DES style=3D'mso-bidi-fo=
nt-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Agujas para inyec=
cin
(acero inoxidable; 0,33&nbsp;mm&nbsp;x&nbsp;12 mm,
29&nbsp;G&nbsp;x&nbsp;&quot;).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-pagination:widow-orphan lines-together;page-break-after:avoid;mso-layou=
t-grid-align:
none;text-autospace:none'><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span>=
</p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DES style=3D'mso-bidi-fo=
nt-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Tamao de envase =
de
1&nbsp;cartucho y 10&nbsp;</span><span lang=3DES style=3D'mso-ansi-language=
:ES'>agujas
para inyeccin</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;col=
or:black;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;color:black;background:lightgrey;mso-highlight:lightgrey;mso-ansi-la=
nguage:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'>Puede que solamente estn comercializados algunos tama=
os
de envases</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ans=
i-language:
ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><u><span lang=3DES style=3D'mso-bidi=
-font-size:
11.0pt;mso-ansi-language:ES;mso-bidi-font-style:italic;mso-no-proof:yes'>Ov=
aleap
900&nbsp;UI/1,5&nbsp;ml solucin inyectable</span></u><span lang=3DES
style=3D'mso-ansi-language:ES'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DES style=3D'mso-ansi-la=
nguage:
ES'>Cartucho </span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;colo=
r:black;
mso-ansi-language:ES;mso-no-proof:yes'>(</span><span lang=3DES style=3D'mso=
-ansi-language:
ES'>vidrio de tipo I</span><span lang=3DES style=3D'mso-bidi-font-size:11.0=
pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>) con un pistn de goma
(goma de bromobutilo) y una cpsula de cierre (aluminio) con un septo (goma=
 de
bromobutilo), que contiene </span><span lang=3DES style=3D'mso-ansi-languag=
e:ES'>1,5&nbsp;ml
de solucin.</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color=
:black;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DES style=3D'mso-bidi-fo=
nt-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Agujas para inyec=
cin
(acero inoxidable; 0,33&nbsp;mm&nbsp;x&nbsp;12&nbsp;mm,
29&nbsp;G&nbsp;x&nbsp;&quot;).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DES style=3D'mso-bidi-fo=
nt-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DES style=3D'mso-bidi-fo=
nt-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Tamao de envase =
de
1&nbsp;cartucho y 20&nbsp;</span><span lang=3DES style=3D'mso-ansi-language=
:ES'>agujas
para inyeccin</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;col=
or:black;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'>Puede que solamente estn comercializados algunos tama=
os
de envases</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ans=
i-language:
ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1'><a name=3D"OLE_LINK1"><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>6=
.6<span
style=3D'mso-tab-count:1'> </span></span></b></a><span style=3D'mso-boo=
kmark:
OLE_LINK1'><b><span lang=3DES style=3D'mso-ansi-language:ES'>Precauciones
especiales de eliminacin y otras manipulaciones</span></b></span><span
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DES style=3D'mso-bidi-font-siz=
e:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></span></p>

<span style=3D'mso-bookmark:OLE_LINK1'></span>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
12.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Ninguna especial para su
eliminacin</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-an=
si-language:
ES;mso-no-proof:yes'>.</span><span lang=3DES style=3D'mso-ansi-language:ES'=
><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>La solucin no se debe usar si contiene partculas o si la solucin no =
es transparente</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap </span><s=
pan
lang=3DES style=3D'mso-ansi-language:ES'>est diseado </span><span lang=3D=
ES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>para uso exclusivo con la Ovaleap Pen.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Se deben seguir
minuciosamente las instrucciones de uso de la pluma.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Cada cartucho se =
debe
usar en un nico paciente.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Los cartuchos vac=
os
no deben rellenarse. Los cartuchos Ovaleap </span><span lang=3DES
style=3D'mso-ansi-language:ES'>no estn diseados para permitir </span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>la mezcla de ningn otro medicamento en el cartucho.</spa=
n><span
lang=3DES style=3D'mso-ansi-language:ES'> Las agujas utilizadas se deben de=
sechar
inmediatamente tras la inyeccin.</span><span lang=3DES style=3D'mso-bidi-f=
ont-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>7.<span style=3D'mso-tab-coun=
t:
1'> </span></span></b><b><span lang=3DES style=3D'mso-ansi-language:E=
S'>TITULAR
DE LA AUTORIZACIN DE COMERCIALIZACIN</span></b><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Theramex Ireland Limited<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-family:
Verdana;color:black'>3<sup>rd</sup> Floor, </span><span lang=3DNL
style=3D'mso-ansi-language:NL'>Kilmore House,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Park Lane, Spencer Dock,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Dublin 1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>D01 YE64<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Irlanda<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>8.<span style=3D'mso-tab-coun=
t:
1'> </span></span></b><b><span lang=3DES style=3D'mso-ansi-language:E=
S'>NMERO(S)
DE AUTORIZACIN DE COMERCIALIZACIN</span></b><b style=3D'mso-bidi-font-wei=
ght:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'> <o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap
300&nbsp;UI/0,5&nbsp;ml </span></u><u><span lang=3DES style=3D'mso-ansi-lan=
guage:
ES'>solucin inyectable</span></u><span lang=3DES style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'>EU/1/13/871/001<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:ES;mso-bidi-font-style:italic;mso-no-proof:yes'>Ovaleap
450&nbsp;UI/0,75&nbsp;ml solucin inyectable</span></u><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'>EU/1/13/871/002<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:ES;mso-bidi-font-style:italic;mso-no-proof:yes'>Ovaleap
900&nbsp;UI/1,5&nbsp;ml solucin inyectable</span></u><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'>EU/1/13/871/003<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>9.<span style=3D'mso-tab-coun=
t:
1'> </span></span></b><b><span lang=3DES style=3D'mso-ansi-language:E=
S'>FECHA
DE LA PRIMERA AUTORIZACIN/RENOVACIN DE LA AUTORIZACIN</span></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Fecha de la primera autorizacin</span><span lang=3DES style=3D'mso-bid=
i-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>: 27/septiembre/2=
013.<i
style=3D'mso-bidi-font-style:normal'><o:p></o:p></i></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'>Fecha de la ltima renovacin: 16/mayo/2018.<o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>10.<span style=3D'mso-tab-cou=
nt:
1'> </span></span></b><b><span lang=3DES style=3D'mso-ansi-language:ES'=
>FECHA
DE LA REVISIN DEL TEXTO</span></b><b style=3D'mso-bidi-font-weight:normal'=
><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-bidi-font-style=
:italic;
mso-no-proof:yes'>La informacin detallada de este medicamento est disponi=
ble
en la pgina web de la Agencia Europea de Medicamentos </span><span lang=3D=
EN-GB><a
href=3D"http://www.ema.europa.eu"><span lang=3DES style=3D'mso-bidi-font-si=
ze:12.0pt;
mso-ansi-language:ES;mso-no-proof:yes'>http://www.ema.e<span style=3D'mso-b=
ookmark:
_Hlt145757343'><span style=3D'mso-bookmark:_Hlt145757344'>u</span></span>ro=
p<span
style=3D'mso-bookmark:_Hlt145757384'>a</span>.eu</span></a><![if !supportNe=
stedAnchors]><a
name=3D"_Hlt145757384"></a><a name=3D"_Hlt145757344"></a><a name=3D"_Hlt145=
757343"></a><![endif]></span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>.<o:p></o:p></span></p>

<b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'font-size=
:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:SimSun;mso-ansi=
-language:
ES;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br
clear=3Dall style=3D'mso-special-character:line-break;page-break-before:alw=
ays'>
</span></b>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b><span la=
ng=3DES
style=3D'mso-ansi-language:ES'>ANEXO II</span></b><span lang=3DES style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:42.45pt;margin-bo=
ttom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>A.<span style=3D'mso-tab-coun=
t:
1'> </span></span></b><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>FABRICANTE DEL PRINCIPIO ACTIVO BIOLGICO Y FABRICANTES RESPONSABLES D=
E LA
LIBERACIN DE LOS LOTES</span></b><b style=3D'mso-bidi-font-weight:normal'>=
<span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:42.45pt;margin-bo=
ttom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>B.<span style=3D'mso-tab-coun=
t:
1'> </span></span></b><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>CONDICIONES O RESTRICCIONES DE SUMINISTRO Y USO</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:42.45pt;margin-bo=
ttom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>C.<span style=3D'mso-tab-coun=
t:
1'> </span></span></b><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>OTRAS CONDICIONES Y REQUISITOS DE LA AUTORIZACIN DE COMERCIALIZACIN<=
/span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:77.9pt;margin-bot=
tom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:42.45pt;margin-bo=
ttom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt;mso-pagin=
ation:
widow-orphan no-line-numbers'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'>D.<span
style=3D'mso-tab-count:1'> </span></span></b><b style=3D'mso-bidi-fo=
nt-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:12.0pt;text-transform:u=
ppercase;
mso-ansi-language:ES'>Condiciones o restricciones EN RELACIN CON LA UTILIZ=
ACIN
SEGURA y EFICAZ del medicamento</span></b><b style=3D'mso-bidi-font-weight:=
normal'><span
lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'> </span></b><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ans=
i-language:
ES;mso-no-proof:yes'><o:p></o:p></span></p>

<b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'font-size=
:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:SimSun;mso-ansi=
-language:
ES;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br
clear=3Dall style=3D'page-break-before:always'>
</span></b>

<p class=3DTitleB><span lang=3DES style=3D'mso-ansi-language:ES'>A.<span
style=3D'mso-tab-count:1'> </span>FABRICANTE DEL PRINCIPIO ACTIVO BIOL=
GICO
Y FABRICANTES RESPONSABLES DE LA LIBERACIN DE LOS LOTES<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-outline-level:1'><u
style=3D'text-underline:black'><span lang=3DES style=3D'mso-ansi-language:E=
S'>Nombre
y direccin del fabricante del principio activo biolgico</span></u><u><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE;mso-bidi-=
font-weight:
bold'>Teva Biotech GmbH<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE;mso-bidi-=
font-weight:
bold'>Dornierstrae 10<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE;mso-bidi-=
font-weight:
bold'>D-89079 Ulm<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;tab-stops:.5in'><span la=
ng=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'>Alemania<o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-outline-level:1'><u
style=3D'text-underline:black'><span lang=3DES style=3D'mso-ansi-language:E=
S'>Nombre
y direccin de </span></u><u><span lang=3DES style=3D'mso-bidi-font-size:11=
.0pt;
mso-ansi-language:ES;mso-no-proof:yes'>los fabricantes responsables de la
liberacin de los lotes</span></u><span lang=3DES style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE;mso-bidi-=
font-weight:
bold'>Teva Biotech GmbH<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE;mso-bidi-=
font-weight:
bold'>Dornierstrae 10<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE;mso-bidi-=
font-weight:
bold'>D-89079 Ulm<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;tab-stops:.5in'><span la=
ng=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'>Alemania<o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Teva Pharmaceuticals Europe B=
.V.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Swensweg 5<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>NL-2031 GA Haarlem<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Pases Bajos</span><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Merckle GmbH<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Graf-Arco-Strae 3<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>89079 Ulm, <o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;tab-stops:.5in'><span la=
ng=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'>Alemania<o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES;mso-no-p=
roof:yes'>El
prospecto impreso del medicamento debe especificar el nombre y direccin del
fabricante responsable de la liberacin del lote en cuestin.<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DTitleB><a name=3D"OLE_LINK2"><span lang=3DES style=3D'mso-ansi-l=
anguage:
ES'>B.</span></a><span lang=3DES style=3D'mso-ansi-language:ES'><span
style=3D'mso-tab-count:1'> </span>CONDICIONES O RESTRICCIONES DE SUMIN=
ISTRO
Y USO<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-list:skip'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>M=
edicamento
sujeto a prescripcin mdica restringida (ver Anexo I: Ficha Tcnica o Resu=
men
de las Caractersticas del Producto, seccin&nbsp;4.2).<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-list:skip'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-list:skip'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DTitleB><span lang=3DES style=3D'mso-ansi-language:ES'>C.<span
style=3D'mso-tab-count:1'> </span>OTRAS CONDICIONES Y REQUISITOS DE LA
AUTORIZACIN DE COMERCIALIZACIN<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l19 level1 lfo4'><![if !supportLists]><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fami=
ly:
Symbol;mso-ansi-language:ES;mso-no-proof:yes'><span style=3D'mso-list:Ignor=
e'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>Informes peridicos de seguridad </span></b><b style=3D'mso-bidi-font-=
weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-languag=
e:ES'>(IPS)</span></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-ansi-language:
ES'>Los requerimientos para la presentacin de los informes peridicos de
seguridad para este medicamento se establecen en la lista de fechas de
referencia de la Unin (lista EURD) prevista en el artculo 107quater, apar=
tado
7, de la Directiva 2001/83/CE y cualquier actualizacin posterior publicada=
 en
el portal web europeo sobre medicamentos</span><span lang=3DES style=3D'mso=
-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DTitleB><span lang=3DES style=3D'mso-ansi-language:ES'>D.<span
style=3D'mso-tab-count:1'> </span>CONDICIONES O RESTRICCIONES EN RELAC=
IN
CON LA UTILIZACIN SEGURA Y EFICAZ DEL MEDICAMENTO<o:p></o:p></span></p>

<p class=3DTitleB><span lang=3DES style=3D'mso-ansi-language:ES'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-28.4pt;margin-bo=
ttom:
0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.5in;mso-pagination:
widow-orphan no-line-numbers;mso-list:l19 level1 lfo4'><![if !supportLists]=
><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast=
-font-family:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-bidi-font-weigh=
t:
bold'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New=
 Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b><span lang=3DES style=3D'mso-bidi-font-si=
ze:12.0pt;
mso-ansi-language:ES;mso-no-proof:yes'>Plan de Gestin de Riesgos (PGR)</sp=
an></b><b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'><o:p></o=
:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:28.35pt;tab-stops:0in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:28.35pt;tab-stops:0in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES;mso-no-proof:yes'>El TAC realizar las activi=
dades
e intervenciones de farmacovigilancia necesarias segn lo acordado en la
versin del PGR incluido en el Mdulo 1.8.2 de la Autorizacin de
Comercializacin y en cualquier actualizacin del PGR que se acuerde
posteriormente.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:28.35pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:28.35pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
12.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Se debe presentar un PGR
actualizado</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-an=
si-language:
ES;mso-no-proof:yes'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:28.35pt;margin-bo=
ttom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-10.5pt;mso-list:
l19 level1 lfo4'><![if !supportLists]><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fami=
ly:
Symbol;mso-ansi-language:ES;mso-no-proof:yes'><span style=3D'mso-list:Ignor=
e'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>A peticin de la Agencia Europea de Medicamentos.</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:28.35pt;margin-bo=
ttom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-10.5pt;mso-list:
l19 level1 lfo4'><![if !supportLists]><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fami=
ly:
Symbol;mso-ansi-language:ES;mso-no-proof:yes'><span style=3D'mso-list:Ignor=
e'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span></span><!=
[endif]><span
lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>Cuando se modifique el sistema de gestin de riesgos, especialmente co=
mo
resultado de nueva informacin disponible que pueda conllevar cambios
relevantes en el perfil beneficio/riesgo, o como resultado de la consecuci=
n de
un hito importante (farmacovigilancia o minimizacin de riesgos).</span><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.05pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
12.0pt;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'font-size=
:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:SimSun;mso-ansi=
-language:
ES;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br
clear=3Dall style=3D'mso-special-character:line-break;page-break-before:alw=
ays'>
</span></b>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-right:-.05pt;text-align=
:center'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b><span lang=3DES style=3D'mso-ansi-language:ES'>ANEXO III</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b><span lang=3DES style=3D'mso-ansi-language:ES'>ETIQUETADO Y PROSPECTO=
</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<span lang=3DES style=3D'font-size:11.0pt;font-family:"Times New Roman",ser=
if;
mso-fareast-font-family:SimSun;mso-ansi-language:ES;mso-fareast-language:EN=
-US;
mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'mso-spec=
ial-character:
line-break;page-break-before:always'>
</span>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b><=
/p>

<p class=3DTitleA><span lang=3DES style=3D'mso-ansi-language:ES'>A. ETIQUET=
ADO<o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<span lang=3DES style=3D'font-size:11.0pt;font-family:"Times New Roman",ser=
if;
mso-fareast-font-family:SimSun;color:black;mso-color-alt:windowtext;mso-ans=
i-language:
ES;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br
clear=3Dall style=3D'page-break-before:always'>
</span>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=3DMsoNormal style=3D'background:white;border:none;mso-border-alt:s=
olid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DES
style=3D'color:black;mso-color-alt:windowtext;mso-ansi-language:ES'>INFORMA=
CIN
QUE DEBE FIGURAR EN EL EMBALAJE EXTERIOR</span></b><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;back=
ground:
white;mso-shading:transparent;border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-bidi-font-weigh=
t:
bold;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'background:white;mso-shading:transparent;bord=
er:none;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-ansi-lan=
guage:
ES;mso-no-proof:yes'>EMBALAJE</span></b><b style=3D'mso-bidi-font-weight:no=
rmal'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'> EXTERIOR</span></b><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:ES;mso-bidi-font-weight:bold;mso-no-proof:yes'><o:p></o:p=
></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>1=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>NOMBRE DEL MEDICAMENTO</span></b><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap 300&nbsp;=
UI/0,5&nbsp;ml
</span><span lang=3DES style=3D'mso-ansi-language:ES'>solucin inyectable</=
span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>folitro=
pina alfa</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>2=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>PRINCIPIO(S) ACTIVO(S)</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>Cada</s=
pan><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'> cartucho contiene </span><span lang=3DES style=3D'mso-an=
si-language:
ES'>300&nbsp;UI (equivalentes a 22&nbsp;microgramos) de folitropina alfa </=
span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>en 0,5&nbsp;ml de solucin. Cada ml de la solucin contie=
ne </span><span
lang=3DES style=3D'mso-ansi-language:ES'>600&nbsp;UI</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'> </span><span lang=3DES style=3D'mso-ansi-language:ES'>(equivalentes a
44&nbsp;microgramos) de folitropina alfa.</span><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>3=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>LISTA DE EXCIPIENTES</span></b><span lang=3D=
ES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>Excipie=
ntes</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>: dihidrogenofosfato de sodio dihidrato, hidrxido de sodio (<st1:metr=
icconverter
ProductID=3D"2 M" w:st=3D"on">2 M</st1:metricconverter>) (para ajuste del p=
H),
manitol, metionina, polisorbato 20, alcohol benclico, cloruro de benzalcon=
io, </span><span
lang=3DES style=3D'mso-ansi-language:ES'>agua para preparaciones inyectable=
s</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>4=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>FORMA FARMACUTICA Y CONTENIDO DEL ENVASE</s=
pan></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'background:lightgrey;mso-high=
light:
lightgrey;mso-ansi-language:ES'>Solucin inyectable</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>1&nbsp;cartucho c=
on
0,5 ml&nbsp;de solucin y 10&nbsp;</span><span lang=3DES style=3D'mso-ansi-=
language:
ES'>agujas para inyeccin</span><span lang=3DES style=3D'mso-bidi-font-size=
:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>5=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>FORMA Y VA(S) DE ADMINISTRACIN</span></b><=
span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>Para uso exclusivo con la Ovaleap Pen.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>Leer el=
 prospecto
antes de utilizar este medicamento</span><span lang=3DES style=3D'mso-bidi-=
font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-ansi-language:ES'>Va subcutnea</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-fareast-languag=
e:
DE'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>6=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>ADVERTENCIA ESPECIAL DE QUE EL MEDICAMENTO D=
EBE
MANTENERSE FUERA DE LA VISTA Y DEL ALCANCE DE LOS NIOS</span></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1'><span lang=3DES style=3D=
'mso-ansi-language:
ES'>Mantener fuera de la vista y del alcance de los nios</span><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.=
<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>7=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>OTRA(S) ADVERTENCIA(S) ESPECIAL(ES), SI ES
NECESARIO</span></b><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-=
ansi-language:
ES;mso-no-proof:yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-outline-level:1;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>8=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>FECHA DE CADUCIDAD</span></b><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'>CAD<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;tab-stops:.5in'><span =
lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;tab-stops:.5in'><span =
lang=3DES
style=3D'mso-ansi-language:ES'>El cartucho en uso dentro de la pluma puede
conservarse durante un periodo mximo de 28&nbsp;das a temperatura no supe=
rior
a <st1:metricconverter ProductID=3D"25&#65466;C" w:st=3D"on">25C</st1:metr=
icconverter></span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;page=
-break-after:
avoid;mso-outline-level:1;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>9.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>CONDICIONES ESPECIALES DE CONSERVA=
CIN</span></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Conservar en nevera</span><span lang=3DES style=3D'mso-bidi-font-size:1=
1.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>No congelar</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES;mso-no-proof:yes'>Conservar<b style=3D'mso-bidi-font-weight:normal'> </b=
>el
cartucho en el embalaje exterior</span><span lang=3DES style=3D'mso-ansi-la=
nguage:
ES'> para protegerlo de la luz</span><span lang=3DES style=3D'mso-bidi-font=
-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'>Antes de la apertura, puede conservarse a temperatura =
no
superior a<span style=3D'color:black'> </span></span><st1:metricconverter
ProductID=3D"25&#65466;C" w:st=3D"on"><span lang=3DES style=3D'mso-ansi-lan=
guage:ES'>25C</span></st1:metricconverter><span
lang=3DES style=3D'mso-ansi-language:ES'> durante un mximo de 3&nbsp;meses=
</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>. </span><span lang=3DES style=3D'mso-ansi-language:ES'>D=
ebe
desecharse </span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:=
black;
mso-ansi-language:ES;mso-no-proof:yes'>si no se ha utilizado en 3&nbsp;mese=
s.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>1=
0.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>PRECAUCIONES ESPECIALES DE ELIMINACIN DEL M=
EDICAMENTO
NO UTILIZADO Y DE LOS MATERIALES DERIVADOS DE SU USO, CUANDO CORRESPONDA</s=
pan></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>1=
1.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>NOMBRE Y DIRECCIN DEL TITULAR DE LA AUTORIZ=
ACIN
DE COMERCIALIZACIN</span></b><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Theramex Ireland Limited<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-family:
Verdana;color:black'>3<sup>rd</sup> Floor, </span><span lang=3DNL
style=3D'mso-ansi-language:NL'>Kilmore House,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Park Lane, Spencer Dock,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Dublin 1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>D01 YE64<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Irlanda<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>12.<span style=3D'mso-tab-count:1'> </span></span></b=
><b><span
lang=3DES style=3D'mso-ansi-language:ES'>NMERO(S) DE AUTORIZACIN DE
COMERCIALIZACIN</span></b><span lang=3DES style=3D'mso-bidi-font-size:11.0=
pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>EU/1/13/871/001<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>13.<span style=3D'mso-tab-count:1'> </span></span></b=
><b><span
lang=3DES style=3D'mso-ansi-language:ES'>NMERO DE LOTE</span></b><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'>Lote<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>14.<span style=3D'mso-tab-count:1'> </span></span></b=
><b><span
lang=3DES style=3D'mso-ansi-language:ES'>CONDICIONES GENERALES DE DISPENSAC=
IN</span></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:2.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>15.<span style=3D'mso-tab-count:1'> </span></span></b=
><b><span
lang=3DES style=3D'mso-ansi-language:ES'>INSTRUCCIONES DE USO</span></b><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>16.<span style=3D'mso-tab-count:1'> </span>I</span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>NFORMACIN EN </span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>BRAILLE</span></b><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap 300&nbsp;=
UI/0,5&nbsp;ml<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;bac=
kground:
#CCCCCC;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
margin-left:-.15pt;margin-right:0in'>

<p class=3DMsoNormal style=3D'page-break-after:avoid;mso-outline-level:1;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-ansi-language:ES;mso-no-proof:yes'>17.<span style=3D'mso-tab-c=
ount:
1'> </span>IDENTIFICADOR NICO - CDIGO DE BARRAS 2D</span></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DES style=3D'mso-ansi-lang=
uage:ES;
mso-no-proof:yes'><o:p></o:p></span></i></p>

</div>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'background:lightgrey;mso-high=
light:
lightgrey;mso-ansi-language:ES;mso-no-proof:yes'>Incluido el cdigo de barr=
as
2D que lleva el identificador nico.</span><span lang=3DES style=3D'mso-bid=
i-font-size:
11.0pt;background:#CCCCCC;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;bac=
kground:
#CCCCCC;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
margin-left:-.15pt;margin-right:0in'>

<p class=3DMsoNormal style=3D'page-break-after:avoid;mso-outline-level:1;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-ansi-language:ES;mso-no-proof:yes'>18.<span style=3D'mso-tab-c=
ount:
1'> </span>IDENTIFICADOR NICO - INFORMACIN EN CARACTERES VISUALES</sp=
an></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DES style=3D'mso-ansi-lang=
uage:ES;
mso-no-proof:yes'><o:p></o:p></span></i></p>

</div>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>PC:</sp=
an><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>SN:</sp=
an><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'><o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-ansi-language:
ES'>NN:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<span lang=3DES style=3D'font-size:11.0pt;font-family:"Times New Roman",ser=
if;
mso-fareast-font-family:SimSun;color:black;mso-color-alt:windowtext;backgro=
und:
#CCCCCC;mso-ansi-language:ES;mso-fareast-language:EN-US;mso-bidi-language:A=
R-SA;
mso-no-proof:yes'><br clear=3Dall style=3D'page-break-before:always'>
</span>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=3DMsoNormal style=3D'background:white;border:none;mso-border-alt:s=
olid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DES
style=3D'color:black;mso-color-alt:windowtext;mso-ansi-language:ES'>INFORMA=
CIN
QUE DEBE FIGURAR EN EL EMBALAJE EXTERIOR</span></b><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'background:white;border:none;mso-border-alt:s=
olid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'background:white;mso-shading:transparent;bord=
er:none;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b><span
lang=3DES style=3D'mso-ansi-language:ES;mso-no-proof:yes'>EMBALAJE</span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'> EXTERIOR</span></b><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-bidi-font-weigh=
t:
bold;mso-no-proof:yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>1=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>NOMBRE DEL MEDICAMENTO</span></b><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap 450&nbsp;=
UI/0,75&nbsp;ml
</span><span lang=3DES style=3D'mso-ansi-language:ES'>solucin inyectable</=
span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>folitro=
pina alfa</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>2=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>PRINCIPIO(S) ACTIVO(S)</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>Cada</s=
pan><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'> cartucho contiene </span><span lang=3DES style=3D'mso-an=
si-language:
ES'>450&nbsp;UI (equivalentes a 33&nbsp;microgramos) de folitropina alfa </=
span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>en 0,75&nbsp;ml de solucin. Cada ml de la solucin conti=
ene </span><span
lang=3DES style=3D'mso-ansi-language:ES'>600&nbsp;UI</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'> </span><span lang=3DES style=3D'mso-ansi-language:ES'>(equivalentes a
44&nbsp;microgramos) de folitropina alfa.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>3=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>LISTA DE EXCIPIENTES</span></b><span lang=3D=
ES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'>Excipientes: dihidrogenofosfato de sodio dihidrato,
hidrxido de sodio (<st1:metricconverter ProductID=3D"2 M" w:st=3D"on">2 M<=
/st1:metricconverter>)
(para ajuste del pH), manitol, metionina, polisorbato 20, alcohol benclico,
cloruro de benzalconio, </span><span lang=3DES style=3D'mso-ansi-language:E=
S'>agua
para preparaciones inyectables</span><span lang=3DES style=3D'mso-bidi-font=
-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>4=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>FORMA FARMACUTICA Y CONTENIDO DEL ENVASE</s=
pan></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'background:lightgrey;mso-high=
light:
lightgrey;mso-ansi-language:ES'>Solucin inyectable</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>1&nbsp;cartucho c=
on
0,75&nbsp;ml de solucin y 10&nbsp;</span><span lang=3DES style=3D'mso-ansi=
-language:
ES'>agujas para inyeccin</span><span lang=3DES style=3D'mso-bidi-font-size=
:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>5=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>FORMA Y VA(S) DE ADMINISTRACIN</span></b><=
span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>Para uso exclusivo con la Ovaleap Pen.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;bac=
kground:
lightgrey;mso-highlight:lightgrey;mso-ansi-language:ES;mso-no-proof:yes'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>Leer el=
 prospecto
antes de utilizar este medicamento</span><span lang=3DES style=3D'mso-bidi-=
font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-ansi-language:ES'>Va subcutnea</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-fareast-languag=
e:
DE'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>6=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>ADVERTENCIA ESPECIAL DE QUE EL MEDICAMENTO D=
EBE
MANTENERSE FUERA DE LA VISTA Y DEL ALCANCE DE LOS NIOS</span></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1'><span lang=3DES style=3D=
'mso-ansi-language:
ES'>Mantener fuera de la vista y del alcance de los nios</span><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.=
<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>7=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>OTRA(S) ADVERTENCIA(S) ESPECIAL(ES), SI ES
NECESARIO</span></b><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-=
ansi-language:
ES;mso-no-proof:yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-outline-level:1;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>8=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>FECHA DE CADUCIDAD</span></b><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DES style=3D'mso-ansi-language:ES'>CAD<=
/span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;tab-stops:.5in'><span =
lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;tab-stops:.5in'><span =
lang=3DES
style=3D'mso-ansi-language:ES'>El cartucho en uso dentro de la pluma puede
conservarse durante un periodo mximo de 28&nbsp;das a temperatura no supe=
rior
a <st1:metricconverter ProductID=3D"25&#65466;C" w:st=3D"on">25C</st1:metr=
icconverter></span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;page=
-break-after:
avoid;mso-outline-level:1;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>9.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>CONDICIONES ESPECIALES DE CONSERVA=
CIN</span></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Conservar en nevera</span><span lang=3DES style=3D'mso-bidi-font-size:1=
1.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>No congelar</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES;mso-no-proof:yes'>Conservar<b style=3D'mso-bidi-font-weight:normal'> </b=
>el
cartucho en el embalaje exterior</span><span lang=3DES style=3D'mso-ansi-la=
nguage:
ES'> para protegerlo de la luz</span><span lang=3DES style=3D'mso-bidi-font=
-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'>Antes de la apertura, puede conservarse a temperatura =
no
superior a<span style=3D'color:black'> </span></span><st1:metricconverter
ProductID=3D"25&#65466;C" w:st=3D"on"><span lang=3DES style=3D'mso-ansi-lan=
guage:ES'>25C</span></st1:metricconverter><span
lang=3DES style=3D'mso-ansi-language:ES'> durante un mximo de 3&nbsp;meses=
</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>. </span><span lang=3DES style=3D'mso-ansi-language:ES'>D=
ebe
desecharse </span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:=
black;
mso-ansi-language:ES;mso-no-proof:yes'>si no se ha utilizado en 3&nbsp;mese=
s.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>1=
0.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>PRECAUCIONES ESPECIALES DE ELIMINACIN DEL M=
EDICAMENTO
NO UTILIZADO Y DE LOS MATERIALES DERIVADOS DE SU USO, CUANDO CORRESPONDA</s=
pan></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>1=
1.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>NOMBRE Y DIRECCIN DEL TITULAR DE LA AUTORIZ=
ACIN
DE COMERCIALIZACIN</span></b><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Theramex Ireland Limited<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-family:
Verdana;color:black'>3<sup>rd</sup> Floor, </span><span lang=3DNL
style=3D'mso-ansi-language:NL'>Kilmore House,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Park Lane, Spencer Dock,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Dublin 1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>D01 YE64<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Irlanda<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>12.<span style=3D'mso-tab-count:1'> </span></span></b=
><b><span
lang=3DES style=3D'mso-ansi-language:ES'>NMERO(S) DE AUTORIZACIN DE
COMERCIALIZACIN</span></b><span lang=3DES style=3D'mso-bidi-font-size:11.0=
pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>EU/1/13/871/002<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>13.<span style=3D'mso-tab-count:1'> </span></span></b=
><b><span
lang=3DES style=3D'mso-ansi-language:ES'>NMERO DE LOTE</span></b><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'>Lote<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>14.<span style=3D'mso-tab-count:1'> </span></span></b=
><b><span
lang=3DES style=3D'mso-ansi-language:ES'>CONDICIONES GENERALES DE DISPENSAC=
IN</span></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:2.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>15.<span style=3D'mso-tab-count:1'> </span></span></b=
><b><span
lang=3DES style=3D'mso-ansi-language:ES'>INSTRUCCIONES DE USO</span></b><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>16.<span style=3D'mso-tab-count:1'> </span></span></b=
><b><span
lang=3DES style=3D'mso-ansi-language:ES'>INFORMACIN EN BRAILLE</span></b><=
span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap 450&nbsp;=
UI/0,75&nbsp;ml<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;bac=
kground:
#CCCCCC;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;bac=
kground:
#CCCCCC;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
margin-left:-.15pt;margin-right:0in'>

<p class=3DMsoNormal style=3D'page-break-after:avoid;mso-outline-level:1;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-ansi-language:ES;mso-no-proof:yes'>17.<span style=3D'mso-tab-c=
ount:
1'> </span>IDENTIFICADOR NICO - CDIGO DE BARRAS 2D</span></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DES style=3D'mso-ansi-lang=
uage:ES;
mso-no-proof:yes'><o:p></o:p></span></i></p>

</div>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'background:lightgrey;mso-high=
light:
lightgrey;mso-ansi-language:ES;mso-no-proof:yes'>Incluido el cdigo de barr=
as
2D que lleva el identificador nico.</span><span lang=3DES style=3D'mso-bid=
i-font-size:
11.0pt;background:#CCCCCC;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;bac=
kground:
#CCCCCC;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
margin-left:-.15pt;margin-right:0in'>

<p class=3DMsoNormal style=3D'page-break-after:avoid;mso-outline-level:1;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-ansi-language:ES;mso-no-proof:yes'>18.<span style=3D'mso-tab-c=
ount:
1'> </span>IDENTIFICADOR NICO - INFORMACIN EN CARACTERES VISUALES</sp=
an></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DES style=3D'mso-ansi-lang=
uage:ES;
mso-no-proof:yes'><o:p></o:p></span></i></p>

</div>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>PC:</sp=
an><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>SN:</sp=
an><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'><o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-ansi-language:
ES'>NN:<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;bac=
kground:
#CCCCCC;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<span lang=3DES style=3D'font-size:11.0pt;font-family:"Times New Roman",ser=
if;
mso-fareast-font-family:SimSun;color:black;mso-color-alt:windowtext;backgro=
und:
#CCCCCC;mso-ansi-language:ES;mso-fareast-language:EN-US;mso-bidi-language:A=
R-SA;
mso-no-proof:yes'><br clear=3Dall style=3D'page-break-before:always'>
</span>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=3DMsoNormal style=3D'background:white;border:none;mso-border-alt:s=
olid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DES
style=3D'color:black;mso-color-alt:windowtext;mso-ansi-language:ES'>INFORMA=
CIN
QUE DEBE FIGURAR EN EL EMBALAJE EXTERIOR</span></b><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;back=
ground:
white;mso-shading:transparent;border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-bidi-font-weigh=
t:
bold;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'background:white;mso-shading:transparent;bord=
er:none;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b><span
lang=3DES style=3D'mso-ansi-language:ES;mso-no-proof:yes'>EMBALAJE</span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'> EXTERIOR</span></b><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-bidi-font-weigh=
t:
bold;mso-no-proof:yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>1=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>NOMBRE DEL MEDICAMENTO</span></b><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap 900&nbsp;=
UI/1,5&nbsp;ml
solucin inyectable<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>folitro=
pina alfa</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>2=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>PRINCIPIO(S) ACTIVO(S)</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Cada</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:bla=
ck;
mso-ansi-language:ES;mso-no-proof:yes'> cartucho contiene 90</span><span
lang=3DES style=3D'mso-ansi-language:ES'>0&nbsp;UI (equivalentes a
66&nbsp;microgramos) de folitropina alfa </span><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>en 1,5&nbsp;ml de
solucin. Cada ml de la solucin contiene </span><span lang=3DES
style=3D'mso-ansi-language:ES'>600&nbsp;UI</span><span lang=3DES style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'> </span><span
lang=3DES style=3D'mso-ansi-language:ES'>(equivalentes a 44&nbsp;microgramo=
s) de
folitropina alfa.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>3=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>LISTA DE EXCIPIENTES</span></b><span lang=3D=
ES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'>Excipientes: dihidrogenofosfato de sodio dihidrato, hi=
drxido
de sodio (<st1:metricconverter ProductID=3D"2 M" w:st=3D"on">2 M</st1:metri=
cconverter>)
(para ajuste del pH), manitol, metionina, polisorbato 20, alcohol benclico,
cloruro de benzalconio, </span><span lang=3DES style=3D'mso-ansi-language:E=
S'>agua
para preparaciones inyectables</span><span lang=3DES style=3D'mso-bidi-font=
-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>4=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>FORMA FARMACUTICA Y CONTENIDO DEL ENVASE</s=
pan></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'background:lightgrey;mso-high=
light:
lightgrey;mso-ansi-language:ES'>Solucin inyectable</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>1&nbsp;cartucho c=
on
1,5&nbsp;ml de solucin y 20&nbsp;</span><span lang=3DES style=3D'mso-ansi-=
language:
ES'>agujas para inyeccin</span><span lang=3DES style=3D'mso-bidi-font-size=
:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>5=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>FORMA Y VA(S) DE ADMINISTRACIN</span></b><=
span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'>Para uso exclusivo con la Ovaleap Pen.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;bac=
kground:
lightgrey;mso-highlight:lightgrey;mso-ansi-language:ES;mso-no-proof:yes'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>Leer el=
 prospecto
antes de utilizar este medicamento</span><span lang=3DES style=3D'mso-bidi-=
font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-ansi-language:ES'>Va subcutnea</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-fareast-languag=
e:
DE'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>6=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>ADVERTENCIA ESPECIAL DE QUE EL MEDICAMENTO D=
EBE
MANTENERSE FUERA DE LA VISTA Y DEL ALCANCE DE LOS NIOS</span></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1'><span lang=3DES style=3D=
'mso-ansi-language:
ES'>Mantener fuera de la vista y del alcance de los nios</span><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.=
<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>7=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>OTRA(S) ADVERTENCIA(S) ESPECIAL(ES), SI ES
NECESARIO</span></b><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-=
ansi-language:
ES;mso-no-proof:yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-outline-level:1;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>8=
.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>FECHA DE CADUCIDAD</span></b><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'>CAD<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;tab-stops:.5in'><span =
lang=3DES
style=3D'mso-ansi-language:ES'>El cartucho en uso dentro de la pluma puede
conservarse durante un periodo mximo de 28&nbsp;das a temperatura no supe=
rior
a <st1:metricconverter ProductID=3D"25&#65466;C" w:st=3D"on">25C</st1:metr=
icconverter></span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;page=
-break-after:
avoid;mso-outline-level:1;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>9.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>CONDICIONES ESPECIALES DE CONSERVA=
CIN</span></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Conservar en nevera</span><span lang=3DES style=3D'mso-bidi-font-size:1=
1.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>No congelar</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES;mso-no-proof:yes'>Conservar<b style=3D'mso-bidi-font-weight:normal'> </b=
>el
cartucho en el embalaje exterior</span><span lang=3DES style=3D'mso-ansi-la=
nguage:
ES'> para protegerlo de la luz</span><span lang=3DES style=3D'mso-bidi-font=
-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'>Antes de la apertura, puede conservarse a temperatura =
no
superior a<span style=3D'color:black'> </span></span><st1:metricconverter
ProductID=3D"25&#65466;C" w:st=3D"on"><span lang=3DES style=3D'mso-ansi-lan=
guage:ES'>25C</span></st1:metricconverter><span
lang=3DES style=3D'mso-ansi-language:ES'> durante un mximo de 3&nbsp;meses=
</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'>. </span><span lang=3DES style=3D'mso-ansi-language:ES'>D=
ebe
desecharse </span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:=
black;
mso-ansi-language:ES;mso-no-proof:yes'>si no se ha utilizado en 3&nbsp;mese=
s.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>1=
0.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>PRECAUCIONES ESPECIALES DE ELIMINACIN DEL
MEDICAMENTO NO UTILIZADO Y DE LOS MATERIALES DERIVADOS DE SU USO, CUANDO
CORRESPONDA</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>1=
1.<span
style=3D'mso-tab-count:1'> </span></span></b><b><span lang=3DES
style=3D'mso-ansi-language:ES'>NOMBRE Y DIRECCIN DEL TITULAR DE LA AUTORIZ=
ACIN
DE COMERCIALIZACIN</span></b><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Theramex Ireland Limited<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-family:
Verdana;color:black'>3<sup>rd</sup> Floor, </span><span lang=3DNL
style=3D'mso-ansi-language:NL'>Kilmore House,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Park Lane, Spencer Dock,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Dublin 1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>D01 YE64<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Irlanda<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>12.<span style=3D'mso-tab-count:1'> </span></span></b=
><b><span
lang=3DES style=3D'mso-ansi-language:ES'>NMERO(S) DE AUTORIZACIN DE
COMERCIALIZACIN</span></b><span lang=3DES style=3D'mso-bidi-font-size:11.0=
pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>EU/1/13/871/003<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>13.<span style=3D'mso-tab-count:1'> </span></span></b=
><b><span
lang=3DES style=3D'mso-ansi-language:ES'>NMERO DE LOTE</span></b><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'>Lote<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>14.<span style=3D'mso-tab-count:1'> </span></span></b=
><b><span
lang=3DES style=3D'mso-ansi-language:ES'>CONDICIONES GENERALES DE DISPENSAC=
IN</span></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:2.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>15.<span style=3D'mso-tab-count:1'> </span></span></b=
><b><span
lang=3DES style=3D'mso-ansi-language:ES'>INSTRUCCIONES DE USO</span></b><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>16.<span style=3D'mso-tab-count:1'> </span></span></b=
><b><span
lang=3DES style=3D'mso-ansi-language:ES'>INFORMACIN EN BRAILLE</span></b><=
span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap 900&nbsp;=
UI/1,5&nbsp;ml<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;bac=
kground:
#CCCCCC;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
margin-left:-.15pt;margin-right:0in'>

<p class=3DMsoNormal style=3D'page-break-after:avoid;mso-outline-level:1;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-ansi-language:ES;mso-no-proof:yes'>17.<span style=3D'mso-tab-c=
ount:
1'> </span>IDENTIFICADOR NICO - CDIGO DE BARRAS 2D</span></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DES style=3D'mso-ansi-lang=
uage:ES;
mso-no-proof:yes'><o:p></o:p></span></i></p>

</div>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'background:lightgrey;mso-high=
light:
lightgrey;mso-ansi-language:ES;mso-no-proof:yes'>Incluido el cdigo de barr=
as
2D que lleva el identificador nico.</span><span lang=3DES style=3D'mso-bid=
i-font-size:
11.0pt;background:#CCCCCC;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;bac=
kground:
#CCCCCC;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
margin-left:-.15pt;margin-right:0in'>

<p class=3DMsoNormal style=3D'page-break-after:avoid;mso-outline-level:1;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-ansi-language:ES;mso-no-proof:yes'>18.<span style=3D'mso-tab-c=
ount:
1'> </span>IDENTIFICADOR NICO - INFORMACIN EN CARACTERES VISUALES</sp=
an></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DES style=3D'mso-ansi-lang=
uage:ES;
mso-no-proof:yes'><o:p></o:p></span></i></p>

</div>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>PC:</sp=
an><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>SN:</sp=
an><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'><o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-ansi-language:
ES'>NN:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<span lang=3DES style=3D'font-size:11.0pt;font-family:"Times New Roman",ser=
if;
mso-fareast-font-family:SimSun;color:black;mso-color-alt:windowtext;backgro=
und:
#CCCCCC;mso-ansi-language:ES;mso-fareast-language:EN-US;mso-bidi-language:A=
R-SA;
mso-no-proof:yes'><br clear=3Dall style=3D'page-break-before:always'>
</span>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DES
style=3D'mso-ansi-language:ES'>INFORMACIN MNIMA QUE DEBE INCLUIRSE EN PEQ=
UEOS
ACONDICIONAMIENTOS PRIMARIOS</span></b><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>CARTUCHO<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>1.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>NOMBRE DEL MEDICAMENTO Y VA(S) DE
ADMINISTRACIN</span></b><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap 300&nbsp;=
UI/0,5&nbsp;ml
inyeccin<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>folitro=
pina alfa</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>SC</spa=
n><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>2.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>FORMA DE ADMINISTRACIN</span></b>=
<b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>3.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>FECHA DE CADUCIDAD</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>CAD<o:p=
></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>4.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>NMERO DE LOTE</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Lote<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>5.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>CONTENIDO EN PESO, EN VOLUMEN O EN
UNIDADES</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>0,5&nbsp;ml<o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>6.<span style=3D'mso-tab-count:1'> </span>OTROS<o:p=
></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<span lang=3DES style=3D'font-size:11.0pt;font-family:"Times New Roman",ser=
if;
mso-fareast-font-family:SimSun;mso-ansi-language:ES;mso-fareast-language:EN=
-US;
mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'page-bre=
ak-before:
always'>
</span>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DES
style=3D'mso-ansi-language:ES'>INFORMACIN MNIMA QUE DEBE INCLUIRSE EN PEQ=
UEOS
ACONDICIONAMIENTOS PRIMARIOS</span></b><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>CARTUCHO<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>1.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>NOMBRE DEL MEDICAMENTO Y VA(S) DE
ADMINISTRACIN</span></b><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap 450&nbsp;=
UI/0,75&nbsp;ml
inyeccin<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>folitro=
pina alfa</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>SC</spa=
n><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>2.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>FORMA DE ADMINISTRACIN</span></b>=
<b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>3.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>FECHA DE CADUCIDAD</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>CAD</sp=
an><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>4.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>NMERO DE LOTE</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Lote<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>5.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>CONTENIDO EN PESO, EN VOLUMEN O EN
UNIDADES</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>0,75&nbsp;ml<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>6.<span style=3D'mso-tab-count:1'> </span>OTROS<o:p=
></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<span lang=3DES style=3D'font-size:11.0pt;font-family:"Times New Roman",ser=
if;
mso-fareast-font-family:SimSun;mso-ansi-language:ES;mso-fareast-language:EN=
-US;
mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'page-bre=
ak-before:
always'>
</span>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DES
style=3D'mso-ansi-language:ES'>INFORMACIN MNIMA QUE DEBE INCLUIRSE EN PEQ=
UEOS
ACONDICIONAMIENTOS PRIMARIOS</span></b><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>CARTUCHO<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>1.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>NOMBRE DEL MEDICAMENTO Y VA(S) DE
ADMINISTRACIN</span></b><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DES style=3D'ms=
o-bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap 900&nbsp;=
UI/1,5&nbsp;ml
inyeccin<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>folitro=
pina alfa</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>SC</spa=
n><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>2.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>FORMA DE ADMINISTRACIN</span></b>=
<b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>3.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>FECHA DE CADUCIDAD</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>CAD</sp=
an><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>4.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>NMERO DE LOTE</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Lote<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>5.<span style=3D'mso-tab-count:1'> </span></span></=
b><b><span
lang=3DES style=3D'mso-ansi-language:ES'>CONTENIDO EN PESO, EN VOLUMEN O EN
UNIDADES</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>1,5&nbsp;ml<o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>6.<span style=3D'mso-tab-count:1'> </span>OTROS <o:=
p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DES style=3D=
'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<span lang=3DES style=3D'font-size:11.0pt;font-family:"Times New Roman",ser=
if;
mso-fareast-font-family:SimSun;mso-ansi-language:ES;mso-fareast-language:EN=
-US;
mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'mso-spec=
ial-character:
line-break;page-break-before:always'>
</span>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DES style=3D'mso-ansi-language:ES;mso-no-proof:yes'><o:=
p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DTitleA><span lang=3DES style=3D'mso-ansi-language:ES'>B. PROSPEC=
TO<o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-an=
si-language:
ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<span lang=3DES style=3D'font-size:11.0pt;font-family:"Times New Roman",ser=
if;
mso-fareast-font-family:SimSun;mso-ansi-language:ES;mso-fareast-language:EN=
-US;
mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'page-bre=
ak-before:
always'>
</span>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1;tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES
style=3D'mso-ansi-language:ES;mso-no-proof:yes'>Prospecto: informacin para=
 el
usuario</span></b><span lang=3DES style=3D'mso-ansi-language:ES;mso-no-proo=
f:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-list:ski=
p;
tab-stops:.5in;background:white'><span lang=3DES style=3D'mso-ansi-language=
:ES;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1;tab-stops:28.35pt 49.65pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DES style=3D'mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap 300&nbsp;=
UI/0,5&nbsp;ml
</span></b><b><span lang=3DES style=3D'mso-ansi-language:ES'>solucin inyec=
table</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-ansi-lan=
guage:
ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1;tab-stops:28.35pt 49.65pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DES style=3D'mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap 450&nbsp;=
UI/0,75&nbsp;ml
</span></b><b><span lang=3DES style=3D'mso-ansi-language:ES'>solucin inyec=
table</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-ansi-lan=
guage:
ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1;tab-stops:28.35pt 49.65pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DES style=3D'mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap 900&nbsp;=
UI/1,5&nbsp;ml
</span></b><b><span lang=3DES style=3D'mso-ansi-language:ES'>solucin inyec=
table</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-ansi-lan=
guage:
ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DES style=3D'mso-ansi-language:ES;mso-no-proof:=
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DES style=3D'mso-ansi-language:ES'>folitropina =
alfa<span
style=3D'mso-no-proof:yes'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'mso-hyphenate:none;tab-stops:.5in'><b><span l=
ang=3DES
style=3D'mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-hyphenate:none;tab-stops:.5in'><b><span l=
ang=3DES
style=3D'mso-ansi-language:ES'>Lea todo el prospecto detenidamente antes de
empezar a usar este medicamento</span></b><b style=3D'mso-bidi-font-weight:=
normal'><span
lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>, porque contiene informacin importante para usted</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-ansi-lan=
guage:
ES;mso-no-proof:yes'>.</span></b><span lang=3DES style=3D'mso-ansi-language=
:ES;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l10=
 level1 lfo1;
tab-stops:.5in'><![if !supportLists]><span lang=3DES style=3D'mso-fareast-f=
ont-family:
"Times New Roman";mso-ansi-language:ES;mso-no-proof:yes'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Conserve
este prospecto, ya que puede tener que volver a leerlo<span style=3D'mso-no=
-proof:
yes'>. <o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l10=
 level1 lfo1;
tab-stops:.5in'><![if !supportLists]><span lang=3DES style=3D'mso-fareast-f=
ont-family:
"Times New Roman";mso-ansi-language:ES;mso-no-proof:yes'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Si
tiene alguna duda, consulte a su mdico, farmacutico o enfermero<span
style=3D'mso-no-proof:yes'>.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l10=
 level1 lfo1;
tab-stops:.5in'><![if !supportLists]><span lang=3DES style=3D'mso-fareast-f=
ont-family:
"Times New Roman";mso-ansi-language:ES;mso-no-proof:yes'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Este
medicamento se le ha recetado</span><span lang=3DES style=3D'mso-bidi-font-=
size:
12.0pt;mso-ansi-language:ES;mso-no-proof:yes'> solamente</span><span lang=
=3DES
style=3D'mso-ansi-language:ES'> a usted, y no debe drselo a otras personas
aunque tengan los mismos sntomas que usted, ya que puede perjudicarles<span
style=3D'mso-no-proof:yes'>.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l10 level1 lfo1'><![if !supportLists]><span lang=3DES style=3D'mso-fareast-=
font-family:
"Times New Roman";mso-ansi-language:ES;mso-no-proof:yes'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-bidi-font-size:=
12.0pt;
mso-ansi-language:ES;mso-no-proof:yes'>Si experimenta efectos adversos,
consulte a su mdico, farmacutico o enfermero,<span style=3D'color:red'> <=
/span>incluso
si se trata de efectos adversos que no aparecen en este prospecto</span><sp=
an
lang=3DES style=3D'mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;tab-stops:.5in'><span lang=
=3DES
style=3D'mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;tab-stops:.5in'><span lang=
=3DES
style=3D'mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;tab-stops:21.3pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-ansi-lan=
guage:
ES'>Contenido del prospecto<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;tab-stops:21.3pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-ansi-lan=
guage:
ES'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;tab-stops:21.3pt'><span =
lang=3DES
style=3D'mso-ansi-language:ES'>1.<span style=3D'mso-tab-count:1'> </span=
>Qu es <span
style=3D'mso-no-proof:yes'>Ovaleap</span> y para qu se utiliza<o:p></o:p><=
/span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;tab-stops:21.3pt'><span =
lang=3DES
style=3D'mso-ansi-language:ES'>2.<span style=3D'mso-tab-count:1'> </span=
></span><span
lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>Qu necesita saber</span><span lang=3DES style=3D'mso-bidi-font-size:1=
2.0pt;
mso-ansi-language:ES'> antes de empezar a</span><span lang=3DES style=3D'ms=
o-ansi-language:
ES'> usar <span style=3D'mso-no-proof:yes'>Ovaleap</span> <o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;tab-stops:21.3pt'><span =
lang=3DES
style=3D'mso-ansi-language:ES'>3.<span style=3D'mso-tab-count:1'> </span=
>Cmo
usar <span style=3D'mso-no-proof:yes'>Ovaleap</span> <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;tab-stops:21.3pt'><span =
lang=3DES
style=3D'mso-ansi-language:ES'>4.<span style=3D'mso-tab-count:1'> </span=
>Posibles
efectos adversos<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;tab-stops:21.3pt'><span =
lang=3DES
style=3D'mso-ansi-language:ES'>5.<span style=3D'mso-tab-count:1'> </span=
>Conservacin
de <span style=3D'mso-no-proof:yes'>Ovaleap</span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;tab-stops:21.3pt'><span =
lang=3DES
style=3D'mso-ansi-language:ES'>6.<span style=3D'mso-tab-count:1'> </span=
></span><span
lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>Contenido del envase e </span><span lang=3DES style=3D'mso-ansi-langua=
ge:ES'>informacin
adicional<span style=3D'mso-no-proof:yes'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>1.<span style=3D'mso-tab-count:1'> </span>Qu es Ov=
aleap
y para qu se utiliza<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;tab-stops:.5in'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Qu es Ovaleap<o:p></o:p></sp=
an></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;tab-stops:.5in'><span lang=
=3DES
style=3D'mso-ansi-language:ES'>Este medicamento contiene el principio activo
folitropina alfa, que es casi idntica a una hormona natural producida por =
el
organismo llamada &quot;hormona foliculoestimulante&quot; (FSH). La FSH es =
una
gonadotropina, un tipo de hormona que juega un papel importante en la
fertilidad y la reproduccin humanas. En las mujeres, la FSH es necesaria p=
ara
el crecimiento y desarrollo de las bolsas (folculos) ovricas que contienen
los vulos. En los hombres, la FSH es necesaria para la produccin de esper=
ma.</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;tab-stops:.5in'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;tab-stops:.5in'><b><span l=
ang=3DES
style=3D'mso-ansi-language:ES'>Para qu se utiliza</span></b><b style=3D'ms=
o-bidi-font-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'> Ovaleap<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;tab-stops:.5in'><u><span l=
ang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;tab-stops:.5in'><u><span l=
ang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>En
mujeres adultas, Ovaleap se utiliza:<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l22 level1 lfo5;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-no-proof:yes'><=
span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>para
ayudar a la ovulacin (liberacin de un vulo maduro del folculo) en mujer=
es
que no pueden ovular y que no han respondido al tratamiento con una sustanc=
ia
llamada &quot;citrato de clomifeno&quot;</span><span lang=3DES style=3D'mso=
-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l22 level1 lfo5;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-no-proof:yes'><=
span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>para
ayudar al desarrollo de los folculos en mujeres que se someten a tcnicas =
de
reproduccin asistida (tcnicas que pueden ayudarla a quedarse embarazada),
como la &quot;fertilizacin <i style=3D'mso-bidi-font-style:normal'>in vitr=
o</i>&quot;,
la &quot;transferencia intratubrica de gametos&quot; o la &quot;transferen=
cia
intratubrica de cigotos&quot;<span style=3D'mso-no-proof:yes'>.</span></sp=
an><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l22 level1 lfo5;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-no-proof:yes'><=
span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>junto
con otra substancia llamada &quot;lutropina alfa&quot; (una versin de otra
gonadotropina, la &quot;hormona luteinizante&quot; o LH), para ayudar a la
ovulacin en mujeres que no estn ovulando porque su organismo produce
cantidades demasiado escasas de FSH y LH<span style=3D'mso-no-proof:yes'>.<=
/span></span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES;mso-no-p=
roof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><u><span lang=3DES style=3D'mso-ansi-language:ES;
mso-no-proof:yes'>En hombres adultos, Ovaleap se utiliza:<o:p></o:p></span>=
</u></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l16 level1 lfo6'><![if !supportLists]><span lang=3DES style=3D'font-family:=
Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-languag=
e:
ES;mso-no-proof:yes'><span style=3D'mso-list:Ignore'><span style=3D'font:7=
.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>en
combinacin con una sustancia llamada &quot;gonadotropina corinica humana&=
quot;
(hCG), para ayudar a producir esperma en hombres que son estriles debido a
concentraciones bajas de ciertas hormonas<span style=3D'mso-no-proof:yes'>.=
<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;tab-stops:.5in'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;background:yellow;mso-highlight:yellow;
mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DES
style=3D'mso-ansi-language:ES;mso-no-proof:yes'>2.<span style=3D'mso-tab-co=
unt:
1'> </span>Qu necesita saber antes de empezar a usar Ovaleap</span><=
/b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;mso-outline-level:1;mso-list:skip;tab-stops:.5in'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DES style=3D'mso-bidi-font=
-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></i><=
/p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;mso-outline-level:1;mso-list:skip;tab-stops:.5in'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>No use Ovaleap:</span></b><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l16 level1 lfo6;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-no-proof:yes'><=
span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>si es
alrgico a la folitropina alfa, la hormona foliculoestimulante (FSH) o a al=
guno
de los dems componentes de este medicamento (incluidos en la seccin&nbsp;=
6)</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l16 level1 lfo6;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-no-proof:yes'><=
span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>si
tiene un tumor en el hipotlamo o en la hipfisis (partes del cerebro)</spa=
n><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l16 level1 lfo6;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-no-proof:yes'><=
span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>si
usted es <span style=3D'mso-bidi-font-weight:bold'>una<b> <i style=3D'mso-b=
idi-font-style:
normal'>mujer</i> </b>con</span></span><span lang=3DES style=3D'mso-bidi-fo=
nt-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:74.55pt;text-indent:-17.85pt;mso-=
list:
l21 level1 lfo7;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-ansi-language:ES;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-<sp=
an
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>ovarios
grandes o bolsas de lquido en el interior de los ovarios (quistes ovricos=
) de
origen desconocido</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:74.55pt;text-indent:-17.85pt;mso-=
list:
l21 level1 lfo7;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-ansi-language:ES;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-<sp=
an
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>hemorragia
vaginal inexplicada<span style=3D'mso-no-proof:yes'>.</span></span><span la=
ng=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:74.55pt;text-indent:-17.85pt;mso-=
list:
l21 level1 lfo7;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-ansi-language:ES;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-<sp=
an
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>cncer
de ovario, de tero o de mama<span style=3D'mso-no-proof:yes'>.</span></spa=
n><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:74.55pt;text-indent:-17.85pt;mso-=
list:
l21 level1 lfo7;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-ansi-language:ES;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-<sp=
an
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>alguna
afeccin que normalmente hace que el embarazo sea imposible, como la
insuficiencia ovrica (menopausia precoz), tumores fibroides del tero o una
malformacin de los rganos reproductivos<span style=3D'mso-no-proof:yes'>.=
</span></span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l17 level1 lfo8'><![if !supportLists]><span lang=3DES style=3D'font-family:=
Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-languag=
e:
ES;mso-no-proof:yes'><span style=3D'mso-list:Ignore'><span style=3D'font:7=
.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>si
usted es <span style=3D'mso-bidi-font-weight:bold'>un<b> <i style=3D'mso-bi=
di-font-style:
normal'>hombre</i> </b>con</span><span style=3D'mso-no-proof:yes'>:<o:p></o=
:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-left:74.55pt;text-indent:-17.85pt;mso-=
list:
l21 level1 lfo7;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-fareast-font-family:"Times New Roman";mso-ansi-language:ES;
mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0p=
t "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>insuficiencia
testicular que no se puede tratar<span style=3D'mso-no-proof:yes'>.<o:p></o=
:p></span></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES;mso-no-p=
roof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>No use =
este
medicamento si alguna de las condiciones anteriores le aplica a usted. Si no
est seguro, pregunte a su mdico o farmacutico antes de usar este medicam=
ento<span
style=3D'mso-no-proof:yes'>.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;mso-list:skip;tab-stops:.=
5in'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
12.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Advertencias y precauciones</=
span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>Un mdico con experiencia en el tratamiento de los trastornos de la
fertilidad debe evaluar su fertilidad y la de su pareja antes de iniciar el
tratamiento.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><u style=3D'tex=
t-underline:
black'><span lang=3DES style=3D'mso-ansi-language:ES'>Porfiria</span></u><u=
><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-ansi-language:ES'>Informe a su mdico antes de iniciar el
tratamiento, si usted o algn miembro de su familia padece porfiria. Esta es
una afeccin que se puede transmitir de padres a hijos,</span><span lang=3D=
ES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'> =
que
consiste en </span><span lang=3DES style=3D'mso-ansi-language:ES'>una incap=
acidad
para degradar las porfirinas (compuestos orgnicos</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>)=
.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-ansi-language:ES'>Informe inmediatamente a su mdico si</span>=
<span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l17 level1 lfo8;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-no-proof:yes'><=
span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>su
piel se vuelve frgil y le salen ampollas con facilidad, en especial en las
zonas expuestas al sol con frecuencia, y/o</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l17 level1 lfo8;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-no-proof:yes'><=
span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>si
tiene dolor de estmago, de brazos o piernas<span style=3D'mso-no-proof:yes=
'>.</span></span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-ansi-language:ES'>Si presenta estos sntomas, su mdico puede
recomendarle que interrumpa el tratamiento</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><u style=3D'tex=
t-underline:
black'><span lang=3DES style=3D'mso-ansi-language:ES'>Sndrome de hiperesti=
mulacin
ovrica (SHO)</span></u><u><span lang=3DES style=3D'mso-bidi-font-size:11.0=
pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-ansi-language:ES'>Si es usted una mujer, este medicamento aume=
nta el
riesgo de que presente un SHO. Esto ocurre cuando sus folculos se desarrol=
lan
demasiado y se convierten en quistes de gran tamao</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-ansi-language:ES'>Informe inmediatamente a su mdico si</span>=
<span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l17 level1 lfo8;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-no-proof:yes'><=
span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-bidi-font-size:=
11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'>presenta dolor en la parte baja del
abdomen (barriga),<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l17 level1 lfo8;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-no-proof:yes'><=
span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-bidi-font-size:=
11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'>aumenta de peso rpidamente,<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l17 level1 lfo8;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-no-proof:yes'><=
span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-bidi-font-size:=
11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'>presenta nuseas o vmitos,<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l17 level1 lfo8;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-no-proof:yes'><=
span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-bidi-font-size:=
11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'>presenta dificultad para respirar.<o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-ansi-language:ES'>Si presenta estos sntomas, su mdico </span=
><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>podra indicarle </span><span lang=3DES style=3D'mso-ansi-language:ES'=
>que
interrumpa el uso de este medicamento</span><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'> (ver tambin la seccin&nbsp=
;4,
bajo el epgrafe</span><span lang=3DES style=3D'mso-ansi-language:ES'> </sp=
an><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>Efectos adversos graves en mujeres&quot;).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-ansi-language:ES'>Si no ovula y se siguen la dosis y los tiemp=
os de
administracin recomendados, ese sndrome es menos probable que ocurra. El
tratamiento con Ovaleap rara vez causa un sndrome de hiperestimulacin ov=
rica
grave, a menos que se administre el medicamento que se usa para la maduraci=
n
folicular final (que contiene gonadotropina corinica humana, hCG). En caso=
 de
desarrollar SHO, su mdico puede no recetarle hCG en este ciclo de tratamie=
nto.
Es posible que le aconsejen que se abstenga de realizar el coito o que util=
ice
mtodos anticonceptivos de barrera durante al menos 4&nbsp;das</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><u style=3D'tex=
t-underline:
black'><span lang=3DES style=3D'mso-ansi-language:ES'>Embarazo mltiple</sp=
an></u><u><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-ansi-language:ES'>Si usa este medicamento, tiene un riesgo ms=
 alto
de quedarse embarazada de ms de un nio (es decir, &quot;embarazo
mltiple&quot;, habitualmente gemelos), que si se queda embarazada por
concepcin natural. El embarazo mltiple puede causar complicaciones mdicas
para usted y sus bebs. Usted puede reducir el riesgo de embarazo mltiple
usando la dosis correcta de este medicamento a las horas correctas. Si se
somete a tcnicas de reproduccin asistida, el riesgo de embarazo mltiple =
est
relacionado con su edad y con la calidad y el nmero de vulos fertilizados=
 o
embriones que se coloquen en su interior</span><span lang=3DES style=3D'mso=
-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><u style=3D'tex=
t-underline:
black'><span lang=3DES style=3D'mso-ansi-language:ES'>Aborto</span></u><u><=
span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-ansi-language:ES'>Si se somete a tcnicas de reproduccin asis=
tida o
a estimulacin de sus ovarios para producir vulos, la probabilidad de tene=
r un
aborto es mayor que en el promedio de las mujeres</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><u><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>E=
mbarazo
ectpico<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-ansi-language:ES'>Si se somete a tcnicas de reproduccin asis=
tida y
presenta lesiones en las trompas de Falopio, la probabilidad de tener un
embarazo fuera del tero (embarazo ectpico) es mayor que en el promedio de=
 las
mujeres</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-l=
anguage:
ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><u><span lang=
=3DES
style=3D'mso-ansi-language:ES'>Anomalas congnitas<o:p></o:p></span></u></=
p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-ansi-language:ES'>Un beb concebido con tcnicas de reproducci=
n
asistida puede presentar un riesgo ligeramente mayor de anomalas congnitas
que si hubiera sido concebido de manera natural. Esto se podra asociar a l=
os embarazos
mltiples o a las caractersticas de los padres como, por ejemplo, la edad =
materna
o las caractersticas del esperma.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><u style=3D'tex=
t-underline:
black'><span lang=3DES style=3D'mso-ansi-language:ES'><o:p><span style=3D't=
ext-decoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><u style=3D'tex=
t-underline:
black'><span lang=3DES style=3D'mso-ansi-language:ES'>Problemas de coagulac=
in de
la sangre (episodios tromboemblicos)</span></u><u><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-ansi-language:ES'>Si usted o algn miembro de su familia ha su=
frido
alguna vez cogulos de sangre en la pierna o en el pulmn, infarto de mioca=
rdio
o ictus, informe a su mdico. Usted podra tener un riesgo ms alto de
presentar estos problemas o de que empeorasen con el tratamiento con Ovalea=
p</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><u style=3D'tex=
t-underline:
black'><span lang=3DES style=3D'mso-ansi-language:ES'>Hombres con niveles a=
ltos de
FSH en la sangre</span></u><u><span lang=3DES style=3D'mso-bidi-font-size:1=
1.0pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-ansi-language:ES'>Si usted es hombre, unos niveles demasiado a=
ltos
de FSH natural en la sangre pueden ser un signo de lesin de los testculos.
Por lo general, este medicamento no suele ser eficaz en estos casos</span><=
span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>. </span><span lang=3DES style=3D'mso-ansi-language:ES'>Si su mdico d=
ecide
intentar el tratamiento con Ovaleap, es posible que su mdico lo controle
pidindole que se haga un anlisis de semen, de <st1:metricconverter
ProductID=3D"4 a" w:st=3D"on">4 a</st1:metricconverter> 6&nbsp;meses despu=
s de
iniciar el tratamiento</span><span lang=3DES style=3D'mso-bidi-font-size:11=
.0pt;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><b><span lang=
=3DES
style=3D'mso-ansi-language:ES;mso-no-proof:yes'>Nios y adolescentes<o:p></=
o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-ansi-language:ES'>Este medicamento</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'> =
</span><span
lang=3DES style=3D'mso-ansi-language:ES'>no est indicado en nios</span><s=
pan
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'> y adolescentes </span><span lang=3DES style=3D'mso-bidi-font-size:11.=
0pt;
mso-ansi-language:ES'>menores de 18 aos<span style=3D'mso-no-proof:yes'>.<=
o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><b><span lang=
=3DES
style=3D'mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b=
></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><b><span
lang=3DES style=3D'mso-ansi-language:ES'>Otros medicamentos y Ovaleap</span=
></b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>Informe a su mdico o farmacutico si est utilizando, ha utilizado
recientemente o pudiera tener que utilizar cualquier otro medicamento</span=
><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l11 level1 lfo9;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-no-proof:yes'><=
span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Si
usa </span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
ES;mso-no-proof:yes'>Ovaleap</span><span lang=3DES style=3D'mso-ansi-langua=
ge:ES'>
con otros medicamentos que ayudan a la ovulacin como, por ejemplo, gonadot=
ropina
corinica humana (hCG) o citrato de clomifeno, la respuesta de sus folculos
puede verse aumentada</span><span lang=3DES style=3D'mso-bidi-font-size:11.=
0pt;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l11 level1 lfo9;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-no-proof:yes'><=
span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Si
usa </span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
ES;mso-no-proof:yes'>Ovaleap</span><span lang=3DES style=3D'mso-ansi-langua=
ge:ES'>
al mismo tiempo que un agonista o un antagonista de la &quot;hormona libera=
dora
de gonadotropinas&quot; (GnRH) (estos medicamentos disminuyen las
concentraciones de las hormonas sexuales y detienen la ovulacin), puede
necesitar una dosis ms alta de </span><span lang=3DES style=3D'mso-bidi-fo=
nt-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap</span><span lang=3DES
style=3D'mso-ansi-language:ES'> para producir folculos</span><span lang=3D=
ES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;background:yellow;mso-highligh=
t:yellow;
mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-outline-level:1;mso-li=
st:skip;
tab-stops:.5in'><b><span lang=3DES style=3D'mso-ansi-language:ES'>Embarazo y
lactancia</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-ansi-language:ES'>No debe usar este medicamento</span><span la=
ng=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'> =
</span><span
lang=3DES style=3D'mso-ansi-language:ES'>si est embarazada o durante el pe=
riodo de
lactancia</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi=
-language:
ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-outline-level:1;mso-li=
st:skip;
tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-outline-level:1;mso-li=
st:skip;
tab-stops:.5in'><b><span lang=3DES style=3D'mso-ansi-language:ES'>Conducci=
n y uso
de mquinas</span></b><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-ansi-language:ES'>Este medicamento no afecta a su ca=
pacidad
para conducir y utilizar mquinas</span><span lang=3DES style=3D'mso-bidi-f=
ont-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-outline-level:1;mso-li=
st:skip;
tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>O=
valeap
</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES'>contie=
ne
sodio, cloruro de benzalconio y alcohol benclico</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Este medicamento contiene menos de 1&nbsp;mmol de sodio (23&nbsp;mg) por
dosis; esto es, esencialmente exento de sodio</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'>.<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-ansi-language:ES'>Este medicamento tambin contiene 0,02&nbsp;=
mg por
ml de cloruro de benzalconio y 10,0&nbsp;mg por ml de alcohol benclico.
Consulte a su mdico o farmacutico si tiene enfermedades de hgado o rin=
 y
si est embarazada o en periodo de lactancia. Esto es debido a que se pueden
acumular en el organismo grandes cantidades de alcohol benclico y provocar
efectos adversos (acidosis metablica).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><u><span =
lang=3DES
style=3D'mso-ansi-language:ES'><o:p><span style=3D'text-decoration:none'>&n=
bsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES;
mso-no-proof:yes'>3.<span style=3D'mso-tab-count:1'> </span>Cmo usar=
</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-ansi-lan=
guage:
ES;mso-no-proof:yes'> Ovaleap</span></b><b style=3D'mso-bidi-font-weight:no=
rmal'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DES style=3D'mso-bidi-font=
-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></i><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>Siga exactamente las instrucciones de administracin de este medicamen=
to
indicadas por su mdico o farmacutico. En caso de duda, consulte de nuevo =
a su
mdico o farmacutico</span><span lang=3DES style=3D'mso-bidi-font-size:11.=
0pt;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'>Este med=
icamento
se administra en forma de inyeccin en el tejido que se encuentra justo por
debajo de la piel (inyeccin subcutnea). Su mdico o enfermero le indicar
cmo se inyecta el medicamento. Si se autoadministra este medicamento, lea y
siga de manera detenida las Instrucciones de uso de la pluma.<span
style=3D'mso-no-proof:yes'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Cul es la dosis recomendada<=
o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>Su mdi=
co
decidir qu cantidad de medicamento se administrar y con qu frecuencia. =
Las
dosis que se describen a continuacin estn expresadas en Unidades
Internacionales (UI).<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'><o:p>&n=
bsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DES style=3D'mso-ansi-language:ES'>Muje=
res<o:p></o:p></span></u></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'><o:p>&n=
bsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><u><span lang=3DES style=3D'mso-ansi-language:ES'>S=
i no
est ovulando y tiene menstruaciones irregulares o no tiene menstruacin<o:=
p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-list:l14 level1 lfo1=
0'><![if !supportLists]><span
lang=3DES style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bi=
di-font-family:
Symbol;mso-ansi-language:ES'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Este
medicamento se administra generalmente todos los das.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l14 level1 lfo10'><![if !supportLists]><span lang=3DES style=3D'font-family=
:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-languag=
e:
ES'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Si
usted tiene una menstruacin irregular, empiece usando este medicamento en =
los
7&nbsp;primeros das del ciclo menstrual. Si no tiene menstruacin, puede
empezar a usar el medicamento cualquier da que le resulte cmodo.<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l14 level1 lfo10'><![if !supportLists]><span lang=3DES style=3D'font-family=
:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-languag=
e:
ES'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>La
dosis inicial habitual de este medicamento es de <st1:metricconverter
ProductID=3D"75 a" w:st=3D"on">75 a</st1:metricconverter> 150&nbsp;UI cada =
da.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l14 level1 lfo10'><![if !supportLists]><span lang=3DES style=3D'font-family=
:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-languag=
e:
ES'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Su
dosis de este medicamento se puede aumentar cada 7  14&nbsp;das en <st1:m=
etricconverter
ProductID=3D"37,5 a" w:st=3D"on">37,5 a</st1:metricconverter> 75&nbsp;UI, h=
asta que
se obtenga la respuesta deseada.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l14 level1 lfo10'><![if !supportLists]><span lang=3DES style=3D'font-family=
:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-languag=
e:
ES'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>La
dosis mxima diaria de este medicamento no suele ser mayor de 225&nbsp;UI.<=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l14 level1 lfo10'><![if !supportLists]><span lang=3DES style=3D'font-family=
:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-languag=
e:
ES'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Cuando
se obtenga la respuesta deseada, se le administrar hCG o &quot;hCG
recombinante&quot; (r&#8209;hCG, una hCG fabricada en un laboratorio median=
te
una tcnica especial de ADN). La inyeccin nica ser de 250&nbsp;microgram=
os
de r&#8209;hCG  de <st1:metricconverter ProductID=3D"5.000 a" w:st=3D"on">=
5.000 a</st1:metricconverter>
10.000&nbsp;UI de hCG, <st1:metricconverter ProductID=3D"24 a" w:st=3D"on">=
24 a</st1:metricconverter>
48&nbsp;horas despus de la ltima inyeccin de Ovaleap. El mejor momento p=
ara
mantener relaciones sexuales es el mismo da de la inyeccin de hCG y al da
siguiente. De manera alternativa, se puede realizar una inseminacin
intrauterina introduciendo el esperma en la cavidad uterina.<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'><o:p>&n=
bsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>Si su m=
dico no
observa la respuesta deseada despus de 4&nbsp;semanas de tratamiento, ese
ciclo de tratamiento con Ovaleap debe interrumpirse. Para el siguiente cicl=
o,
su mdico le administrar una dosis inicial ms alta de este medicamento qu=
e la
anterior.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'><o:p>&n=
bsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>Si se o=
btiene una
respuesta excesiva, se interrumpir su tratamiento y no le administrarn hCG
(ver tambin la seccin&nbsp;2, bajo el epgrafe &quot;Sndrome de
hiperestimulacin ovrica (SHO)&quot;). Para el siguiente ciclo, su mdico =
le
administrar una dosis de Ovaleap ms baja que la del ciclo previo.<o:p></o=
:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'background:yellow;mso-highlig=
ht:yellow;
mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DES style=3D'mso-ansi-language:ES'>Si t=
iene que
desarrollar varios vulos para su extraccin previamente a cualquier tcnic=
a de
reproduccin asistida<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l12 level1 lfo11'><![if !supportLists]><span lang=3DES style=3D'font-family=
:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-languag=
e:
ES'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>La
dosis inicial habitual de este medicamento es de <st1:metricconverter
ProductID=3D"150 a" w:st=3D"on">150 a</st1:metricconverter> 225&nbsp;UI cad=
a da,
desde el 2 o 3</span><span lang=3DES style=3D'mso-bidi-font-size:7.0pt;mso=
-ansi-language:
ES'>er </span><span lang=3DES style=3D'mso-ansi-language:ES'>da de su ciclo
menstrual.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l12 level1 lfo11'><![if !supportLists]><span lang=3DES style=3D'font-family=
:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-languag=
e:
ES'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>La
dosis se puede aumentar, dependiendo de su respuesta. La dosis diaria mxim=
a es
de 450&nbsp;UI.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l12 level1 lfo11'><![if !supportLists]><span lang=3DES style=3D'font-family=
:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-languag=
e:
ES'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>El
tratamiento contina hasta que los vulos se hayan desarrollado hasta el pu=
nto
deseado. Esto requiere normalmente unos 10&nbsp;das, pero puede variar ent=
re 5
y 20&nbsp;das. Su mdico lo comprobar mediante anlisis de sangre y/o
ecografas.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l12 level1 lfo11'><![if !supportLists]><span lang=3DES style=3D'font-family=
:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-languag=
e:
ES'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Cuando
los vulos estn listos, se le administrar hCG o r&#8209;hCG. La inyeccin
nica ser de 250&nbsp;microgramos de r-hCG  de <st1:metricconverter
ProductID=3D"5.000 a" w:st=3D"on">5.000 a</st1:metricconverter> 10.000&nbsp=
;UI de
hCG, <st1:metricconverter ProductID=3D"24 a" w:st=3D"on">24 a</st1:metricco=
nverter>
48&nbsp;horas despus de la ltima inyeccin de Ovaleap. Esto hace que sus
vulos estn listos para su extraccin.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DES style=3D'mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>En otro=
s casos,
su mdico puede interrumpir primero la ovulacin, mediante el uso de un
agonista o un antagonista de la hormona liberadora de gonadotropinas (GnRH)=
. En
tales casos, la administracin de Ovaleap se inicia aproximadamente 2&nbsp;=
semanas
despus de iniciar el tratamiento con el agonista, continuando ambos
tratamientos hasta lograr un desarrollo folicular adecuado.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal><span lang=3DES style=3D'background:yellow;mso-highlig=
ht:yellow;
mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><u><span lang=3DES style=3D'mso-ansi-language:ES'>S=
i no
est ovulando, no tiene menstruacin y se le han diagnosticado niveles muy
bajos de hormonas FSH y LH<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;mso-list:l=
18 level1 lfo13'><![if !supportLists]><span
lang=3DES style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bi=
di-font-family:
Symbol;mso-ansi-language:ES'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>La
dosis inicial habitual de Ovaleap es de <st1:metricconverter ProductID=3D"7=
5 a"
w:st=3D"on">75 a</st1:metricconverter> 150&nbsp;UI junto con 75&nbsp;UI de
lutropina alfa.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l12 level1 lfo11'><![if !supportLists]><span lang=3DES style=3D'font-family=
:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-languag=
e:
ES'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Usar
estos dos medicamentos cada da durante un mximo de 5&nbsp;semanas.<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l12 level1 lfo11'><![if !supportLists]><span lang=3DES style=3D'font-family=
:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-languag=
e:
ES'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>La
dosis de Ovaleap se puede aumentar cada 7  14&nbsp;das en <st1:metricconv=
erter
ProductID=3D"37,5 a" w:st=3D"on">37,5 a</st1:metricconverter> 75&nbsp;UI, h=
asta que
se obtenga la respuesta deseada.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l12 level1 lfo11'><![if !supportLists]><span lang=3DES style=3D'font-family=
:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-languag=
e:
ES'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Cuando
se obtenga la respuesta deseada, se le administrar hCG o r&#8209;hCG. La
inyeccin nica ser de 250 microgramos de r&#8209;hCG  de <st1:metricconv=
erter
ProductID=3D"5.000 a" w:st=3D"on">5.000 a</st1:metricconverter> 10.000 UI d=
e hCG, <st1:metricconverter
ProductID=3D"24 a" w:st=3D"on">24 a</st1:metricconverter> 48&nbsp;horas des=
pus de
las ltimas inyecciones de Ovaleap y lutropina alfa. El mejor momento para
mantener relaciones sexuales es el mismo da de la inyeccin de hCG y al da
siguiente. De forma alternativa, se puede realizar una inseminacin intraut=
erina
introduciendo el esperma en la cavidad uterina.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DES style=3D'mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>Si su m=
dico no
observa una respuesta despus de 5 semanas de tratamiento, ese ciclo de
tratamiento se debe interrumpir. Para el siguiente ciclo, su mdico le
administrar una dosis inicial ms alta de este medicamento que la anterior=
.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'><o:p>&n=
bsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-ansi-language:ES'>Si se o=
btiene una
respuesta excesiva, se interrumpir su tratamiento con Ovaleap y no le
administrarn hCG (ver tambin la seccin&nbsp;2, bajo el epgrafe
&quot;Sndrome de hiperestimulacin ovrica (SHO)&quot;). Para el siguiente
ciclo, su mdico le administrar una dosis de Ovaleap ms baja que la del c=
iclo
previo.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'background:yellow;mso-highlig=
ht:yellow;
mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DES style=3D'mso-ansi-language:ES'>Homb=
res<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l12 level1 lfo11'><![if !supportLists]><span lang=3DES style=3D'font-family=
:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-languag=
e:
ES'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>La
dosis habitual de este medicamento es de 150&nbsp;UI junto con hCG.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l12 level1 lfo11'><![if !supportLists]><span lang=3DES style=3D'font-family=
:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-languag=
e:
ES'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Usted
usar estos dos medicamentos tres veces por semana, durante al menos 4&nbsp=
;meses.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l12 level1 lfo11'><![if !supportLists]><span lang=3DES style=3D'font-family=
:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-ansi-languag=
e:
ES'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Si no
ha respondido al tratamiento despus de 4&nbsp;meses, su mdico puede suger=
irle
que siga usando estos dos medicamentos al menos durante 18&nbsp;meses.<o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><b style=3D'mso=
-bidi-font-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-languag=
e:ES'>Cmo
se administran las inyecciones?<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'>Este medicamento se
administra en forma de inyeccin en el tejido que se encuentra justo por de=
bajo
de la piel (inyeccin subcutnea) utilizando la Ovaleap Pen<span
style=3D'mso-no-proof:yes'>. La Ovaleap Pen es un dispositivo (una
&quot;pluma&quot;) utilizado para la administracin de inyecciones </span>e=
n el
tejido que se encuentra justo por debajo de la piel.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'><o:p>&nbsp;</o:p><=
/span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'>Su mdic=
o puede
sugerirle que aprenda a inyectarse usted mismo este medicamento. Su mdico o
enfermero le darn instrucciones sobre cmo hacerlo y tambin puede
encontrarlas en las instrucciones de uso por separado de la pluma. No inten=
te autoadministrarse
este medicamento si no ha recibido esta formacin por parte de su mdico o
enfermero. La primera inyeccin de este medicamento se debe administrar sie=
mpre
en presencia de un mdico o enfermero. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'><o:p>&nb=
sp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'>Ovaleap =
solucin
inyectable en cartuchos se ha diseado para uso en la Ovaleap Pen. Debe seg=
uir
minuciosamente las instrucciones de uso por separado de la Ovaleap Pen. Las
instrucciones de uso de la pluma se facilitarn junto con la Ovaleap Pen. No
obstante, el adecuado tratamiento de su afeccin requiere una constante y
estrecha colaboracin con su mdico.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'><o:p>&nb=
sp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>Deseche las agujas utilizadas inmediatamente despus de la inyeccin.<=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-outline-level:1;mso-li=
st:skip;
tab-stops:.5in'><b><span lang=3DES style=3D'mso-ansi-language:ES'>Si usa m=
s </span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap</span></b><b><span
lang=3DES style=3D'mso-ansi-language:ES'> del que debe</span></b><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-outline-level:1;mso-li=
st:skip;
tab-stops:.5in'><span lang=3DES style=3D'mso-ansi-language:ES'>Se desconoce=
n los
efectos de usar una cantidad excesiva de Ovaleap. Sin embargo, se puede esp=
erar
que se produzca un sndrome de hiperestimulacin ovrica, que se describe e=
n la
seccin&nbsp;4 bajo el epgrafe &quot;Efectos adversos graves en mujeres&qu=
ot;.
Sin embargo, este sndrome slo ocurrir si se administra tambin hCG (ver
tambin la seccin&nbsp;2, bajo el epgrafe &quot;Sndrome de hiperestimula=
cin
ovrica (SHO)&quot;)</span><span lang=3DES style=3D'mso-bidi-font-size:11.0=
pt;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-outline-level:1;mso-li=
st:skip;
tab-stops:.5in'><i style=3D'mso-bidi-font-style:normal'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;background:yellow;mso-highlight:yellow;
mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-outline-level:1;mso-li=
st:skip;
tab-stops:.5in'><b><span lang=3DES style=3D'mso-ansi-language:ES'>Si olvid=
 usar</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'> Ovaleap</span></b><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-ansi-language:ES'>No use una dosis doble para compen=
sar las dosis
olvidadas. Consulte a su mdico tan pronto como se d cuenta de que se ha
olvidado de tomar una dosis</span><span lang=3DES style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;background:yellow;mso-highligh=
t:yellow;
mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DES style=3D'mso-ansi-language:ES'>Si tiene cualquier otra duda sobre=
 el uso
de este medicamento, pregunte a su mdico, farmacutico o enfermero<span
style=3D'mso-no-proof:yes'>.</span></span><span lang=3DES style=3D'mso-bidi=
-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><a name=3D"OLE_LINK6"></a><a name=3D"OLE_LINK7"><span
style=3D'mso-bookmark:OLE_LINK6'><b style=3D'mso-bidi-font-weight:normal'><=
span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>4.<span style=3D'mso-tab-count:1'> </span></span></b></span></a>=
<span
style=3D'mso-bookmark:OLE_LINK7'><span style=3D'mso-bookmark:OLE_LINK6'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
12.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Posibles efectos adversos</sp=
an></b></span></span><span
style=3D'mso-bookmark:OLE_LINK7'><span style=3D'mso-bookmark:OLE_LINK6'><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></span></span></p>

<span style=3D'mso-bookmark:OLE_LINK6'></span><span style=3D'mso-bookmark:O=
LE_LINK7'></span>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DES style=3D'mso-ansi-language:ES'>Al igual que todos los medicamento=
s, </span><span
lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>este medicamento</span><span lang=3DES style=3D'mso-ansi-language:ES'>=
 puede
producir efectos adversos, aunque no todas las personas los sufran</span><s=
pan
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Efectos adversos importantes<=
o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><u><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>Efectos adversos graves en hombres y en mujeres<o:p></o:p></span></u><=
/p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-no-proof:yes'><=
span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-bidi-font-size:=
11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'>Se han notificado casos muy raros
(pueden afectar hasta a 1 de cada 10.000 personas) de </span><span lang=3DES
style=3D'mso-ansi-language:ES'>reacciones alrgicas como erupcin cutnea</=
span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>, zonas de piel elevadas y pruriginosas y </span><span lang=3DES
style=3D'mso-ansi-language:ES'>reacciones alrgicas</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'> =
graves
con debilidad, cada de la presin arterial, </span><span lang=3DES
style=3D'mso-ansi-language:ES'>dificultad para respirar</span><span lang=3D=
ES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'> =
e </span><span
lang=3DES style=3D'mso-ansi-language:ES'>hinchazn de la cara</span><span l=
ang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.=
 Si
cree que est sufriendo este tipo de reaccin, debe interrumpir la inyecci=
n de
Ovaleap y buscar ayuda mdica inmediatamente<span style=3D'font-variant:sma=
ll-caps'>.</span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><u><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>Efectos adversos graves en mujeres<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-no-proof:yes'><=
span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>El
dolor de estmago, acompaado de nuseas o vmitos, pueden ser sntomas del
sndrome de hiperestimulacin ovrica (SHO). Esto puede indicar que los ova=
rios
han reaccionado de forma excesiva al tratamiento y se han desarrollado quis=
tes
ovricos de gran tamao (ver tambin la seccin&nbsp;2, en Sndrome de
hiperestimulacin ovrica (SHO)). Este efecto adverso es frecuente (puede
afectar hasta 1 de cada 10&nbsp;personas).</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-no-proof:yes'><=
span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>El
sndrome de hiperestimulacin ovrica se puede agravar con ovarios claramen=
te
aumentados de tamao, disminucin de la produccin de orina, aumento de pes=
o,
dificultad para respirar y/o posible acumulacin de lquido en el abdomen o=
 en
el pecho. Este efecto adverso es poco frecuente (puede afectar hasta 1 de c=
ada
100&nbsp;personas).</span><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-no-proof:yes'><=
span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>En
casos raros (pueden afectar hasta 1 de cada 1.000&nbsp;personas), tambin s=
e pueden
producir complicaciones del sndrome de hiperestimulacin ovrica como tors=
in
ovrica o coagulacin de la sangre.</span><span lang=3DES style=3D'mso-bidi=
-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;font-family:Symbol;mso-fareast-font-fami=
ly:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:ES;mso-no-proof:yes'><=
span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>En
casos muy raros (pueden afectar hasta 1&nbsp;de cada 10.000&nbsp;personas)
pueden producirse algunas veces complicaciones graves de la coagulacin de =
la
sangre (episodios tromboemblicos), a veces independientes del sndrome de
hiperestimulacin ovrica. Esto podra causar dolor en el pecho, sensacin =
de
falta de aire, ictus o infarto de miocardio (ver tambin la seccin&nbsp;2,=
 en Problemas
de coagulacin de la sangre (episodios tromboemblicos)).</span><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>Si observa alguno de los efectos adversos antes mencionados, debe
consultar inmediatamente </span><span lang=3DES style=3D'mso-ansi-language:=
ES;
mso-bidi-font-weight:bold'>a su mdico, quien puede pedirle que interrumpa =
el
tratamiento con Ovaleap.</span><span lang=3DES style=3D'mso-bidi-font-size:=
11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;background:yellow;mso-highligh=
t:yellow;
mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><b><span
lang=3DES style=3D'mso-ansi-language:ES'>Otros efectos adversos en mujeres<=
/span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-ansi-lan=
guage:
ES'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;background:yellow;mso-highligh=
t:yellow;
mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><u
style=3D'text-underline:black'><span lang=3DES style=3D'mso-ansi-language:E=
S'>Muy
frecuentes</span></u><span lang=3DES style=3D'mso-ansi-language:ES'> (pueden
afectar a ms de 1 de cada 10&nbsp;personas</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>)=
</span><u><span
lang=3DES style=3D'mso-ansi-language:ES'><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol;mso-ansi-language:ES'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Reacciones
locales en la zona de inyeccin, como dolor, enrojecimiento, hematoma,
hinchazn y/o irritacin<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol;mso-ansi-language:ES'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Dolor
de cabeza<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol;mso-ansi-language:ES'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Bolsas
de lquido en el interior de los ovarios (quistes ovricos)<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><u style=3D'text-underline:black'><span lang=3DES style=3D'=
mso-ansi-language:
ES'>Frecuentes</span></u><span lang=3DES style=3D'mso-ansi-language:ES'> (p=
ueden
afectar hasta 1 de cada 10&nbsp;personas</span><span lang=3DES style=3D'mso=
-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>)</span><u><span lang=3DES
style=3D'mso-ansi-language:ES'><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol;mso-ansi-language:ES'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Dolor
de estmago<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol;mso-ansi-language:ES'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Flatulencias
abdominales<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol;mso-ansi-language:ES'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Retortijones
abdominales<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol;mso-ansi-language:ES'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Nuseas<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol;mso-ansi-language:ES'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Vmitos<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol;mso-ansi-language:ES'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Diarrea<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><u style=3D'text-underline:black'><span lang=3DES style=3D'=
mso-ansi-language:
ES'>Muy raros</span></u><span lang=3DES style=3D'mso-ansi-language:ES'> (pu=
eden afectar
hasta 1 de cada 10.000&nbsp;personas</span><span lang=3DES style=3D'mso-bid=
i-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>)</span><u><span lang=3DES
style=3D'mso-ansi-language:ES'><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol;mso-ansi-language:ES'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>El
asma puede empeorar.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DES style=3D'mso-ansi-language:ES'><o:p>&nbsp;<=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-list:skip;tab-stops:
.5in'><b><span lang=3DES style=3D'mso-ansi-language:ES'>Otros efectos adver=
sos en hombres</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-ansi-lan=
guage:
ES'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-list:skip;tab-stops:
.5in'><span lang=3DES style=3D'mso-ansi-language:ES'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-list:skip;tab-stops:
.5in'><u style=3D'text-underline:black'><span lang=3DES style=3D'mso-ansi-l=
anguage:
ES'>Muy frecuentes</span></u><span lang=3DES style=3D'mso-ansi-language:ES'=
> (pueden
afectar a ms de 1 de cada 10&nbsp;personas</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>)=
</span><u><span
lang=3DES style=3D'mso-ansi-language:ES'><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:.5in;margin-bottom:.0001pt;text-indent:-.5in;mso-list:l15 l=
evel1 lfo12'><![if !supportLists]><span
lang=3DES style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bi=
di-font-family:
Symbol;mso-ansi-language:ES'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Reacciones
locales en la zona de inyeccin, como dolor, enrojecimiento, hematoma,
hinchazn y/o irritacin<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><u style=3D'text-underline:black'><span lang=3DES style=3D'=
mso-ansi-language:
ES'>Frecuentes</span></u><span lang=3DES style=3D'mso-ansi-language:ES'> (p=
ueden
afectar hasta 1 de cada 10 personas</span><span lang=3DES style=3D'mso-bidi=
-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>)</span><u><span lang=3DES
style=3D'mso-ansi-language:ES'><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol;mso-ansi-language:ES'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Hinchazn
de las venas por encima y por detrs de los testculos (varicocele)<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol;mso-ansi-language:ES'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Desarrollo
de mamas<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol;mso-ansi-language:ES'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Acn<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol;mso-ansi-language:ES'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Aumento
de peso<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><u style=3D'text-underline:black'><span lang=3DES style=3D'=
mso-ansi-language:
ES'>Muy raros</span></u><span lang=3DES style=3D'mso-ansi-language:ES'> (pu=
eden afectar
hasta 1 de cada 10.000&nbsp;personas</span><span lang=3DES style=3D'mso-bid=
i-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>)</span><u><span lang=3DES
style=3D'mso-ansi-language:ES'><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
l15 level1 lfo12;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol;mso-ansi-language:ES'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>El
asma puede empeorar.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><b style=3D'mso=
-bidi-font-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-languag=
e:ES'>Comunicacin
de efectos adversos</span></b><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'><o:p></o=
:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-ansi-language:ES'>Si experimenta </span><span lang=3DES
style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-proof:yes'>c=
ualquier
tipo de efecto adverso</span><span lang=3DES style=3D'mso-ansi-language:ES'=
>,
consulte a su mdico, farmacutico o enfermero, incluso si se trata de </sp=
an><span
lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>posibles </span><span lang=3DES style=3D'mso-ansi-language:ES'>efectos
adversos que no aparecen en este prospecto.</span><span lang=3DES
style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES'> <span style=3D'ms=
o-no-proof:
yes'>Tambin puede comunicarlos directamente a travs del <span
style=3D'background:lightgrey;mso-highlight:lightgrey'>sistema nacional de
notificacin incluido en el </span></span></span><span lang=3DEN-GB><a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc"><span
lang=3DES style=3D'mso-bidi-font-size:12.0pt;background:lightgrey;mso-highl=
ight:
lightgrey;mso-ansi-language:ES;mso-no-proof:yes'>Apndice&nbsp;V</span></a>=
</span><span
lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>. Mediante la comunicacin de efectos adversos usted puede contribuir a
proporcionar ms informacin sobre la seguridad de este medicamento.</span>=
<span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>5=
.<span
style=3D'mso-tab-count:1'> </span>Conservacin de Ovaleap<o:p></o:p><=
/span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-ansi-language:ES'>Mantener </span><span lang=3DES
style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-proof:yes'>e=
ste
medicamento </span><span lang=3DES style=3D'mso-ansi-language:ES'>fuera de =
la vista
y del alcance de los nios</span><span lang=3DES style=3D'mso-bidi-font-siz=
e:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-ansi-language:ES'>No utilice este medicamento despu=
s de la
fecha de caducidad que aparece en la etiqueta y en el <span style=3D'mso-no=
-proof:
yes'>embalaje</span> exterior despus de CAD. La fecha de caducidad es el
ltimo da del mes que se indica</span><span lang=3DES style=3D'mso-bidi-fo=
nt-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Conservar en nevera (entre <st1:metricconverter ProductID=3D"2&#65466;C"
w:st=3D"on">2C</st1:metricconverter> y <st1:metricconverter ProductID=3D"8=
&#65466;C"
w:st=3D"on">8C</st1:metricconverter>).</span><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>No congelar</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES;mso-no-proof:yes'>Conservar<b style=3D'mso-bidi-font-weight:normal'> </b=
>el
cartucho en </span><span lang=3DES style=3D'mso-ansi-language:ES'>el <span
style=3D'mso-no-proof:yes'>embalaje exterior</span></span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:ES;mso-no-=
proof:
yes'> </span><span lang=3DES style=3D'mso-ansi-language:ES;mso-no-proof:yes=
'>para
protegerlo de la luz</span><span lang=3DES style=3D'mso-bidi-font-size:11.0=
pt;
color:black;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>Antes de la apert=
ura
y dentro de su periodo de validez, puede extraer este medicamento de la nev=
era,
sin refrigerar de nuevo, hasta un mximo de 3&nbsp;meses. No conservar a
temperatura superior a <st1:metricconverter ProductID=3D"25&#65466;C" w:st=
=3D"on">25C</st1:metricconverter>.
Debe desechar este medicamento si no se ha utilizado en 3&nbsp;meses.<o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
ansi-language:
ES'>Una vez abierto, el cartucho en uso dentro de la pluma puede conservars=
e durante
un periodo mximo de 28&nbsp;das. </span><span lang=3DES style=3D'mso-bidi=
-font-size:
11.0pt;color:black;mso-ansi-language:ES;mso-no-proof:yes'>No conservar</spa=
n><span
lang=3DES style=3D'mso-ansi-language:ES'> a temperatura superior a <st1:met=
ricconverter
ProductID=3D"25&#65466;C" w:st=3D"on">25C</st1:metricconverter>.</span><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-ansi-language:=
ES;
mso-no-proof:yes'> Anote la fecha del primer uso en el diario del paciente,=
 que
se facilitar con la Ovaleap Pen.<span style=3D'background:yellow;mso-highl=
ight:
yellow'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;background:yellow;mso-highligh=
t:yellow;
mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>Coloque de nuevo la cpsula de cierre de la pluma en la <span
style=3D'color:black'>Ovaleap Pen despus de cada inyeccin para proteger el
cartucho de la luz.</span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>No utilice este medicamento si observa</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'> =
que
est turbio o contiene partculas</span><span lang=3DES style=3D'mso-bidi-f=
ont-size:
11.0pt;mso-ansi-language:ES'>.<span style=3D'mso-no-proof:yes'><o:p></o:p><=
/span></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>Los medicamentos no se deben tirar por los desages.</span><span lang=
=3DES
style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES'> Pregunte a su
farmacutico cmo deshacerse de<span style=3D'mso-no-proof:yes'> </span>los
envases y de los medicamentos que ya no <span style=3D'mso-no-proof:yes'>ne=
cesita</span>.
<span style=3D'mso-no-proof:yes'>De esta forma, ayudar a proteger el medio
ambiente.</span></span><i><span lang=3DES style=3D'mso-bidi-font-size:11.0p=
t;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>6.<span style=3D'mso-tab-coun=
t:
1'> </span></span></b><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DES style=3D'mso-bidi-font-size:12.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>Contenido del envase e informacin adicional</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><b><span
lang=3DES style=3D'mso-ansi-language:ES'>Composicin de</span></b><b><span =
lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'> =
Ovaleap
<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l10 level1 lfo2;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-ansi-language:ES;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-<sp=
an
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>El principio
activo es folitropina alfa</span><span lang=3DES style=3D'mso-bidi-font-siz=
e:11.0pt;
mso-ansi-language:ES;mso-no-proof:yes'>.<br>
Ovaleap 300&nbsp;</span><span lang=3DES style=3D'mso-ansi-language:ES'>UI</=
span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'> /0,5&nbsp;</span><span lang=3DES style=3D'mso-ansi-language:ES'>ml</s=
pan><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>: Cada cartucho contiene 300&nbsp;</span><span lang=3DES style=3D'mso-=
ansi-language:
ES'>UI</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
ES;mso-no-proof:yes'> (equivalentes a 22&nbsp;microgramos) de </span><span
lang=3DES style=3D'mso-ansi-language:ES'>folitropina alfa</span><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'> =
en 0,5&nbsp;</span><span
lang=3DES style=3D'mso-ansi-language:ES'>ml</span><span lang=3DES style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'> de solucin.<br>
Ovaleap 450&nbsp;</span><span lang=3DES style=3D'mso-ansi-language:ES'>UI</=
span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'> /0,75&nbsp;ml: Cada cartucho contiene 450&nbsp;</span><span lang=3DES
style=3D'mso-ansi-language:ES'>UI</span><span lang=3DES style=3D'mso-bidi-f=
ont-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'> (equivalentes a
33&nbsp;microgramos) de </span><span lang=3DES style=3D'mso-ansi-language:E=
S'>folitropina
alfa</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
ES;mso-no-proof:yes'> en 0,75&nbsp;de solucin.<br>
Ovaleap 900&nbsp;</span><span lang=3DES style=3D'mso-ansi-language:ES'>UI</=
span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'> /1,5&nbsp;ml: Cada cartucho contiene 900&nbsp;</span><span lang=3DES
style=3D'mso-ansi-language:ES'>UI</span><span lang=3DES style=3D'mso-bidi-f=
ont-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'> (equivalentes a
66&nbsp;microgramos) de </span><span lang=3DES style=3D'mso-ansi-language:E=
S'>folitropina
alfa</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-lang=
uage:
ES;mso-no-proof:yes'> en 1,5&nbsp;</span><span lang=3DES style=3D'mso-ansi-=
language:
ES'>ml</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
ES;mso-no-proof:yes'> de solucin.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-indent:28.35pt;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>C=
ada ml
de la solucin contiene 600&nbsp;</span><span lang=3DES style=3D'mso-ansi-l=
anguage:
ES'>UI</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-la=
nguage:
ES;mso-no-proof:yes'> (equivalentes a 44&nbsp;microgramos) de </span><span
lang=3DES style=3D'mso-ansi-language:ES'>folitropina alfa.</span><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l10 level1 lfo2;tab-stops:.5in'><![if !supportLists]><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-ansi-language:ES;mso-no-proof:yes'><span style=3D'mso-list:Ignore'>-<sp=
an
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DES style=3D'mso-ansi-language:E=
S'>Los
dems componentes son</span><span lang=3DES style=3D'mso-bidi-font-size:11.=
0pt;
mso-ansi-language:ES;mso-no-proof:yes'> dihidrogenofosfato de sodio dihidra=
to,
hidrxido de sodio (<st1:metricconverter ProductID=3D"2 M" w:st=3D"on">2 M<=
/st1:metricconverter>)
(para ajuste del pH), manitol, metionina, polisorbato 20, alcohol benclico,
cloruro de benzalconio y </span><span lang=3DES style=3D'mso-ansi-language:=
ES'>agua
para preparaciones inyectables</span><span lang=3DES style=3D'mso-bidi-font=
-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;tab-stops:.5in'><span lan=
g=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>T=
odas
las presentaciones mencionadas anteriormente contienen los dems componente=
s.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><b><span
lang=3DES style=3D'mso-ansi-language:ES'>Aspecto del producto y contenido d=
el
envase</span></b><b><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-=
ansi-language:
ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'> es una solucin
inyectable (inyeccin). <span style=3D'mso-no-proof:yes'>Ovaleap</span> es =
una
solucin transparente e incolora.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Ovaleap 300&nbsp;UI/0,5&nbsp;=
ml se
presenta </span><span lang=3DES style=3D'mso-ansi-language:ES'>en cajas que
contienen</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi=
-language:
ES;mso-no-proof:yes'> 1&nbsp;cartucho y 10 </span><span lang=3DES
style=3D'mso-ansi-language:ES'>agujas para inyeccin</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.=
<br>
Ovaleap 450&nbsp;UI/0,75&nbsp;ml se presenta </span><span lang=3DES
style=3D'mso-ansi-language:ES'>en cajas que contienen</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>
1&nbsp;cartucho y 10&nbsp;</span><span lang=3DES style=3D'mso-ansi-language=
:ES'>aguja</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>s</span><span lang=3DES style=3D'mso-ansi-language:ES'> para inyeccin=
</span><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'>.<br>
Ovaleap 900&nbsp;UI/1,5&nbsp;ml se presenta </span><span lang=3DES
style=3D'mso-ansi-language:ES'>en cajas que contienen</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>
1&nbsp;cartucho y 20&nbsp;</span><span lang=3DES style=3D'mso-ansi-language=
:ES'>agujas
para inyeccin</span><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
11.0pt;mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DES style=3D'mso-=
bidi-font-size:
12.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Puede que solamente estn
comercializados algunos tamaos de envases</span><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'>.<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><=
o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><b><span
lang=3DES style=3D'mso-ansi-language:ES'>Titular de la autorizacin de
comercializacin</span></b><b><span lang=3DES style=3D'mso-bidi-font-size:1=
1.0pt;
mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Theramex Ireland Limited<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-family:
Verdana;color:black'>3<sup>rd</sup> Floor, </span><span lang=3DNL
style=3D'mso-ansi-language:NL'>Kilmore House,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Park Lane, Spencer Dock,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Dublin 1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>D01 YE64<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Irlanda<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><b><span
lang=3DES style=3D'mso-ansi-language:ES'>Responsable de la fabricacin</spa=
n></b><b><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><a name=3D"OLE_=
LINK8"></a><a
name=3D"OLE_LINK9"><span style=3D'mso-bookmark:OLE_LINK8'><span lang=3DES
style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-bidi-font-weigh=
t:
bold'>Teva Biotech GmbH<o:p></o:p></span></span></a></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span style=3D'=
mso-bookmark:
OLE_LINK9'><span style=3D'mso-bookmark:OLE_LINK8'><span lang=3DES style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-bidi-font-weight:bold'>Dornierstrae 10<o:p=
></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span style=3D'=
mso-bookmark:
OLE_LINK9'><span style=3D'mso-bookmark:OLE_LINK8'><span lang=3DES style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-bidi-font-weight:bold'>89079 Ulm<o:p></o:p>=
</span></span></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span style=3D'mso-bookmark:O=
LE_LINK9'><span
style=3D'mso-bookmark:OLE_LINK8'><span lang=3DES style=3D'mso-bidi-font-siz=
e:11.0pt;
mso-ansi-language:ES'>Alemania<o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span style=3D'mso-bookmark:O=
LE_LINK9'><span
style=3D'mso-bookmark:OLE_LINK8'><span lang=3DES style=3D'mso-bidi-font-siz=
e:11.0pt;
mso-ansi-language:ES'><o:p>&nbsp;</o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in;background:silver'><span
style=3D'mso-bookmark:OLE_LINK9'><span style=3D'mso-bookmark:OLE_LINK8'><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:wind=
owtext;
mso-ansi-language:ES'>Teva Pharmaceuticals Europe B.V.</span></span></span>=
<span
style=3D'mso-bookmark:OLE_LINK9'><span style=3D'mso-bookmark:OLE_LINK8'><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'><o:p></o=
:p></span></span></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in;background:silver'><span
style=3D'mso-bookmark:OLE_LINK9'><span style=3D'mso-bookmark:OLE_LINK8'><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:wind=
owtext;
mso-ansi-language:ES'>Swensweg 5</span></span></span><span style=3D'mso-boo=
kmark:
OLE_LINK9'><span style=3D'mso-bookmark:OLE_LINK8'><span lang=3DES style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:ES'><o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in;background:silver'><span
style=3D'mso-bookmark:OLE_LINK9'><span style=3D'mso-bookmark:OLE_LINK8'><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:wind=
owtext;
mso-ansi-language:ES'>2031 GA Haarlem</span></span></span><span
style=3D'mso-bookmark:OLE_LINK9'><span style=3D'mso-bookmark:OLE_LINK8'><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES'><o:p></o=
:p></span></span></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in;background:silver'><span
style=3D'mso-bookmark:OLE_LINK9'><span style=3D'mso-bookmark:OLE_LINK8'><sp=
an
lang=3DES style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:wind=
owtext;
mso-ansi-language:ES'>Pases Bajos</span></span></span><span style=3D'mso-b=
ookmark:
OLE_LINK9'><span style=3D'mso-bookmark:OLE_LINK8'><span lang=3DES style=3D'=
mso-bidi-font-size:
11.0pt;mso-ansi-language:ES'><o:p></o:p></span></span></span></p>

<span style=3D'mso-bookmark:OLE_LINK8'></span><span style=3D'mso-bookmark:O=
LE_LINK9'></span>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DES style=
=3D'mso-bidi-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in;background:silver'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:windowtext;
mso-ansi-language:ES'>Merckle GmbH</span><span lang=3DES style=3D'mso-bidi-=
font-size:
11.0pt;mso-ansi-language:ES'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in;background:silver'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:windowtext;
mso-ansi-language:ES'>Graf-Arco-Strae 3</span><span lang=3DES style=3D'mso=
-bidi-font-size:
11.0pt;mso-ansi-language:ES'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in;background:silver'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:windowtext;
mso-ansi-language:ES'>89079 Ulm, </span><span lang=3DES style=3D'mso-bidi-f=
ont-size:
11.0pt;mso-ansi-language:ES'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in;background:silver'><span lang=
=3DES
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:windowtext;
mso-ansi-language:ES'>Alemania</span><span lang=3DES style=3D'mso-bidi-font=
-size:
11.0pt;mso-ansi-language:ES'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:ES;mso-no-pr=
oof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid;mso-outline-level:1;mso-list:skip;tab-stops:.5in'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
12.0pt;mso-ansi-language:ES;mso-no-proof:yes'>Fecha de la ltima revisin d=
e este
prospecto:</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
ES
style=3D'mso-ansi-language:ES;mso-no-proof:yes'> </span></b><b style=3D'mso=
-bidi-font-weight:
normal'><span lang=3DES style=3D'mso-bidi-font-size:12.0pt;font-family:"MS =
Mincho";
mso-hansi-font-family:SimSun;mso-ansi-language:ES;mso-no-proof:yes'>{</span=
></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
12.0pt;mso-ansi-language:ES;mso-no-proof:yes'>mes AAAA}.</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid;mso-list:skip'><span lang=3DES style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-ansi-language:ES;mso-bidi-font-style:italic;mso-no-proof:yes'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.0pt;mso-pagination:widow-orph=
an lines-together;
page-break-after:avoid'><span lang=3DES style=3D'mso-ansi-language:ES'>La
informacin detallada de este medicamento est disponible en la pgina web =
de
la Agencia Europea de Medicamentos</span><span lang=3DES style=3D'mso-bidi-=
font-size:
11.0pt;mso-ansi-language:ES;mso-bidi-font-style:italic;mso-no-proof:yes'>: =
</span><span
lang=3DEN-GB><a href=3D"http://www.ema.europa.eu"><span lang=3DES style=3D'=
mso-bidi-font-size:
12.0pt;mso-ansi-language:ES;mso-no-proof:yes'>http://www.ema.euro<span
style=3D'mso-bookmark:_Hlt145757439'>p</span>a.eu</span></a><![if !supportN=
estedAnchors]><a
name=3D"_Hlt145757439"></a><![endif]></span><span lang=3DES style=3D'mso-bi=
di-font-size:
11.0pt;mso-ansi-language:ES;mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DES style=3D'mso-bidi-font-size:11.0pt;mso=
-ansi-language:
ES'><o:p>&nbsp;</o:p></span></p>

</div>

</body>

</html>

------=_NextPart_01D75BBF.AB96D8F0
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/item0001.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"utf-8"?><ct:contentTypeSchema ct:_=3D"" m=
a:_=3D"" ma:contentTypeName=3D"Document" ma:contentTypeID=3D"0x010100726F91=
DD1AE57B44B1BCEB7F1056F5D0" ma:contentTypeVersion=3D"6" ma:contentTypeDescr=
iption=3D"Create a new document." ma:contentTypeScope=3D"" ma:versionID=3D"=
80d1dd17cb0c17b7740334051d5d16b2" xmlns:ct=3D"http://schemas.microsoft.com/=
office/2006/metadata/contentType" xmlns:ma=3D"http://schemas.microsoft.com/=
office/2006/metadata/properties/metaAttributes">
<xsd:schema targetNamespace=3D"http://schemas.microsoft.com/office/2006/met=
adata/properties" ma:root=3D"true" ma:fieldsID=3D"c170dc105f61f60cf84b7b3e6=
d807e4f" ns2:_=3D"" ns3:_=3D"" xmlns:xsd=3D"http://www.w3.org/2001/XMLSchem=
a" xmlns:xs=3D"http://www.w3.org/2001/XMLSchema" xmlns:p=3D"http://schemas.=
microsoft.com/office/2006/metadata/properties" xmlns:ns2=3D"a6a35199-84b7-4=
ca5-aa1c-39e9ca4c46ff" xmlns:ns3=3D"0ac2e3cc-46bd-4320-b2ac-d7f7d167e1a9">
<xsd:import namespace=3D"a6a35199-84b7-4ca5-aa1c-39e9ca4c46ff"/>
<xsd:import namespace=3D"0ac2e3cc-46bd-4320-b2ac-d7f7d167e1a9"/>
<xsd:element name=3D"properties">
<xsd:complexType>
<xsd:sequence>
<xsd:element name=3D"documentManagement">
<xsd:complexType>
<xsd:all>
<xsd:element ref=3D"ns2:MediaServiceMetadata" minOccurs=3D"0"/>
<xsd:element ref=3D"ns2:MediaServiceFastMetadata" minOccurs=3D"0"/>
<xsd:element ref=3D"ns2:MediaServiceAutoKeyPoints" minOccurs=3D"0"/>
<xsd:element ref=3D"ns2:MediaServiceKeyPoints" minOccurs=3D"0"/>
<xsd:element ref=3D"ns3:SharedWithUsers" minOccurs=3D"0"/>
<xsd:element ref=3D"ns3:SharedWithDetails" minOccurs=3D"0"/>
</xsd:all>
</xsd:complexType>
</xsd:element>
</xsd:sequence>
</xsd:complexType>
</xsd:element>
</xsd:schema>
<xsd:schema targetNamespace=3D"a6a35199-84b7-4ca5-aa1c-39e9ca4c46ff" elemen=
tFormDefault=3D"qualified" xmlns:xsd=3D"http://www.w3.org/2001/XMLSchema" x=
mlns:xs=3D"http://www.w3.org/2001/XMLSchema" xmlns:dms=3D"http://schemas.mi=
crosoft.com/office/2006/documentManagement/types" xmlns:pc=3D"http://schema=
s.microsoft.com/office/infopath/2007/PartnerControls">
<xsd:import namespace=3D"http://schemas.microsoft.com/office/2006/documentM=
anagement/types"/>
<xsd:import namespace=3D"http://schemas.microsoft.com/office/infopath/2007/=
PartnerControls"/>
<xsd:element name=3D"MediaServiceMetadata" ma:index=3D"8" nillable=3D"true"=
 ma:displayName=3D"MediaServiceMetadata" ma:hidden=3D"true" ma:internalName=
=3D"MediaServiceMetadata" ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note"/>
</xsd:simpleType>
</xsd:element>
<xsd:element name=3D"MediaServiceFastMetadata" ma:index=3D"9" nillable=3D"t=
rue" ma:displayName=3D"MediaServiceFastMetadata" ma:hidden=3D"true" ma:inte=
rnalName=3D"MediaServiceFastMetadata" ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note"/>
</xsd:simpleType>
</xsd:element>
<xsd:element name=3D"MediaServiceAutoKeyPoints" ma:index=3D"10" nillable=3D=
"true" ma:displayName=3D"MediaServiceAutoKeyPoints" ma:hidden=3D"true" ma:i=
nternalName=3D"MediaServiceAutoKeyPoints" ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note"/>
</xsd:simpleType>
</xsd:element>
<xsd:element name=3D"MediaServiceKeyPoints" ma:index=3D"11" nillable=3D"tru=
e" ma:displayName=3D"KeyPoints" ma:internalName=3D"MediaServiceKeyPoints" m=
a:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note">
<xsd:maxLength value=3D"255"/>
</xsd:restriction>
</xsd:simpleType>
</xsd:element>
</xsd:schema>
<xsd:schema targetNamespace=3D"0ac2e3cc-46bd-4320-b2ac-d7f7d167e1a9" elemen=
tFormDefault=3D"qualified" xmlns:xsd=3D"http://www.w3.org/2001/XMLSchema" x=
mlns:xs=3D"http://www.w3.org/2001/XMLSchema" xmlns:dms=3D"http://schemas.mi=
crosoft.com/office/2006/documentManagement/types" xmlns:pc=3D"http://schema=
s.microsoft.com/office/infopath/2007/PartnerControls">
<xsd:import namespace=3D"http://schemas.microsoft.com/office/2006/documentM=
anagement/types"/>
<xsd:import namespace=3D"http://schemas.microsoft.com/office/infopath/2007/=
PartnerControls"/>
<xsd:element name=3D"SharedWithUsers" ma:index=3D"12" nillable=3D"true" ma:=
displayName=3D"Shared With" ma:internalName=3D"SharedWithUsers" ma:readOnly=
=3D"true">
<xsd:complexType>
<xsd:complexContent>
<xsd:extension base=3D"dms:UserMulti">
<xsd:sequence>
<xsd:element name=3D"UserInfo" minOccurs=3D"0" maxOccurs=3D"unbounded">
<xsd:complexType>
<xsd:sequence>
<xsd:element name=3D"DisplayName" type=3D"xsd:string" minOccurs=3D"0"/>
<xsd:element name=3D"AccountId" type=3D"dms:UserId" minOccurs=3D"0" nillabl=
e=3D"true"/>
<xsd:element name=3D"AccountType" type=3D"xsd:string" minOccurs=3D"0"/>
</xsd:sequence>
</xsd:complexType>
</xsd:element>
</xsd:sequence>
</xsd:extension>
</xsd:complexContent>
</xsd:complexType>
</xsd:element>
<xsd:element name=3D"SharedWithDetails" ma:index=3D"13" nillable=3D"true" m=
a:displayName=3D"Shared With Details" ma:internalName=3D"SharedWithDetails"=
 ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note">
<xsd:maxLength value=3D"255"/>
</xsd:restriction>
</xsd:simpleType>
</xsd:element>
</xsd:schema>
<xsd:schema targetNamespace=3D"http://schemas.openxmlformats.org/package/20=
06/metadata/core-properties" elementFormDefault=3D"qualified" attributeForm=
Default=3D"unqualified" blockDefault=3D"#all" xmlns=3D"http://schemas.openx=
mlformats.org/package/2006/metadata/core-properties" xmlns:xsd=3D"http://ww=
w.w3.org/2001/XMLSchema" xmlns:xsi=3D"http://www.w3.org/2001/XMLSchema-inst=
ance" xmlns:dc=3D"http://purl.org/dc/elements/1.1/" xmlns:dcterms=3D"http:/=
/purl.org/dc/terms/" xmlns:odoc=3D"http://schemas.microsoft.com/internal/ob=
d">
<xsd:import namespace=3D"http://purl.org/dc/elements/1.1/" schemaLocation=
=3D"http://dublincore.org/schemas/xmls/qdc/2003/04/02/dc.xsd"/>
<xsd:import namespace=3D"http://purl.org/dc/terms/" schemaLocation=3D"http:=
//dublincore.org/schemas/xmls/qdc/2003/04/02/dcterms.xsd"/>
<xsd:element name=3D"coreProperties" type=3D"CT_coreProperties"/>
<xsd:complexType name=3D"CT_coreProperties">
<xsd:all>
<xsd:element ref=3D"dc:creator" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element ref=3D"dcterms:created" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element ref=3D"dc:identifier" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"contentType" minOccurs=3D"0" maxOccurs=3D"1" type=3D"x=
sd:string" ma:index=3D"0" ma:displayName=3D"Content Type"/>
<xsd:element ref=3D"dc:title" minOccurs=3D"0" maxOccurs=3D"1" ma:index=3D"4=
" ma:displayName=3D"Title"/>
<xsd:element ref=3D"dc:subject" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element ref=3D"dc:description" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"keywords" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:=
string"/>
<xsd:element ref=3D"dc:language" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"category" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:=
string"/>
<xsd:element name=3D"version" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:s=
tring"/>
<xsd:element name=3D"revision" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:=
string">
<xsd:annotation>
<xsd:documentation>
                        This value indicates the number of saves or revisio=
ns. The application is responsible for updating this value after each revis=
ion.
                    </xsd:documentation>
</xsd:annotation>
</xsd:element>
<xsd:element name=3D"lastModifiedBy" minOccurs=3D"0" maxOccurs=3D"1" type=
=3D"xsd:string"/>
<xsd:element ref=3D"dcterms:modified" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"contentStatus" minOccurs=3D"0" maxOccurs=3D"1" type=3D=
"xsd:string"/>
</xsd:all>
</xsd:complexType>
</xsd:schema>
<xs:schema targetNamespace=3D"http://schemas.microsoft.com/office/infopath/=
2007/PartnerControls" elementFormDefault=3D"qualified" attributeFormDefault=
=3D"unqualified" xmlns:pc=3D"http://schemas.microsoft.com/office/infopath/2=
007/PartnerControls" xmlns:xs=3D"http://www.w3.org/2001/XMLSchema">
<xs:element name=3D"Person">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:DisplayName" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:AccountId" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:AccountType" minOccurs=3D"0"></xs:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"DisplayName" type=3D"xs:string"></xs:element>
<xs:element name=3D"AccountId" type=3D"xs:string"></xs:element>
<xs:element name=3D"AccountType" type=3D"xs:string"></xs:element>
<xs:element name=3D"BDCAssociatedEntity">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:BDCEntity" minOccurs=3D"0" maxOccurs=3D"unbounded"></=
xs:element>
</xs:sequence>
<xs:attribute ref=3D"pc:EntityNamespace"></xs:attribute>
<xs:attribute ref=3D"pc:EntityName"></xs:attribute>
<xs:attribute ref=3D"pc:SystemInstanceName"></xs:attribute>
<xs:attribute ref=3D"pc:AssociationName"></xs:attribute>
</xs:complexType>
</xs:element>
<xs:attribute name=3D"EntityNamespace" type=3D"xs:string"></xs:attribute>
<xs:attribute name=3D"EntityName" type=3D"xs:string"></xs:attribute>
<xs:attribute name=3D"SystemInstanceName" type=3D"xs:string"></xs:attribute>
<xs:attribute name=3D"AssociationName" type=3D"xs:string"></xs:attribute>
<xs:element name=3D"BDCEntity">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:EntityDisplayName" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityInstanceReference" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId1" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId2" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId3" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId4" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId5" minOccurs=3D"0"></xs:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"EntityDisplayName" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityInstanceReference" type=3D"xs:string"></xs:elemen=
t>
<xs:element name=3D"EntityId1" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId2" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId3" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId4" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId5" type=3D"xs:string"></xs:element>
<xs:element name=3D"Terms">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:TermInfo" minOccurs=3D"0" maxOccurs=3D"unbounded"></x=
s:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"TermInfo">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:TermName" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:TermId" minOccurs=3D"0"></xs:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"TermName" type=3D"xs:string"></xs:element>
<xs:element name=3D"TermId" type=3D"xs:string"></xs:element>
</xs:schema>
</ct:contentTypeSchema>
------=_NextPart_01D75BBF.AB96D8F0
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/props002.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{52216923-1CD4-4264-A3ED-66553970293E}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.microsoft.com/office/20=
06/metadata/contentType"/><ds:schemaRef ds:uri=3D"http://schemas.microsoft.=
com/office/2006/metadata/properties/metaAttributes"/><ds:schemaRef ds:uri=
=3D"http://www.w3.org/2001/XMLSchema"/><ds:schemaRef ds:uri=3D"http://schem=
as.microsoft.com/office/2006/metadata/properties"/><ds:schemaRef ds:uri=3D"=
a6a35199-84b7-4ca5-aa1c-39e9ca4c46ff"/><ds:schemaRef ds:uri=3D"0ac2e3cc-46b=
d-4320-b2ac-d7f7d167e1a9"/><ds:schemaRef ds:uri=3D"http://schemas.microsoft=
.com/office/2006/documentManagement/types"/><ds:schemaRef ds:uri=3D"http://=
schemas.microsoft.com/office/infopath/2007/PartnerControls"/><ds:schemaRef =
ds:uri=3D"http://schemas.openxmlformats.org/package/2006/metadata/core-prop=
erties"/><ds:schemaRef ds:uri=3D"http://purl.org/dc/elements/1.1/"/><ds:sch=
emaRef ds:uri=3D"http://purl.org/dc/terms/"/><ds:schemaRef ds:uri=3D"http:/=
/schemas.microsoft.com/internal/obd"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D75BBF.AB96D8F0
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/item0003.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"utf-8"?><p:properties xmlns:p=3D"http://s=
chemas.microsoft.com/office/2006/metadata/properties" xmlns:xsi=3D"http://w=
ww.w3.org/2001/XMLSchema-instance" xmlns:pc=3D"http://schemas.microsoft.com=
/office/infopath/2007/PartnerControls"><documentManagement/></p:properties>
------=_NextPart_01D75BBF.AB96D8F0
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/props004.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{8DD67AB3-3D3F-4A87-81DB-77EC8B9CDBED}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.microsoft.com/office/20=
06/metadata/properties"/><ds:schemaRef ds:uri=3D"http://schemas.microsoft.c=
om/office/infopath/2007/PartnerControls"/></ds:schemaRefs></ds:datastoreIte=
m>
------=_NextPart_01D75BBF.AB96D8F0
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/item0005.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?mso-contentType?><FormTemplates xmlns=3D"http://schemas.microsoft.com/sha=
repoint/v3/contenttype/forms"><Display>DocumentLibraryForm</Display><Edit>D=
ocumentLibraryForm</Edit><New>DocumentLibraryForm</New></FormTemplates>
------=_NextPart_01D75BBF.AB96D8F0
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/props006.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{5DE4ADEF-F438-4391-9B06-658712551999}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.microsoft.com/sharepoin=
t/v3/contenttype/forms"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D75BBF.AB96D8F0
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/themedata.thmx
Content-Transfer-Encoding: base64
Content-Type: application/vnd.ms-officetheme
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------=_NextPart_01D75BBF.AB96D8F0
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/colorschememapping.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"yes"?>
<a:clrMap xmlns:a=3D"http://schemas.openxmlformats.org/drawingml/2006/main"=
 bg1=3D"lt1" tx1=3D"dk1" bg2=3D"lt2" tx2=3D"dk2" accent1=3D"accent1" accent=
2=3D"accent2" accent3=3D"accent3" accent4=3D"accent4" accent5=3D"accent5" a=
ccent6=3D"accent6" hlink=3D"hlink" folHlink=3D"folHlink"/>
------=_NextPart_01D75BBF.AB96D8F0
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/header.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1252"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns:st1=3D"urn:schemas-microsoft-com:office:smarttags"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
2">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 15">
<meta name=3DOriginator content=3D"Microsoft Word 15">
<link id=3DMain-File rel=3DMain-File href=3D"../Ovaleap_clean.htm">
<![if IE]>
<base href=3D"file:///C:/C467A08E/Ovaleap_clean_files/header.htm"
id=3D"webarch_temp_base_tag">
<![endif]><o:SmartTagType
 namespaceuri=3D"urn:schemas-microsoft-com:office:smarttags"
 name=3D"metricconverter"/>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"4097"/>
</xml><![endif]-->
</head>

<body lang=3DEN-US link=3Dblue vlink=3Dpurple>

<div style=3D'mso-element:footnote-separator' id=3Dfs>

<p class=3DMsoNormal><span lang=3DEN-GB><span style=3D'mso-special-characte=
r:footnote-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:footnote-continuation-separator' id=3Dfcs>

<p class=3DMsoNormal><span lang=3DEN-GB><span style=3D'mso-special-characte=
r:footnote-continuation-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:endnote-separator' id=3Des>

<p class=3DMsoNormal><span lang=3DEN-GB><span style=3D'mso-special-characte=
r:footnote-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:endnote-continuation-separator' id=3Decs>

<p class=3DMsoNormal><span lang=3DEN-GB><span style=3D'mso-special-characte=
r:footnote-continuation-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:footer' id=3Df1>

<p class=3DMsoFooter align=3Dcenter style=3D'margin-right:4.8pt;text-align:=
center;
tab-stops:28.35pt center 3.15in right 415.3pt 446.55pt'><!--[if supportFiel=
ds]><span
lang=3DEN-GB><span style=3D'mso-element:field-begin'></span><span
style=3D'mso-spacerun:yes'></span>EQ </span><![endif]--><!--[if supportFie=
lds]><span
lang=3DEN-GB><span style=3D'mso-element:field-end'></span></span><![endif]-=
-><!--[if supportFields]><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'><span
style=3D'mso-element:field-begin'></span>PAGE<span style=3D'mso-spacerun:ye=
s'>
</span><span style=3D'mso-element:field-separator'></span></span></span><![=
endif]--><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'>15</span></span><!--[if supportFields]><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'><span
style=3D'mso-element:field-end'></span></span></span><![endif]--></p>

</div>

<div style=3D'mso-element:footer' id=3Dff1>

<p class=3DMsoFooter align=3Dcenter style=3D'margin-right:4.8pt;text-align:=
center;
tab-stops:28.35pt center 3.15in right 415.3pt 446.55pt'><!--[if supportFiel=
ds]><span
lang=3DEN-GB><span style=3D'mso-element:field-begin'></span><span
style=3D'mso-spacerun:yes'></span>EQ </span><![endif]--><!--[if supportFie=
lds]><span
lang=3DEN-GB><span style=3D'mso-element:field-end'></span></span><![endif]-=
-><!--[if supportFields]><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'><span
style=3D'mso-element:field-begin'></span>PAGE<span style=3D'mso-spacerun:ye=
s'>
</span><span style=3D'mso-element:field-separator'></span></span></span><![=
endif]--><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'>1</span></span><!--[if supportFields]><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'><span
style=3D'mso-element:field-end'></span></span></span><![endif]--></p>

</div>

</body>

</html>

------=_NextPart_01D75BBF.AB96D8F0
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/filelist.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml; charset="utf-8"

<xml xmlns:o=3D"urn:schemas-microsoft-com:office:office">
 <o:MainFile HRef=3D"../Ovaleap_clean.htm"/>
 <o:File HRef=3D"item0001.xml"/>
 <o:File HRef=3D"props002.xml"/>
 <o:File HRef=3D"item0003.xml"/>
 <o:File HRef=3D"props004.xml"/>
 <o:File HRef=3D"item0005.xml"/>
 <o:File HRef=3D"props006.xml"/>
 <o:File HRef=3D"themedata.thmx"/>
 <o:File HRef=3D"colorschememapping.xml"/>
 <o:File HRef=3D"header.htm"/>
 <o:File HRef=3D"filelist.xml"/>
</xml>
------=_NextPart_01D75BBF.AB96D8F0--
